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Salmonella (S.) is a zoonotic pathogen which prevalence in the food chain supposes a 
considerable impact on public health. After campylobacteriosis (246,571 confirmed cases in 
2018), salmonellosis remains the second most commonly reported gastrointestinal infection 
in humans in Europe (91,857 confirmed cases in 2018) (EFSA 2019a). Non-typhoidal 
salmonellosis occurs worldwide and is acquired through direct or indirect contact between 
humans and animals. Consumption of insufficiently cooked food that may carry Salmonella 
enterica (S. enterica) increases the risk of infection. The disease is mainly characterized by 
gastroenteritis, but its severity can vary from mild symptoms (self-limiting diarrhea) to invasive 
life-threatening extra-intestinal infection. Salmonellosis enteric disease is caused by a great 
variety of non-typhoidal Salmonella (NTS) serovars. From 2011 until 2016, the most-reported 
NTS serovars responsible for human cases were S. enterica serovar (S.) Enteritidis, S. 
Typhimurium (including monophasic S. Typhimurium), and S. Infantis (EFSA 2019a). Due to its 
relevance in public health, these serovars are considered as target serovars in the context of 
poultry production and National Control Programmes in poultry (e.g. Regulation (EC) No. 
2160/2003) aimed at reducing its prevalence. Despite a decreasing trend in the prevalence of 
the target serovars observed during 2007-2018, S. Infantis became the most dominant serovar 
of all the serovars reported from broilers (36.5%) and broiler meat (56.7%) in 2018 (EFSA 
2019a, b). The most frequent sources of contamination are broiler meat and derivate products 
but it is also found in pork and beef (RAJIC et al. 2005, LINDQVIST et al. 2007, EFSA 2019a).  
In Germany, a total of 13,693 Salmonella human cases were reported in 2019 at the same level 
as previous years (13,592 in 2018) according to the Robert-Koch-Institut (RKI) (RKI 2019, 2020). 
The most-reported serovars were S. Enteritidis and S. Typhimurium of all reported 
salmonellosis infections in 2019 and, the consumption of contaminated raw eggs, pork, and 
derivate meat products were the most common sources (RKI 2020). However, compared with 
previous years, no changes in prevalence (less than 1%) of both serovars were observed (BfR 
2020). In Germany, S. Infantis is mainly detected in broiler meat (37.6%), but also in pork 
(2.6%) (BfR 2020). In 2018 and unlike previous years, the European Food Safety Authority 
(EFSA) and the European Centre for Disease Prevention and Control (ECDC) detected in Europe 
an increased level of multidrug-resistant (MDR) S. Infantis isolates recovered from broilers 




consisted of resistance to ciprofloxacin, nalidixic acid, sulfamethoxazole, and tetracycline. 
However, variations of this MDR profile, including extended-spectrum beta-lactamase (ESBL)-
producing and colistin-resistant S. Infantis were identified in broilers as well (FRANCO et al. 
2015, CARFORA et al. 2018, EFSA 2020). Over the last 10 years, several European (EU) and non-
EU countries revealed evidence of the rapid dissemination and clonal emergence of the MDR 
S. Infantis population (EFSA 2019a). The use of Whole-Genome-Sequencing (WGS) and 
bioinformatics tools in public-health laboratories' routine practice have enabled a prompt 
publication of studies on this topic. The most recent, include the report of the complete gap-
free sequenced genome of the emergent “S. Infantis 119944” strain isolated in Israel, and 
comparative detailed genome analysis of the MDR S. Infantis clones and their plasmids 
emerged over the world (GYMOESE et al. 2019, ALBA et al. 2020, COHEN et al. 2020).  
This Doctoral Thesis aimed to identify the potential genetic causes for the increased 
emergence of S. Infantis in German broiler production. For this purpose, first, we conducted a 
primer implementation, application, and evaluation of the performance of an in-house 
bioinformatics pipeline named WGSBAC for Salmonella in silico serotyping. Second, we apply 
the WGSBAC pipeline to characterize and compare S. Infantis strains collected during a 20-
year distant period (from the 1990s to the 2010s) in different German broiler farms. 
Furthermore, we performed a genome comparison analysis between German S. Infantis and 
European S. Infantis genomes from public databases to study possible clonal relatedness. This 
study gives evidence of the occurrence and spread within two decades of an emergent MDR 
and virulent S. Infantis population of ST2283 in the German broiler production chain. The 
acquisition of a megaplasmid encoding resistance, virulence-associated determinants, and 
fitness mechanisms may explain this quick and worrying epidemiological event. The use of 
WGS and the application of a bioinformatics pipeline have been an effective approach in the 
production of accurate and reliable results for Salmonella serovar prediction and the 
characterization of S. Infantis German strains including the comparison with other S. Infantis 







2. LITERATURE OVERVIEW 
2.1. The genus Salmonella and its epidemiological role as a foodborne pathogen 
Salmonella is one of the most well-studied microorganisms and since its discovery in 1885 by 
the veterinarian surgeon Daniel Elmer Salmon and the pathologist Theobald Smith, it has 
taken the attention of many researchers (SALMON et al. 1886). The reason for this concern is 
its significant role as a foodborne pathogen. With approximately 153 million cases worldwide 
and 91,857 confirmed cases in Europe in 2018, it is the second most reported burden of 
foodborne disease after Campylobacter (246 571 cases in 2018) (EFSA 2019a).  
The genus Salmonella is a gram-negative rod-shaped no spore-forming bacteria that is 
generally motile through multiple flagella, and that belongs to the family Enterobacteriaceae 
(GILL et al. 2018). The genus Salmonella consists of two species: Salmonella bongori and 
Salmonella enterica. Salmonella enterica (S. enterica) is further subdivided into six subspecies: 
enterica (I), salamae (II), arizonae (IIIa), diarizonae (IIIb), houtenae (IV), and indica (VI). S. 
enterica subspecies enterica accounts for approximately 99% of all clinical isolates from 
humans and warm-blooded animals (ACHTMAN et al. 2012). Depending on the disease 
syndrome, it is divided into two groups: Typhoidal Salmonella (invasive extra-intestinal 
infection characterized by high fever) and Non-Typhoidal Salmonella (mainly self-limiting 
gastroenteritis). Serological assays based on agglutination are used to make a further 
differentiation of S. enterica into serovars (GRIMONT et al. 2007, ACHTMAN et al. 2012). To 
date, more than 2,579 Salmonella serovars have been recognized and can be classified based 
on their host range into host-adapted, and non-host-adapted serovars (UZZAU et al. 2000). 
Host-adapted serovars that are associated almost exclusively with one host species (e.g. 
Paratyphi and Typhi for humans; Abortus equi for equine or Gallinarum for poultry) are 
referred as host-restricted serovars. Meanwhile, there are host-adapted serovars that are 
mainly associated with one species but may result in disease in others (e.g. Dublin for cattle 
but able to infect small ruminants, pigs, and humans or Choleraesuis for swine but can cause 
diseases in humans). The animals infected by these serovars manifest a carrier state (reservoir) 
as they excrete the pathogen without any clinical signs of infection (UZZAU et al. 2000). 
Meanwhile, although rare, the infection in humans deals with severe systemic disease and 
high mortality. On the other hand, non-adapted serovars such as S. Typhimurium and S. 




associated with gastro-intestinal symptoms dealing with high morbidity but low mortality 
(UZZAU et al. 2000). S. Typhimurium and S. Enteritidis are included within the group of NTS 
serovars and cause non-typhoidal salmonellosis which clinical picture should not be confused 
with the invasive disease caused by serovar Typhi and serovars Paratyphi A, Paratyphi, 
Paratyphi C, and Sendai (CHENG et al. 2019). Most of the infections occurs due to direct 
contact by the consumption of contaminated food containing raw eggs or undercooked meat. 
Fresh products and already-to-eat food (lettuce, sprouts, etc...) are wining importance. 
Indirect transmission of the pathogen may occur between humans and infected animals or 
their environments (RABSCH et al. 2013).  
During the last years, non-adapted Salmonella serovars have been reported by international 
authorities such as the European Food Safety Authority (EFSA) and the European Centre for 
Disease Prevention and Control (ECDC) as causative agents of multi-country foodborne 
outbreaks (FBOs). S. Enteritidis was implicated in the majority of the FBOs through the 
consumption of contaminated eggs, egg products, bakery products, and mixed food (EFSA 
2019a). Currently, the investigation of a FBO of S. Enteritidis linked to eggs and affecting 18 
EU countries including Germany is ongoing and 656 cases have been confirmed. However, the 
source of contamination is not yet identified (ECDC-EFSA 2017, 2020a). Other serovars such 
as S. Typhimurium and S. Anatum were responsible recently for an FBO linked to the 
consumption of Brazil nuts (ECDC-EFSA 2020b). Additionaly, serovar Agona or serovar Poona 
were associated with FBOs linked to contaminated food matrixes such as infant formulas or 
ready-to-eat food (ECDC-EFSA 2018a, 2018b, 2019). According to the German Federal Office 
of Consumer Protection and Food Safety, in Germany, a total of 13,592 cases of salmonellosis 
were reported in 2018 (BVL 2019). Salmonellosis outbreaks investigated in Germany are large, 
regional, and have long been associated with serovars S. Enteritidis and S. Typhimurium in 
agreement with the situation in the EU (EFSA 2019a, UELZE et al. 2021). S. Enteritidis linked to 
eggs or egg-related products is responsible for the largest outbreaks (more than 300 cases), 
however smaller outbreaks associated with pasta, potato salads with mayonnaise, and bakery 
products have occurred as well during the last years (RKI 2019). On the other hand, S. 
Typhimurium is responsible for outbreaks with less number of cases (less than 100 cases) and 
is mostly linked with pork products (UELZE et al. 2021). S. Derby has been as well associated 
with the largest FBOs related to the consumption of pork products, like the one that occurred 




with a variety of food sources were reported in 2017. Among them S. Kottbus and S. Agona 
were responsible and smoked ham, quail egg, milk products were associated (UELZE et al. 
2021). 
2.2. Most prevalent Salmonella enterica serovars in poultry production 
In the context of poultry production, infections by the host-adapted serovar S. Gallinarum 
were of paramount importance at the beginning of intensive poultry production (the 1920s) 
(METHNER 2013). However, from the 1940s and onwards the ubiquitous S. Typhimurium rise 
in frequency and remained between 1950 and 1985 as a frequent serovar not only in poultry 
but also in beef, dairy products, and pork. During the mid-1980s and onwards, a sudden 
epidemiological change happened when S. Enteritidis rapidly increased in a very short time in 
animals and humans in numerous countries including Germany promoting a pandemic 
situation (METHNER 2013). During approximately ten years, S. Enteritidis was the most 
dominant serovar in laying hens and the cause of a global pandemic. The cause of the sudden 
S. Enteritidis increase remains unknown and is likely that more than one factor was implicated. 
Several hypotheses point out the role of mice as a reservoir in the poultry flocks and the lack 
of effective hygiene measures (HENZLER et al. 1992, WARD et al. 2000). The rapid spread was 
promoted by the consumption of eggs and other poultry products contaminated via vertical 
transmission from breeders through all the poultry chain (METHNER 2013). The urgent need 
for the establishment of control measures and high hygiene standards encouraged the 
development and application in EU state members of the Directive 2003/99/EC of the 17 
November 2003 and the Regulation (EC) No 2160/2003 of 17 November 2003 (PARLIAMENT 
et al. 2003a, 2003b). 
The Regulation (EC) No 2160/2003 of the European Parliament and of the Council of 17 
November 2003 on the control of Salmonella and other specified food-borne zoonotic agents, 
aim to ensure the proper and effective measures to detect and control Salmonella to reduce 
their prevalence and the risk to public health (PARLIAMENT et al. 2003b). Furthermore, the 
Directive 2003/99/EC of the European Parliament and of the Council of 17 November 2003 on 
the monitoring of zoonoses and zoonotic agents, amending Council Decision 90/424/EEC and 
repealing Council Directive 92/117/EEC, regulates the monitoring of zoonoses and food-borne 
outbreaks caused by zoonotic agents (PARLIAMENT et al. 2003a). As a result of the Directive, 




20% to 2.7% in Germany and 3.5% in Europe in 2008 and reached in 2018 a very low 
prevalence of less than 1-2%. 
In Germany, most of the recent human Salmonella infections are associated with S. Enteritidis 
(45%), S. Typhimurium (33%) followed far behind by S. Infantis (2.7%), and S. Derby (1.5%) (RKI 
2019, 2020). In 2018, S. Typhimurium was the most prevalent serovar in cattle followed by the 
host-adapted S. Dublin and S. Enteritidis (METHNER. 2019). In pigs, S. Typhimurium was the 
most prevalent serovar in fattening pigs but second in sows were S. Derby was the dominant 
serovar (UELZE et al. 2021). Regarding poultry, Salmonella is monitored and controlled by the 
“Geflügel-Salmonellen-Verordnung (lfSalmoV)” as an implementation of the Regulation (EC) 
No 2160/2003 aiming at reducing the prevalence of Salmonella serovars with public health 
significance in breeding flocks, laying hens, broilers and turkeys (BUNDESMINISTERIUM 2014). 
During the S. Enteritidis pandemic, the proportion of S. Typhimurium in humans decreased to 
20% in contrast to the proportion of S. Enteritidis that increased from approx. 5% to over 40% 
and that reach a prevalence of 75% in 1992. However, in 2019 and according to the German 
National Salmonella Control program  the prevalence of target serovars (S. Enteritidis and S. 
Typhimurium, including monophasic S. Typhimurium) was for all types of poultry (breeding 
flocks, broilers and fattening turkeys, laying hens and breeding turkeys) below the target value 
of 2 % (BfR 2020). The dominating serovars in broilers were S. Infantis (23.1%), S. Paratyphi B 
d-tartrate-fermenting (dT+) (17.3%), and S. Enteritidis (15.4%) (BVL 2018, 2019).  
Despite a general decreasing trend of the target serovars of Salmonella in flocks due to the 
application of International and National Control Programs, the rapid emergence and 
widespread of multi-drug resistance S. Infantis population is concerning EU and non-EU 
countries (EFSA 2019a). Studies covering this topic have been published in Japan by ASAI et al. 
(2007), Hungary by NÓGRÁDY et al. (2007), Israel by GAL-MOR et al. (2010), Italy by FRANCO 
et al. (2015), CARFORA et al. (2018), and ALBA et al. (2020), Switzerland by HINDERMANN et 
al. (2017), Slovenia by PATE et al. (2019), Russia by BOGOMAZOVA et al. (2019), Turkey by 
ACAR et al. (2019), Peru by VALLEJOS-SANCHEZ et al. (2019), Ecuador by VINUEZA-BURGOS et 
al. (2019), Serbia by JOVCIC et al. (2020), the United States by TYSON et al. (2020), and Chile 





2.3. Salmonella enterica subspecies enterica serovar Infantis: a significant serovar in 
poultry production 
Salmonella enterica subspecies enterica serovar Infantis (S. Infantis) belongs to the group of 
non-host-adapted Salmonella serovars that cause NTS. It occupies since 2016 the fourth in the 
list of most common serovars detected in humans in the EU after S. Enteritidis, S. 
Typhimurium, and monophasic S. Typhimurium (EFSA 2019b). Although S. Infantis is prevalent 
in pigs and cattle, broiler and broiler meat have been regularly identified as the most 
important sources for human infection (RAJIC et al. 2005, LINDQVIST et al. 2007, EFSA 2019a, 
EFSA 2020). During 2018, it was the dominant serovar reported in fowl accounting for 36.7% 
of all serotyped isolates, and unlike in previous years, S. Infantis was massively reported from 
broilers (36.5%) and broiler meat (56.7%)(EFSA 2019a). Studies performed by EFSA and the 
ECDC in 2018, detected an increased level of resistance over time in the EU. A multi-drug 
resistant (MDR) pattern consisting of resistance only to ciprofloxacin, nalidixic acid, 
sulfamethoxazole, and tetracycline was found among the multiresistant S. Infantis isolates 
recovered from broiler (60.3%) and broiler meat (74.2%) (EFSA 2020). Regarding 
fluoroquinolones (i.e. ciprofloxacin and nalidixic acid) it was detected in S. Infantis isolates 
recovered from broilers, fattening turkeys, and poultry meat (EFSA 2020). Besides, tigecycline-
resistant S. Infantis accounted for 85.2% and 88.2% isolates from broiler and their carcasses 
(broiler meat). Meanwhile, resistance to colistin among Salmonella isolates recovered from 
broilers was more common in S. Enteritidis isolates (63.2%). Extended-spectrum beta-
lactamase (ESBL)-producing Salmonella were identified in several serovars (including Infantis) 
from broilers more often than AmpC-producing Salmonella. Two European countries Italy and 
Hungary reported S. Infantis isolates with both ESBL and AmpC resistant phenotypes (FRANCO 
et al. 2015, SZMOLKA et al. 2018, EFSA 2020).  
In Germany, S. Infantis is after S. Enteritidis and S. Typhimurium (including S. Typhimurium 
monophasic variant) the most common serovar involved in human salmonellosis reflecting the 
situation in the EU. In 2016 S. Infantis was by far the most reported serovar in chicken meat 
(61%) (BVL 2019). Regarding antimicrobial resistance, the percentage of sensitive isolates 
recovered from turkey meat (35.9%) and chicken meat (28.6%) were smaller in contrast to the 
percentage of sensitive isolates from pigs (52%). None of the isolates were resistant to 3rd 




However, resistance to ciprofloxacin which is of particular importance as a treatment in 
humans was very common in broiler meat (62.3%). This confirms the results of previous 
investigations that reported significantly higher resistance rates in isolates from poultry 
compared with cattle and pigs (BVL 2019). It also reflects the more frequent use of this class 
of substances in poultry compared to cattle and pigs. 
2.3.1. The detection and characterization of a conjugative megaplasmid (pESI) among the 
multidrug resistant emergent S. Infantis population 
Israel published the first comparative analysis between non-emergent and emergent S. 
Infantis clones (AVIV et al. 2014). They studied in vitro the features of a conjugative 
megaplasmid named pESI (plasmid of Emerging S. Infantis) harbored by the Israeli emergent 
S. Infantis (ESI) clones. Compared with the parental plasmidless S. Infantis strains, the 
presence of the pESI plasmid contributed significantly to the antimicrobial resistance and high 
pathogenicity of the clones. Moreover, they proposed that the possession of this unique 
virulence-resistance pESI might promote the rapid spread of the MDR clones and potential 
replacement of the parental S. Infantis population (AVIV et al. 2014). Recently, the complete 
gap-free genome sequence of the Israeli emergent S. Infantis strain 119944 has been 
published by COHEN et al. (2020), and the genetic composition of its chromosome and pESI 
plasmid have been elucidated in detail improving the knowledge of its genetic composition. 
The genome of S. Infantis 119944 is composed of one chromosome of 4,725,957 bp and a 
258,081 bp megaplasmid (pESI). The chromosome possesses ten known Salmonella 
pathogenicity islands (SPIs) (SPIs1-6, SPI-9, SPI-11, SPI-12, and CS54) and five chromosomal 
bacteriophages (COHEN et al. 2020). The pESI sequence revealed a megaplasmid of modular 
structure, incorporating different mobile genetic elements (MGEs) such as insertion sequence 
elements, transposases, and hypothetical proteins. Moreover, pESI is integrated by a 
conserved backbone comprising AMR, metal-resistance, and virulence-associated factors. 
These determinants define the MDR profile, enhance the pathogenicity, and contribute to the 
bacterial fitness of the ESI clones. Among the resistance factors, pESI contains genes mediating 
AMR to tetracyclines (tetA), sulfonamide (sul1), and trimethoprim resistance (dfrA). It also 
contains genes conferring resistance to quaternary ammonium compounds (QACs) 
(qacEdelta1) and tolerance to toxic compounds including mercury, due to the mercury operon 




yersiniabactin-iron system operon, the Klf (K88-like fimbria), and the Ipf (Infantis plasmid-
encoded fimbria) chaperon-usher fimbriae as previously described (AVIV et al. 2017). 
Furthermore, this virulence-resistance plasmid also carries different sets of toxin/antitoxin 
systems (e.g. CcdA/B, PemK/I, MazE/F, and VagCD) (COHEN et al. 2020).  
The use of WGS and the accuracy of sophisticated bioinformatics tools have recently enabled 
the occurrence of detailed comparative genome analyses between ESI clones from distant 
locations (GYMOESE et al. 2019). Independently of the origin of the strains, a conserved 
chromosomal structure in contrast to the variable nature of the pESI has been described by 
COHEN et al. (2020). This variability may be the reason for the high genetic variation and 
phenotypic diversity existing among the different emergent MDR S. Infantis clones and their 
corresponding plasmids (pESI-like plasmids) (BOGOMAZOVA et al. 2019, ALBA et al. 2020, 
COHEN et al. 2020). Recent comparative genome analysis of the whole-, core- and accessory 
genomes of several S. Infantis strains and a variety of non-Infantis serovar strains revealed the 
high diversity within the accessory genome of S. Infantis. This finding suggests that the 
contribution to the rapid evolution of the ESI clones is more likely to be due to the variability 
in the accessory compared to the conserved chromosome (NAGY et al. 2020). Furthermore, 
ALBA et al. (2020) considered the pESI-like plasmids within ESI isolates in Europe as parasitic 
megaplasmids due to - in the words of the authors - their role to spread and “infect” different 
clonal lineages observed in Europe (ALBA et al. 2020). 
2.3.2. The ongoing emergence and wide dissemination of the multidrug resistant S. 
Infantis population 
In parallel with the rise of the incidence and rapid dissemination of MDR S. Infantis clones in 
broiler populations, over the last decade, several studies worldwide have been published to 
give evidence of this urgent public health concern. By the end of the 2000s, results of 
NÓGRÁDY et al. (2007) and NÓGRÁDY et al. (2008) showed the first evidence of the 
emergence, prevalence, and potential spread of MDR S. Infantis clones in broiler production 
in Hungary. Later, using phage typing and Pulsed-Field Gel Electrophoresis (PFGE) typing they 
observed closely related MDR clones in neighboring EU countries such as Germany, Italy, the 
United Kingdom, Poland, and Austria as well as in further non-EU countries as Japan and Israel 
(NÓGRÁDY et al. 2012). Years later and based on these previous investigations, other 




genomes isolated from different sources (humans and broilers) during different decades to 
understand the rise, spread, and evolution of the Hungarian ESI clones (OLASZ et al. 2015, 
WILK et al. 2016, 2017). By this time, a Japanese group performed a phylogenetic and network 
analysis of S. Infantis strains from chicken meat, eggshells, environment, and human patients 
with and without symptoms (YOKOYAMA et al. 2014). They distinguished an evolutionary 
separation of the S. Infantis population in five genetic clusters, and in a further study 
YOKOYAMA et al. (2015) differentiated within the genetic clusters a novel subpopulation of 
strains carrying a megaplasmid with clear homology to the pESI plasmid recently reported in 
Israel (AVIV et al. 2014).  
Meanwhile, FRANCO et al. (2015) proposed 2011 as the starting time point for the emergence 
of the MDR S. Infantis clones in Italy and detected among all (n=49) the isolates studied 
between 2011 and 2014 the presence of a conjugative plasmid of around 280-320Kb in size 
analogous to the Israeli pESI. However, the pESI-like plasmid from the Italian ESI strains carried 
the gene blaCTX-M-1 leading to resistance to beta-lactamases (cephalosporin). The detection and 
characterization of the mcr-1 gene mediating resistance to colistin among one ESI ESBL-
positive clone completed the resistance profile of ESI in Italy (CARFORA et al. 2018).  
Besides, in 2017, a study in Hungary revealed more details about the molecular epidemiology 
of the pESI-like plasmid found in the endemic S. Infantis strains from Hungary, and they 
detected as well genes for ESBL resistance (blaTEM-1) and qnrS for fluoroquinolone resistance 
(SZMOLKA et al. 2018). Moreover, they discussed the possibility of a switch in the 
epidemiology of S. Infantis isolates in poultry around the 1990s and the early 2000s. The same 
year, in Switzerland HINDERMANN et al. (2017) observed the occurrence of one ESBL-
producing S. Infantis clone harboring the gene blaCTX-M-65 rarely described within the European 
poultry industry. By this year, TATE et al. (2017) reported the existence of pESI-like positive S. 
Infantis in the United States for the first time. The analysis revealed the presence of the gene 
blaCTX-M-65 among ESI clones reflecting the similarities to the Italian ESI clones. One year before, 
an outbreak in Ecuador as well revealed the presence of the blaCTX-M-65 gene within S. Infantis 
strains, and in 2019 colleagues from Peru showed useful information to understand the 
spreading situation of the serovar in Peru (CARTELLE GESTAL et al. 2016, VALLEJOS-SANCHEZ 




More recently, colleagues performed a study in Slovenia in several farms with a focus on the 
virulence profile of the ESI clones to give insights into the mechanisms involved in the 
persistence of specific clones (PATE et al. 2019). They tested the biofilm-forming capacity of 
the MDR S. Infantis clones and concluded that the rapid dissemination of ESI clones in broiler 
production might be more related to the ineffective biosafety measures and disinfection 
practices than to its capacity to form biofilms. The implementation of WGS and bioinformatics 
pipelines in the routine practice of microbiology laboratories allowed the easy collection from 
public databases of complete sequenced genomes and the performance of comparative WGS-
based international studies. GYMOESE et al. (2019) analyzed a collection of strains from 
different decades, sources, and locations providing more insights into the genetic composition 
and the global population structure of S. Infantis. They revealed the polyphyletic nature of the 
serovar Infantis and elucidated several lineages into the serovar population in which 
prophages might play an important role in the evolution of the serovar. The same year, a 
comparative meta-analysis performed in Russia using complete pESI-like sequences from S. 
Infantis isolates from Israel, Japan, Europe, the United States, and South America, provided 
detailed information about the conservative and variable components of pESI-like plasmids 
(BOGOMAZOVA et al. 2019). They detected chromosomal mutations in the gen gyrA (gyrA-
S83Y and gyrA-D87Y) leading to resistance to fluoroquinolones and they propose that the 
presence of a conserved sequence of around 173 Kb, could have a major contribution to the 
global spread of the pESI- like plasmids. At the same time, a study in Turkey performed a single 
nucleotide polymorphism (SNP)-based phylogenetic analysis comparing strains from European 
and non-European countries revealing differences and similarities within the ESI clones (ACAR 
et al. 2019). Among the similarities, they observed similar AMR and virulence profiles among 
the Italian, Hungarian, and American strains. Interestingly, they found for the first time the 
ESBL-genes blaTEM-70, blaTEM-148, and blaTEM-198 within Turkish ESI strains.  
The latest studies on this topic have provided insights into the epidemiology of ESI populations 
focussing as well on the emergence of new AMR patterns ESBL and colistin. ALBA et al. (2020) 
used a chromosome and plasmid-based genotyping approach to elucidate the S. Infantis 
population in Europe confirming the heterogenicity of this serovar. Furthermore, they 
compared two variants of the pESI-like plasmids in terms of possession of blaCTX-M-1 gene (the 
European isolates) or blaCTX-M-65 gene (American isolates) thus updating the knowledge about 




determined to study the diffusion of ESI ESBL-positive in broiler meat production (PROIETTI et 
al. 2020). Meanwhile, JOVCIC et al. (2020) have focussed their research on the study of colistin-
resistant S. Infantis. They observed reduced susceptibility to colistin in the majority of isolates 
and they reported for the first time in an S. Infantis isolate the detection of gene fosA7 for 
resistance to fosfomycin and the gene vgaA for resistance to pleuromutilin.  
Finally, KUREKCI et al. (2021) has provided updated insights into the pESI-like megaplasmid 
circulating in Turkey using ultimate sequencing technologies and hybrid assembly of the 
isolates. Among the ESI strains studied, they identified for the first time a single novel 
sequence type (ST7091) and one ESI isolate carrying the blaCMY-2 gene mediating resistance to 
ceftazidime. In the United States, a very recent publication analyses the variation in gene 
content and the spread rate of a pESI-like plasmid carrying blaCTX-M-65 gene (MCMILLAN et al. 
2020).  
In less than 10 years, several investigations focussed on the widely disseminated MDR and 
virulent S. Infantis population in EU and non-EU poultry farms. These studies have benefited 
from the rise in parallel with the most sophisticated WGS and bioinformatics approaches. 
These approaches warrant detailed knowledge to explain the causes behind the emergence 
and spread of this serovar. 
2.4. Whole-genome sequencing and bioinformatics approaches in public health 
laboratories practice 
WGS and bioinformatics analysis have substantially improved molecular diagnostics and 
foodborne pathogens surveillance (JAGADEESAN et al. 2019, HERNÁNDEZ et al. 2020). The 
application of WGS in microbiology laboratories has evolved rapidly over the last 40 years 
(CARRICO et al. 2018, KUMAR et al. 2019). The first DNA sequencing method (“first-
generation” sequencing) was described in 1975 by Sanger and Coulson who elucidated the 
genome sequence of the bacteriophage φX174. The automated Sanger method deciphered 
the nucleotide sequences in single-stranded DNA using synthetic dideoxynucleosides and the 
enzyme DNA polymerase (SANGER et al. 1975). For almost 20 years, Sanger’s method 
dominated the industry and still has many applications in projects involving sequenced data 
(SLATKO et al. 2018). In 1995, the nucleotide sequence of the genome of the bacterium 
Haemophilus influenzae was completed  by FLEISCHMANN et al. (1995) due to the 




Sequencing (NGS). Four major leading NGS platforms can be mentioned. The platform 454 
Genome Sequencer based on pyrosequencing was the first released technology in 2005 by 
454 Life Sciences (now Roche) (MARGULIES et al. 2005). Only one year later, Solexa/Ilumina 
(now Illumina) sequencing platform appeared in the market and in 2007 applied Biosystems 
(now Life Technologies) released Sequencing by Oligo Ligation Detection (SOLiD). Later on, Ion 
Torrent technology (Ion Torrent Systems) appeared in 2011 using a novel approach based on 
a semiconductor chip that converts chemical information into sequencing information 
(SLATKO et al. 2018). NGS brought three major advances compared with Sanger sequencing. 
First, the need for a previous preparation of sequencing libraries, second, the performance of 
millions of sequencing reactions in parallel, and third, the ability to produce a faster large 
amount of data (VAN DIJK et al. 2014). The differences between them reside in the 
combination of strategies employed and the type of output generated (METZKER. 2010). Even 
though their numerous advantages, NGS platforms are not able to generate single molecules 
in real-time but relatively short reads (currently up to 300-500 bases). Therefore, under the 
names Third-Generation Sequencing (TGS) and Fourth-Generation Sequencing (FGS), real-
time single-molecule sequencing technologies appeared. Pacific Biosciences (PacBio) leads 
currently the commercialization of TGS technologies and is considered the gold standard for 
the generation of contiguous and highly accurate reference genomes. It enables the 
sequencing of a single very long molecule (up to 30-50 kb) in real-time. On the other hand, 
nanopore-based DNA sequencing is being developed and emerged as competitive technology. 
It consists on the use of transmembrane proteins to produce pores that detect the DNA 
nucleotides and measure its current differences. The dominant platform is the portable 
sequencer MinION developed by Oxford Nanopore Technologies (ONT) (JAIN et al. 2016, 
SLATKO et al. 2018). While Illumina is currently the leading NGS platform for short-read 
sequencing (reads of 100-300 bp), MinION promises to be the dominant platform for long-
read sequencing (reads from 10 to 50kb). To improve accuracy and compensate the drawbacks 
of short- and long-read sequencing approaches, PacBio or MinIOn assemblies are combined 
with Illumina data in so called “hybrid” assemblies. Besides, other novel technologies under 
development are currently being used in routine laboratory practice (e.g., in situ nucleic acid 
sequencing, microscopy-based sequencing and, whole mitochondrial genome sequencing) 




The applications of WGS and bioinformatics in public health laboratories provide detailed 
information of genetic treats of strains and samples (e.g., detection of antimicrobial resistance 
genes or virulence determinants, and the identification of plasmid replicons) (HENDRIKSEN et 
al. 2019, CARATTOLI et al. 2020), and the quick detection and tracking of outbreaks (e.g., 
serotyping, core-genome Multi Locus Sequence Typing (cgMLST), whole-genome Single 
Nucleotide Polymorphism (wgSNP) typing, phylogenetic analysis and, pangenome 
comparisons) (PETZOLD et al. 2017, QUAINOO et al. 2017). The possibilities are as wide as the 
informatics capabilities of the researcher and the computational resources of the laboratories. 
The definitions of the most used terms in a bioinformatics analysis are shown in Table 1. 
In the case of Salmonella, research institutions as the Public Health England (PHE), the Sanger 
Institut, the Food and Drug Administration (FDA) ) and the Centers for Disease Control and 
Prevention (CDC) with the global laboratory network PulseNet have been implementing WGS 
as the routine typing tool for Salmonella infections surveillance (WONG et al. 2016, RIBOT et 
al. 2016, ASHTON et al. 2016, NADON et al. 2017, WALDRAM et al. 2018, FELDGARDEN et al. 
2019). Besides, under the name 10KSG (10000 Salmonella Genomes) consortium project, S. 
enterica data is being retrieved worldwide to understand the epidemiology, transmission, and 
virulence of NTS (ACHTMAN et al. 2020). The amount of data retrieved is accessible and freely 
available in public datasets. Currently, the number of publicly available Salmonella sequenced 
data is close to 300,000 genomes and is stored by the European Nucleotide Archive (ENA), the 
Sequence Read Archive (SRA), and Enterobase (ALIKHAN et al. 2018, ZHOU et al. 2020, PEREZ-
SEPULVEDA et al. 2020) which comprises itself more than 287,101 Salmonella strains (in 
February 2021). However, the complete standardization of WGS in the food industry or 
veterinary and public health laboratories is far to be completely implemented. Furthermore, 
there are still limitations in terms of computing capacity and a lack of standard models for 
routine analysis that need to be considered (ECDC 2016). 
Table 1. Definition of most used terms and parameters of a bioinformatics analysis (extracted 
from the ISO standard Microbiology of the food chain — Whole-genome sequencing for typing 
and genomic characterization of foodborne bacteria — General requirements and guidance 






The process of identifying genes and other features on genome 
assemblies 
Assembly 
The output from the process of aligning and merging sequencing reads 
into larger contiguous sequences (contigs) 
Base-calling 
The process of assigning nucleotides and quality scores to positions in 
sequencing reads 
Contig 
A contiguous stretch of DNA sequence that results from the assembly of 
smaller, overlapping DNA sequence reads 
de novo 
assembly 
The process where the reads are assembled without the assistance of a 
reference genome as a template 
Coverage The average number of times each base in a genome is sequenced 




The method of genomic analysis in which nucleotide variants within 
predefined sets of loci, either core genome loci for cgMLST or whole-
genome loci for wgMLST, are identified. For MLST analyses, reads are 
assembled or mapped. Target loci are identified, quality-filtered, and 
compared to a curated cgMLST or wgMLST database. 
Sequencing 
library 
The collection of genomic DNA fragments from a single isolate intended 
for determining genome sequence 
N50 
A measure to describe the quality of assembled genomes that are 
fragmented in contigs of different lengths. The N50 is defined as the 
minimum contig length needed to cover 50% of the genome. It means 
half of the genome sequence is in contigs larger than or equal to the 
N50 contig size. 
Q30 
A Phred-score of Q30 indicates that there is a 1 in 1000 chance that a 
base is incorrectly assigned (i.e. the base call is 99.9% accurate) 
Pipeline 
The software that combines other software to transfer data from file 
type A (e.g. raw sequencing data) via several steps to file type X (e.g. a 
phylogenetic tree) 






The process comprising the mapping of reads against a reference 
genome sequence and the study of the detected significant differences 
between mapped reads and the reference (SNP-calling). As an 
alternative, reads can also be assembled into contigs, and contigs from 
each sample can be aligned to each other to identify SNPs. Potential 
SNPs are quality-filtered to identify SNP positions. Those SNPs present 
within the conserved portion among all genomes are called cgSNPs. The 
matrix of the number of SNPs or cgSNPs differences between samples is 
used to create a phylogenetic tree. 




2.4.1. Implementation and evaluation of a bioinformatics pipeline for the analysis of   
Salmonella spp. sequenced data  
WGS has become the method of choice for the characterization and subtyping assays of 
Salmonella spp. and the list of bioinformatics tools and sophisticated pipelines is growing to 
simplify the automatic processing of sequenced data (CARRICO et al. 2018, TANG et al. 2019, 
BANERJI et al. 2020). 
The last version of the in-house bioinformatics pipeline WGSBAC (v. 2.1.0) developed by the 
bioinformatics group at the Institute of Bacterial Infections and Zoonoses (IBIZ) is a public 
resource available online in https://gitlab.com/FLI_Bioinfo/WGSBAC. It is Linux-based and 
contains several modules including modified computer scripts, R language scripts, and public 
databases (Figure 1). 
The pipeline WGSBAC takes as input raw short-reads (from Illumina) as well as already 
assembled data from own sequenced genomes (from Illumina or long-reads from MinION) or 
collected from public databases. The pipeline WGSBAC workflow is built based on several 
steps that any complete basic bioinformatics analysis should comprise: i) quality assessment 
and control of the sequenced data generated, ii) assembly and quality control of the 
assemblies iii) annotation, subtyping (sometimes including genoserotyping), detection of 
resistance genes, virulence genes and plasmid replicons, etc ... 
When using WGSBAC to analyze genomic data, the first step, quality assessment and quality 
control (QA and QC) is performed by the software FASTQC (v. 0.11.7), that offers several 
statistics to provide an overview evaluation of the quality of the raw reads (ANDREWS 2018). 
WGSBAC uses as well an adapted script to calculate the theoretical coverage that can be 
defined as LN/G, where L is the read length, N is the number of reads and G is the haploid 
genome length (SIMS et al. 2014). For contamination detection, WGSBAC uses the software 
Kraken2 (v. 2.0.7_beta) and the database Kraken2DB (https://benlangmead.github.io/aws-
indexes/k2) (WOOD et al. 2019). Kraken is a software for taxonomical classification of reads 
as well as assembled genomes and is used frequently in metagenomics projects.  
Once the quality of the reads has been accurately checked, the second step of the 
bioinformatics analysis starts with the assembly. WGSBAC uses Shovill (v. 1.0.4) which is itself 




perform the de novo assembly on Illumina paired-end reads (BANKEVICH et al. 2012). Later 
on, the quality of the assemblies is assessed by the software QUAST (v. 5.0.2) that considers 
parameters such as the number of contigs, its average length in the draft genome, the size of 
the assembled genome, and the statistic N50 value (GUREVICH et al. 2013, CARRICO et al. 
2018).  
The third step of WGSBAC analysis comprises a variety of tools that will be set depending on 
the specific goal of the researcher study and that will reveal the biological meaning behind the 
genomes sequenced.  Detection of AMR determinants and virulence factors is possible as well 
due to the screening of AMR or virulence genes as well as plasmid replicons identification. 
WGSBAC uses the tool ABRicate (v. 0.8.10) developed by SEEMANN (2015) and the databases 
ResFinder, the Comprehensive Antimicrobial Resistance Database (CARD), and NCBI  for AMR 
detection and Virulence Factor Database (VFDB) for virulence gene detection (ZANKARI et al. 
2012, FELDGARDEN et al. 2019, ALCOCK et al. 2020. PlasmidFinder is used to identify plasmid 
replicon genes and the tool AMRFinderPlus (v. 3.6.10) to complete the AMR genes screening 
with the detection of chromosomal point mutations dealing with resistance to antibiotics 
(FELDGARDEN et al. 2019, CARATTOLI et al. 2020). In the specific case of Salmonella genomes, 
WGSBAC includes three in silico serotyping tools that predict Salmonella serovars both on the 
reads and on the assemblies: SeqSero2 (v. 1.1.1) by ZHANG et al. (2019), and SISTR (v. 1.0.2) 
by YOSHIDA et al. (2016).  
Furthermore, complete genotyping of the genomes is performed using classical Multilocus 
Sequence Typing (MLST). The corresponding sequence types (STs) will be assessed using the 
mlst software (v. 2.16.1) developed by SEEMANN (2014a) that employs the pubMLST database 
(JOLLEY et al. 2018). Reference base-mapping of the reads to a reference sequence or 
database of reference sequences is performed by Snippy (v. 4.3.6) (SEEMANN 2014b). It 
generates a list of the identified nucleotide variants (e.g., SNPs, cgSNPs, or short 
insertions/deletions) between the query genomes and the reference genomes. The nucleotide 
variants (SNPs and cgSNPs) list and a matrix of cgSNPs differences between samples are used 
for cgSNPs-based phylogenetic reconstruction. Phylogeny trees will be constructed by 
FastTree (v. 2.1.10) and/or RaxML (v. 8.2.12) (PRICE et al. 2009, STAMATAKIS. 2014). To 
complete the phylogenetic reconstruction of the strains, the generation of phylogenomic 




Additionally, software such as parSNP (v. 1.2) for core genome multi-alignment and canSNPer 
(v. 1.0.8) for hierarchical genotyping  can be optionally set within the pipeline  (TREANGEN et 
al. 2014, LÄRKERYD et al. 2014). Identification of subpopulations within the genomes is 
possible as WGSBAC includes an R implementation of hierarchical clustering through the 
hierBAPS algorithm (TONKIN-HILL et al. 2018). Furthermore, WGSBAC uses Prokka (v. 1.14.5) 
by SEEMANN (2014b) to annotate the genomes revealing the location and biological role of 
the genetic features encrypted in the DNA sequence. Later, the software Roary (v. 3.13.0) 
developed by PAGE et al. (2015) works on annotated genomes, generates a multiple 
alignment, and together with a script called Scoary, performs a pan-genome association 
analysis useful to make the association between presence/absence of genes and genetic traits 
related. Pan-genome analysis is interesting for identifying the core and accessory genes and 
to understand the evolution of the genomes. 
Finally, to complement the bioinformatics analysis, external resources can be employed such 
as online tools with a user-friendly interface and curated public databases. For example, when 
using WGSBAC two software options are Ridom SeqSphere+ created by JUNEMANN et al. 
(2013) to infer phylogeny based on cgMLST and the web-based tool iTOL that helps in the 
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Multilocus Sequence Type 2283 in
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Institute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institute, Jena, Germany
During the last decade, Salmonella enterica subspecies enterica serovar Infantis
(S. Infantis) has become more prevalent across Europe with an increased capability
to persist in broiler farms. In this study, we aimed to identify potential genetic causes for
the increased emergence and longer persistence of S. Infantis in German poultry farms
by high-throughput-sequencing. Broiler derived S. Infantis strains from two decades,
the 1990s (n = 12) and the 2010s (n = 18), were examined phenotypically and
genotypically to detect potential differences responsible for increased prevalence and
persistence. S. Infantis organisms were characterized by serotyping and determining
antimicrobial susceptibility using the microdilution method. Genotypic characteristics
were analyzed by whole genome sequencing (WGS) to detect antimicrobial resistance
and virulence genes as well as plasmids. To detect possible clonal relatedness
within S. Infantis organisms, 17 accessible genomes from previous studies about
emergent S. Infantis were downloaded and analyzed using complete genome sequence
of SI119944 from Israel as reference. In contrast to the broiler derived antibiotic-
sensitive S. Infantis strains from the 1990s, the majority of strains from the 2010s
(15 out of 18) revealed a multidrug-resistance (MDR) phenotype that encodes for
at least three antimicrobials families: aminoglycosides [ant(3“)-Ia], sulfonamides (sul1),
and tetracyclines [tet(A)]. Moreover, these MDR strains carry a virulence gene pattern
missing in strains from the 1990s. It includes genes encoding for fimbriae clusters,
the yersiniabactin siderophore, mercury and disinfectants resistance and toxin/antitoxin
complexes. In depth genomic analysis confirmed that the 15 MDR strains from the
2010s carry a pESI-like megaplasmid with resistance and virulence gene patterns
detected in the emerged S. Infantis strain SI119944 from Israel and clones inside and
outside Europe. Genotyping analysis revealed two sequence types (STs) among the
resistant strains from the 2010s, ST2283 (n = 13) and ST32 (n = 2). The sensitive strains
from the 1990s, belong to sequence type ST32 (n = 10) and ST1032 (n = 2). Therefore,
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this study confirms the emergence of a MDR S. Infantis pESI-like clone of ST2283 in
German broiler farms with presumably high tendency of dissemination. Further studies
on the epidemiology and control of S. Infantis in broilers are needed to prevent the
transfer from poultry into the human food chain.
Keywords: Salmonella Infantis, broiler, emergence, multidrug resistance, pESI-like plasmid, whole genome
sequencing
INTRODUCTION
Salmonella enterica subspecies enterica serovar Infantis
(S. Infantis) belongs to the group of Salmonella serovars,
which plays a major epidemiological role in humans and animals.
In the European Union (EU), S. Infantis has been the third most
common serovar in humans since 2006 with a relative share
between 1% and 2% (EFSA, 2019). Although this serovar is
prevalent also in pigs and cattle (Rajic et al., 2005; Lindqvist and
Pelkonen, 2007), poultry especially broiler and their products
have been identified as one of the most important sources of
human infection with S. Infantis (EFSA, 2019, 2020). In 2018,
S. Infantis was the most frequently reported serovar in fowl in
the EU (EFSA, 2019), accounting for 36.7% of all Salmonella
isolates. Moreover, unlike previous years, S. Infantis was not only
detected in a few numbers of countries but widespread among
most member states and massively reported from broilers (36.5%
of all serotyped isolates) and broiler meat (56.7%).
During the last years, antimicrobial resistance has emerged in
S. Infantis organisms from different animal sources and humans
in various European countries (Nógrády et al., 2012; EFSA, 2020).
Increasing incidence and dissemination of different multidrug-
resistant (MDR) S. Infantis clones in broiler populations resulted
in spreading of the organisms in the food chain and via poultry
products to humans in countries such as Hungary (Olasz et al.,
2015), Italy (Franco et al., 2015), Switzerland (Hindermann et al.,
2017), Slovenia (Pate et al., 2019), and Russia (Bogomazova
et al., 2019). Furthermore, observations are indicating a long
persistence of S. Infantis in broiler farms and increased resistance
against cleaning and disinfection procedures (Asai et al., 2007;
Nógrády et al., 2007, 2008; Ross and Heuzenroeder, 2008;
Pate et al., 2019). Thus, we were interested whether recent
S. Infantis organisms gained new properties resulting in the
modified characteristics.
There is evidence that the acquisition of a conjugative mega-
plasmid provides the bacteria with new resistance properties
(EFSA, 2020) but might also confer virulence-associated
characteristics, higher resistance against heavy metals or
disinfectants and fitness characteristics (Aviv et al., 2014).
In view of the increased prevalence of S. Infantis also in
German broiler production in recent years (EFSA, 2020), the
question raised on possible reasons. Therefore, this study aimed
to characterize and compare S. Infantis strains originated from
different broiler farms in Germany from 20-years distant decades,
the 1990s and the 2010s. S. Infantis organisms isolated in different
decades were phenotypically characterized by serotyping and
determining the antimicrobial susceptibility. In this study,
whole genome sequencing (WGS) and bioinformatics analysis
were used to describe the genetic traits of S. Infantis strains




In this study, we analyzed a dataset consisting of 30 S. Infantis
strains that cover a wide range of broiler farms in Germany
(Table 1). Eighteen isolates were collected during the 2010s
(time frame: 2014–2020) and 12 strains were isolated two
decades earlier, in the 1990s (time frame: 1992–1998). S. Infantis
strains were provided by the National Reference Laboratory for
Salmonella at the German Federal Institute for Risk Assessment
(BfR) or were received after request from regional diagnostic
laboratories in different federal states in Germany. To compare
the sequenced German S. Infantis strains with previously
reported emergent S. Infantis clones, we searched for recent
publications regarding S. Infantis. The criteria of selection of
strains were source (broiler), region (central Europe) and, period
of time when they were collected (between the 1990s and the
2010s). Thus, we downloaded sequence data of S. Infantis (n = 17)
from Hungary (Olasz et al., 2015; Wilk et al., 2016, 2017) and
Italy (Franco et al., 2015) (Supplementary Table S1). Beyond
this criteria, we included strains from Israel where pESI was
first studied (Aviv et al., 2014) and kept the strains 1326/28
(LN649235) from the United Kingdom and the non-broiler strain
335-3 (ATHK00000000) as representatives of the historical, or
so-called “pre-emergent” strains. For comparison purposes, we
included the recently published complete genome sequence of
the S. Infantis strain 119944 harboring the pESI like megaplasmid
from Israel (Cohen et al., 2020).
Serotyping and Antimicrobial
Susceptibility Testing
All Salmonella isolates were serotyped using poly- and
monovalent anti-O as well as anti-H sera (SIFIN, Germany)
according to the Kauffmann–White scheme (Grimont and
Weill, 2007). Antimicrobial susceptibility of the S. Infantis
strains was assessed by determining the minimum inhibitory
concentration (MIC) using the broth microdilution method
with SensititreTM EUVSEC plates (Trek Diagnostic Systems
Ltd., East Grinstead, United Kingdom). Epidemiological cut-
off values were used according to the European Committee
on Antimicrobial Susceptibility Testing (EUCAST, 2018).
Antimicrobial susceptibilities to sulfamethoxazole (SMX),
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TABLE 1 | Epidemiological data and phenotypic AMR profile of S. Infantis strains used in this study.
Strain Sample Region of isolation Year of isolation Phenotypic AMR profile
19PM0346 2945 Bavaria farm 1 1992 SMX
19PM0348 2947 Bavaria farm 2 1992 SMX
19PM0349 2948 Bavaria farm 3 1992 SMX
19PM0350 2949 Lower Saxony farm 1 1992 SMX
19PM0351 2951 Lower Saxony farm 2 1994 SMX
20PM0240 3222 Mecklenburg-Western Pomerania 1994 SMX
20PM0243 3225 State of Hesse farm 2 1995 SMX
20PM0245 3227 Thuringia 1995 SMX
20PM0248 3230 State of Hesse farm 3 1996 SMX
20PM0252 3234 Baden-Wuerttemberg farm 2 1997 SMX
20PM0257 3239 Rhineland-Palatinate farm 2 1998 SMX
20PM0260 3242 Lower Saxony farm 4 1998 SMX
20PM0261 3243 Bavaria farm 4 2014 SMX-CIP-TET-NAL-TGC
20PM0263 3245 Lower Saxony farm 5 2014 SMX
20PM0267 3249 Saxony-Anhalt farm 1 2015 SMX-CIP-TET-NAL-TGC
20PM0268 3250 Bavaria farm 5 2015 SMX
20PM0270 3252 Saxony-Anhalt farm 2 2015 SMX-CIP-TET-NAL-TGC
20PM0271 3253 Brandenburg farm 1 2016 SMX-CIP-TET-NAL-TGC
20PM0273 3255 Lower Saxony farm 6 2016 SMX
20PM0275 3257 Bavaria farm 6 2016 SMX-CIP-TET-NAL-TGC
19PM0355 2954 Baden-Wuerttemberg farm 1 2017 SMX-CIP-TET-NAL-TGC
19PM0358 2957 Brandenburg farm 1 2018 SMX-CIP-TET-NAL-TGC
19PM0360 2959 Bavaria farm 4 2019 SMX-CIP-TET-NAL-TGC
19PM0148 2747 Bavaria farm 5 2019 SMX-CIP-TET-NAL-TGC
19PM0149 2748 Bavaria farm 6 2019 SMX-CIP-TET-NAL-TGC
19PM0150 2749 Bavaria farm 7 2019 SMX-CIP-TET-NAL-TGC
19PM0151 2750 Baden-Wuerttemberg farm 2 2019 SMX-CIP-TET-NAL-TGC
19PM0153 2752 Baden-Wuerttemberg farm 3 2019 SMX-CIP-TET-NAL-TGC
19PM0154 2753 Bavaria farm 8 2019 SMX-CIP-TET-NAL-TGC
20PM0045 3027 Bavaria farm 6 2020 SMX-CIP-TET-NAL-TGC
SMX, sulfamethoxazole; CIP, ciprofloxacin; TET, tetracycline; NAL, nalidixic acid; TGC, tigecycline.
trimethoprim (TMP), ciprofloxacin (CIP), tetracycline (TET),
meropenem (MERO), azithromycin (AZI), nalidixic acid (NAL),
cefotaxime (FOT), chloramphenicol (CHL), tigecycline (TGC),
ceftazidime (TAZ), colistin (COL), ampicillin (AMP), and
gentamicin (GEN) were examined.
Sequencing and Bioinformatics Analysis
For paired-end sequencing with Illumina, Genomic DNA of 30 S.
Infantis strains was extracted and purified using the QIAGEN R©
Genomic-tip 20/G kit (QIAGEN, Germany) and the Genomic
DNA Buffer Set (QIAGEN, Germany). The concentration of
the DNA was determined using the Qubit dsDNA BR assay kit
(Invitrogen, United States). Sequencing libraries were created
using the Nextera XT DNA Library Preparation Kit (Illumina
Inc., United States). Paired-end sequencing was performed on
an Illumina MiSeq instrument according to the manufacturer’s
instructions (Illumina Inc., United States).
For long-read sequencing with MinION, a sequencing library
was prepared using the Oxford Nanopore Technologies (ONT)
1D Ligation Sequencing Kit (SQK-LSK109) with the Native
Barcoding Expansion Kit (EXP-NBD104) as recommended
by the manufacturer. Raw FAST5 files were processed using
Guppy toolkit (v. 3.4.1) (Oxford Nanopore Technologies). The
Guppy command guppy_basecaller was used for basecalling and
guppy_barcoder was used for demultiplexing. De novo assembly
for long sequencing reads was performed using Flye (v. 2.6)
(Kolmogorov et al., 2019). Assembly polishing was performed
with four rounds by Racon (v. 1.4.3) (Vaser et al., 2017) and
one final round with Medaka (v. 0.10.0). Finally, Pilon (v. 1.23)
(Walker et al., 2014) was used to correct the final assembled data
from Nanopore with Illumina reads using standard settings.
To analyze the sequencing data in a standardized manner,
the Linux-based bioinformatics pipeline WGSBAC was used
(v. 2.0.0)1 (FLI_Bioinfo, 2020). Input for the pipeline was raw
Illumina data and already assembled data (MinION). WGSBAC
starts with quality control using FastQC (v. 0.11.7)2 (Andrews,
2018). Next, it calculates the raw coverage by the number of
reads multiplied with their average read length and divided by
1https://gitlab.com/FLI_Bioinfo/WGSBAC
2https://www.bioinformatics.babraham.ac.uk/projects/fastqc/
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the genome size. WGSBAC performs assembly using Shovill
(v. 1.0.4) (Seemann, 2018) an optimizer for SPAdes assembler
(Bankevich et al., 2012).
The quality of the assembled genomes is then checked using
QUAST (v. 5.0.2) (Gurevich et al., 2013). Genome annotation is
made by Prokka (v. 1.14.5). In order to identify contamination,
the pipeline uses Kraken 2 (v. 1.1) (Wood et al., 2019) and the
database Kraken2DB to classify both reads and assemblies. For
in silico serotyping, WGSBAC utilizes SISTR (v. 1.0.2) (Yoshida
et al., 2016) on the assembled genomes.
For genotyping, WGSBAC uses classical multilocus sequence
typing (MLST) on assembled genomes using mlst software
(v. 2.16.1)3 (Seemann, 2014a) that incorporates the PubMLST
database4 (Jolley et al., 2018). Furthermore, the pipeline
includes mapping based SNP-typing using Snippy (v. 4.3.6)5
(Seemann, 2014b) with standard settings and FastTree (v.
2.1.10) (Price et al., 2009) to calculate phylogenetic trees from
SNPs. To infer phylogeny based on core genome multilocus
sequence typing (cgMLST), we used the external software Ridom
Seqsphere+ (v. 5.1.0) (Junemann et al., 2013) with default
settings and the specific core genome scheme (cgMLST v2)
for Salmonella enterica with 3,002 target loci developed by
Enterobase (Alikhan et al., 2018).
For detection of antimicrobial resistance genes (AMR),
virulence factors and plasmid replicon genes, WGSBAC uses
Abricate (v. 0.8.10)6 (Seemann, 2015) and the databases:
ResFinder (Zankari et al., 2012) and NCBI (Feldgarden et al.,
2019a), Virulence Factor Database (VFDB) (Chen et al., 2005)
and PlasmidFinder (Carattoli et al., 2014), respectively. For
the detection of point mutations in the gene gyrA leading
to AMR, we used the software AMRFinderPlus (v. 3.6.10)
(Feldgarden et al., 2019b).
For a deeper molecular characterization of the strains, we
downloaded specific pESI119944-encoded gene sequences and
created customized databases for Abricate (Supplementary
Table S2). These databases include sequences of genes encoding
for Salmonella pathogenicity islands (SPIs), Ipf and K88-
like fimbrial clusters and pESI fitness determinants as the
toxin-antitoxin (T/AT) system (CcdAB and PemK/MazF) and
the mercury operon. Furthermore, for plasmid typing, allele
sequences for incompatibility groups of plasmids IncI1 (five loci)
and IncF RST (seven loci) were downloaded from the Plasmid
PubMLST database7 (Carattoli and Hasman, 2020). In order to
complete the plasmid genomic characterization and to test the
chimeric nature of pESI-like plasmids as described before (Aviv
et al., 2014), we tested the detection of the gene sequence encoded
for RepFIB replication protein A (repB) and the oriV of IncP1
plasmids. We used the external software Geneious Prime (v.
2019.2.3)8 to complete the plasmid strain annotation and for







Two phylogenetic trees were constructed for the pESI-like
positive strains using Snippy to study the plasmid SNP-based
phylogeny. One tree using the plasmid sequence (CP047882) as
reference and a second one using the chromosome sequence
(CP047881) as reference of the complete genome sequence of
SI119944 strain (Cohen et al., 2020). Trees were compared
using the tanglegram function of the tool Dendroscope (v 3.5.9)




All isolates were typed according to the Kauffmann–White
scheme and revealed the complete antigenic formula (6, 7: r: 1,
5) for S. Infantis. As listed in Table 1, all S. Infantis strains from
the 1990s were only resistant against SMX. Among the isolates
from the 2010s, three strains were resistant to SMX and 15 were
multidrug-resistant to SMX, CIP, TET, NAL, and TGC.
Genomic Features of Genomes of S.
Infantis Strains
WGS of the 30 S. Infantis strains revealed general genomic
characteristics and allowed genoserotyping of the strains
(Supplementary Table S3). We sequenced an average of
1,439,617 reads per sample (range: 524,688–2,509,738). On
average, assembled genomes consisted of 54 contigs (range: 37–
91) with an average read-coverage of 68 fold (range: 24–128).
The average genome size was 4.8 Mbp (range: 4.6–4.9 Mbp),
GC content was 52.2% and N50 values average 257,721 (range:
90,139–445,475). Kraken2 on Illumina reads classified an average
of 95.31% of reads as “Salmonella” on the genus level and an
average of 94.42% of reads as “Salmonella enterica” at the species
level. To confirm the serological serotyping, SISTR was used
for in silico molecular typing and predicted serovar Infantis
for all the strains included in the study corroborating the
phenotypic findings.
Genotyping and Phylogeny of S. Infantis Strains
After assessing the general sequencing characteristics, classical
MLST on the assembled genomes was carried out to get a broad
overview of the S. Infantis genotypes (Table 2). Among the
complete dataset, 15 out of 30 isolates examined belong to ST32.
The remaining 15 belong to two single-locus variants of ST32,
namely ST2283 (in the gene sucA) and ST1032 (in the gene
dnaN). The majority of the strains from the 1990s belong to ST32
(n = 10) while two strains belong to ST1032. The majority of
the strains from the 2010s belong to ST2283 (n = 13) while five
strains belong to ST32. Within the dataset from the 2010s, only
two strains that belong to ST32 revealed the same MDR pattern as
S. Infantis strains with ST2283. For a deeper phylogenetic analysis
of the 30 S. Infantis strains, a minimum spanning tree based
on core genome MLST (cgMLST) and a phylogenetic tree based
on single nucleotide polymorphisms (SNPs) were constructed.
Although both approaches differ strongly, they produced similar
results (Figures 1A,B). Both phylogenetic approaches group the
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strains into two distinct decade- and ST-related groups except
for samples 2748 and 3027 that belong to ST32 but they are
grouped with the samples collected in the 2010s (Figure 1B)
and three strains from the 2010s that are included within the
group of the 1990s as they have ST32 (marked in red in
Figure 1B). On average, the distance between the strains was 145
SNPs and 76 alleles.
Resistance and Virulence Genes Patterns
The analysis of the genome sequences revealed an AMR gene
pattern specific for the 15 MDR strains from the 2010s. We
named this pattern ESIr (Emergent S. Infantis resistance pattern)
and it consists of the AMR genes: ant(3“)-Ia (aminoglycoside
resistance), sul1 (sulfonamide resistance), tet(A) (TET resistance)
and qacEdelta1 [quaternary ammonium compound (QAC) and
disinfectant resistance] (Table 2). Additionally, we detected
a point mutation in the gene gyrA (gyrA-S83Y) leading to
resistance against (fluoro)quinolones (Supplementary Table S4).
The remaining three strains from the 2010s dataset did not reveal
any of these resistance genes. Two strains from the 1990s, (2947
and 2949) carry the genes ant(3“)-Ia, sul1 and qacEdelta1 as well
as the gene aac(3)-VIa (aminoglycoside resistance) but not the
gene tet(A). The chromosomally encoded gene aac(6’)-Iaa was
detected among all the samples included in this study.
We detected a specific gene pattern of virulence genes among
the 15 MDR strains from the 2010s (Table 3). We named this
pattern ESIv (Emergent S. Infantis virulence) which consists
of genes associated with the fimbrial clusters: K88-like fimbria
(Klf) and the S. Infantis plasmid-encoded fimbria (Ipf) (Aviv
et al., 2017). Moreover, the pattern includes genes encoding
for the virulent yersiniabactin operon (fyuA, irp1, irp2, ybtA,
ybtE, ybtP, ybtQ, ybtS, ybtT, ybtU, ybtX) and the mercury (mer)
operon (merR, merT, merP, merC, merA, merD, merE) conferring
mercury resistance. Finally, ESIv pattern consists of the gene
complex ccdA/B and the pemK/I family (T/AT system). Isolates
from the 1990s did not show any of these genes. Apart from the
ESIv pattern, we found among all the samples from the study
the presence of ten SPIs: SPIs-1-6, SPI-9, SPIs-11-12, and CS-54
(Supplementary Table S5).
As previously reported (Bogomazova et al., 2019), similar
resistance and virulence gene patterns have been determined
by the presence of a pESI-like plasmid carried by emergent S.
Infantis strains. Likely, in the case of the strains of this study,
the presence of a pESI-like plasmid could explain this genetic
profile. Therefore, we aimed at the genomic detection and further
characterization of this pESI-like plasmid among our strains.
Detection, Genomic Characterization and Phylogeny
of a pESI-Like Plasmid
First, we scanned for replicon sequences of plasmids
(Supplementary Table S6). All the 15 MDR strains positive
to ESIr and ESIv patterns, presented the replicon IncFIB
(pN55391) (Table 2). A genomic in-depth analysis for the
typification of the plasmids revealed that the 15 strains positive
for the IncFIB(pN55391) replicon, had the profile: ardA2, pilL3,
sogS9, trbA21 while repI1 was absent. However, they were
positive for the RepFIB replication protein A (repB). Besides,
they were positive for the detection of the sequence of the
plasmid RK2 (from E. coli) DNA transposon (Tn1723) insertion
sites (M20134) revealing the chimeric nature of the pESI-like
plasmid as described previously (Aviv et al., 2014, 2016).
The samples 2947 and 2949 from the 1990s were positive for
replicon IncI1-I(Gamma) and had the complete IncI gene profile:
ardA4, pilL1, sogS2, trbA13, repI1. Sample 2949 simultaneously
carries IncFIC(FII) and IncFII(pSFO) replicons and two alleles
of IncF RST: FII91 and FIC3 (Supplementary Table S6).
Interestingly, sample 3255 from the 2010s, was negative
for the presence of IncFIB (pN55391); however, it carried
additionally three different replicons: IncFIC(FII), IncFII(S) and
IncFII(SARC14) for IncF plasmids (Supplementary Table S6).
Sample 3255 did not present any gene from the IncI1
scheme, nor repB, but two genes from the IncF RST scheme:
FIIS5 and FIC3. The remaining non-resistants trains from
the dataset did not contain any gene for an incompatibility
group of plasmids.
Second, to add further evidence that the 2010s prevalence of S.
Infantis in German broilers may be due to the presence of a pESI-
like megaplasmid, we downloaded and examined the complete
genome sequence of the megaplasmid pESI119944 found for the
first time in the strain SI119944 in Israel (Aviv et al., 2014).
Indeed, the analysis of the complete sequence of this plasmid
showed the presence of the replicon IncFIB(pN553391), the
allele profile of an IncI, the origin of replication of an IncP
and repB (Supplementary Table S6). As shown in Tables 2, 3,
main resistance and virulence traits detected among the German
strains positive for replicon IncFIB(pN553391), were also present
in the Israelian strain SI119944. Third, to have an in-depth
comparison of the pESI-plasmid found within the German
strains, we performed Oxford Nanopore sequencing of the
sample 2747 that represent the samples from the 2010s and
meets the characteristics described above regarding resistance,
virulence genes, and plasmid nature. The hybrid assembly of
sample 2747 resulted in two closed contigs corresponding to the
chromosome (4,678,881 bp length) and the pESI-like plasmid
(278,542 bp length) that we designated as pESI2747. The N50
value of the genome was 4,678,881 bp and the GC content
was 52.18%. Kraken2 gave a match of 100% for Salmonella
enterica. Figures 2A,B show the main features of the alignment
of pESI119944 from Israel and pESI2747 from Germany.
The alignment shows a consensus sequence of ∼285,184 bp.
This consensus sequence consists of a common fragment of
∼277,693 bp (∼97.37%) between both sequences and a non-
common region of ∼7,301 bp (∼2.56%). The repB gene coding
for RepFIB replication protein A is located in the positions
80,555 and 81,580 bps in pESI2747, while on pESI119944 it is
located at the beginning of the plasmid. Moreover, the genes
ardA, pilL, sogS, trbA were found as well in different locations
along pESI2747 compared to pESI119944. The sequence of an
origin of replication for IncP plasmid was found as well in both
plasmid sequences between the mer operon and the resistance
genes tet(A) and tet(R) as previously described (Aviv et al., 2014,
2016). In pESI2747, we found the ESIr and the ESIv pattern
common for the 15 MDR strains from the 2010s. Resistance genes
ant(3“)-la, sul1 and qacEdelta1 were located together in a region
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TABLE 2 | Sequence type (ST), resistance genes (ESIr pattern and other) and plasmid replicons detected in broiler-derived S. Infantis strains from Germany and
comparison with the complete genome sequence of plasmid pESI detected in S. Infantis SI119944 strain from Israel.
Sample Year of isolation MLST (ST) Resistance genes pattern (ESIr) Other resistance genes Plasmid replicon
2945 1992 32 – aac(6′)-Iaa –
2947 1992 32 – aac(3)VIa, ant(3“)-Ia, sul1, aac(6′)-Iaa IncI1-I(Gamma)
2948 1992 32 – aac(6′)-Iaa –
2949 1992 32 – aac(3)VIa, ant(3“)-Ia, sul1, aac(6′)-Iaa IncI1-I(Gamma),
IncFIC(FII), IncFII(pSFO)
2951 1994 32 – aac(6′)-Iaa –
3222 1994 32 – aac(6′)-Iaa –
3225 1995 32 – aac(6′)-Iaa –
3227 1995 1032 – aac(6′)-Iaa –
3230 1996 1032 – aac(6′)-Iaa –
3234 1997 32 – aac(6′)-Iaa –
3239 1998 32 – aac(6′)-Iaa –
3242 1998 32 – aac(6′)-Iaa –
3243 2014 2283 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
3245 2014 32 – aac(6′)-Iaa –
3249 2015 2283 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
3250 2015 32 – aac(6′)-Iaa –
3252 2015 2283 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
3253 2016 2283 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
3255 2016 32 – aac(6′)-Iaa –
3257 2016 2283 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
2954 2017 2283 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
2957 2018 2283 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
2959 2019 2283 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
2747 2019 2283 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
2748 2019 32 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
2749 2019 2283 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
2750 2019 2283 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
2752 2019 2283 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
2753 2019 2283 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
3027 2020 32 + aac(6′)-Iaa, gyrA-S83Y IncFIB(pN55391)
SI119944 2008 32 + aac(6′)-Iaa, dfrA14, gyrA-D87Y IncFIB(pN55391)
flanked by an IS6 transposase IS26, Integrase/recombinase (int)
(Uniprot: P62592)9 and IS21 family transposase IS1326. Resis-
tance genes to TET tet(A) and tet(R) were found as well together,
having upstream the Tn3 family transposase TnAs1. In the non-
common part, we found the TMP resistance encoding gene
dfrA14 only presented in the sequence of pESI119944. Regarding
virulence, we found the k88-like fimbria (Klf) cluster on the
sequences of both plasmids spanning a region of ∼8,000 bp and
the Ipf cluster that occupies a region of 5,100 bp. Between them,
we found the gene cluster ccdA-ccdB encoding for the toxin/
antitoxin system and the vagC and vapC genes. The pemK-pemI
is located in position 95,086. Moreover, we found the 11 genes of
the yersiniabactin operon spanning a region of∼29,000 bp.
To study, if all German strains potentially carrying pESI
have a similar plasmid structure as pESI2747, we mapped the
Illumina short reads to the sequence of pESI119944 and analyzed
their coverage vector (Supplementary Figure S1). We found
that the positive strains cover practically the complete sequence
9https://www.uniprot.org/
of pESI119944 except for a gap at the end of the reference
sequence suppose to be the non-common part observed between
our pESI-like plasmid and the pESI119944. In summary, we add
evidence that multidrug-resistant strains in the 2010s carry a
pESI-like megaplasmid.
Finally, we were interested if the plasmid evolves
independently or if there has occurred a co-evolution together
with the chromosomes. Therefore, we studied the plasmid-based
SNP phylogeny as previously performed (Alba et al., 2020)
for the 15 S. Infantis strains harboring the pESI-like plasmid
(Supplementary Figure S2). In general the plasmid phylogeny
seems to be similar to the chromosomal phylogeny.
Genomic Characteristics of S. Infantis
Strains From Israel, Hungary, and Italy
To compare our findings with recently published results
from the emergent S. Infantis clones, we downloaded a total
of 17 genomes from studies performed in Italy (Franco
et al., 2015), Hungary (Olasz et al., 2015; Wilk et al.,
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FIGURE 1 | (A,B) Phylogeny of broiler-derived S. Infantis strains in Germany and S. Infantis SI119944 from Israel. (A) Phylogenetic tree based on SNPs representing
two main decade- and ST-related groups as the minimum spanning tree based on cgMLST. (B) Plasmid pESI-like is presented in the majority of samples from the
2010s (n = 15) and absent for the data from the 1990s. Samples 3227 and 3230 that belong to ST1032 are grouped within the 1990s group as they do not present
the plasmid pESI-like. Note that samples 2748 and 3027 belong to ST32 but they are grouped with the samples collected in the 2010s (B) and that three strains
from the 2010s are included within the group of the 1990s as they have ST32 (marked in red in B).
2016, 2017) and Israel (Aviv et al., 2014) as described
above and analyzed them using our pipeline (Supplementary
Table S1). Genotyping revealed that ST32 was the only sequence
type of S. Infantis strains presented within the data from
Israel, Hungary and Italy while ST2283 was not detected.
PlasmidFinder found the replicon IncFIB(pN55391) in 13 out
of 17 of the strains and the majority of them (n = 12)
presented the IncI profile: ardA2, pilL3, sogS9, trbA21, and
repI1 absent (Supplementary Table S6). Additionally, we
detected two replicons (IncX1 and IncX3) in two Hungarian
strains (SI240/16 and SI3337/12) and IncI1-I(Gamma) in one
Italian strain (ERS846145) with IncI profile including the
repI1. As expected, samples from Hungary SI69/04, Israel
335-3 and United Kingdom 1326/28 collected before the
2000s did contain neither plasmid replicons, nor IncI genes.
Abricate using ResFinder, revealed a variety of 15 different
resistance genes among the S. Infantis harboring the pESI-
like plasmid (Supplementary Table S4). The ESIr [ant(3“)-
la, sul1, tet(A) and qacEdelta1] was found among 10 out of
17 strains from the three countries. The remaining strains
had a variation of this pattern and presented other additional
genes. Especially, the Italian strains present a wide variety of
resistance genes including resistance genes related to extended-
spectrum β-lactamase (ESBL), like blaCTX-M-1 as reported
previously (Franco et al., 2015). Three out of seven Hungarian
strains presented ESBL genes as well like the blaCTX-M-
14 or blaTEM-104.
Chromosomal mutations of gene gyrA were found as
well: gyrA-S83Y (8 out of 17) and gyrA-D87G (4 out of
17), gyrA_D87Y was found only in SI119944. The ESIv
pattern described above within the German S. Infantis
was found in 12 out of 16 strains (Supplementary
Table S5). Therefore, the results from this study are
in line with the findings in other European countries
regarding the emergence of multidrug and virulent
S. Infantis clones.
To see if there is a clonal transmission of the strains, a
minimum spanning tree based on cgMLST was constructed
(Supplementary Figure S3). German S. Infantis strains of
ST2283 form 2010s are close to two Hungarian strains that
were reported as new S. Infantis clones (Nógrády et al., 2012).
The smallest difference between external strains and German
pESI-like strains is 37 alleles between the Hungarian SI54/04
and the German 2954, therefore we could not detect any clonal
relatedness. The two ST32 strains from the 2010s are most closely
related to two emergent S. Infantis strains from Italy. We could
detect clonal transmission between two Italian strains where the
smallest number of different alleles was 1.
DISCUSSION
Studies performed within and outside Europe revealed an
emergent dissemination of S. Infantis clones in humans and
several animal species (Nógrády et al., 2007, 2008, 2012; Aviv
et al., 2014; Franco et al., 2015; Olasz et al., 2015; Yokoyama
et al., 2015; Wilk et al., 2016; Hindermann et al., 2017; Szmolka
et al., 2018; Acar et al., 2019; Bogomazova et al., 2019). There
is evidence that the acquisition of a conjugative megaplasmid
provides the bacteria with new resistance properties which might
have contributed to the increased occurrence of this serovar. An
in-depth analysis of the genetic characteristics of the plasmid
called pESI (Aviv et al., 2014) or similar pESI-like plasmids
(Franco et al., 2015; Szmolka et al., 2018) revealed that they
also encode for virulence-associated characteristics, resistance
to heavy metals or disinfectants and fitness characteristics. The
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TABLE 3 | Virulence and fitness genes detected in broiler-derived S. Infantis strains from Germany (ESIv pattern) and comparison with the complete genome sequence
of plasmid pESI detected in S. Infantis SI119944 strain from Israel.








2945 1992 – – – – –
2947 1992 – – – – –
2948 1992 – – – – –
2949 1992 – – – – –
2951 1994 – – – – –
3222 1994 – – – – –
3225 1995 – – – – –
3227 1995 – – – – –
3230 1996 – – – – –
3234 1997 – – – – –
3239 1998 – – – – –
3242 1998 – – – – –
3243 2014 + + + + +
3245 2014 – – – – –
3249 2015 + + + + +
3250 2015 – – – – –
3252 2015 + + + + +
3253 2016 + + + + +
3255 2016 – – + – –
3257 2016 + + + + +
2954 2017 + + + + +
2957 2018 + + + + +
2959 2019 + + + + +
2747 2019 + + + + +
2748 2019 + + + + +
2749 2019 + + + + +
2750 2019 + + + + +
2752 2019 + + + + +
2753 2019 + + + + +
3027 2020 + + + + +
SI119944 2008 + + + + +
analysis and genomic comparison of the complete genome
sequence of SI119944 from Israel (Cohen et al., 2020) and strain
2747 from Germany demonstrate and confirm the characteristic
resistance, virulent as well as fitness traits encoded on a pESI-
like plasmid. Furthermore, results from this study confirm the
observed switch in the occurrence of S. Infantis organisms in
broilers from non-MDR strains screened until the 2000s (Asai
et al., 2007; Shahada et al., 2008; Wilk et al., 2017) to the
emergence of MDR clones collected during and after the end
of the 2000s (Nógrády et al., 2007, 2008, 2012). ST32 is a
highly conserved sequence type of S. Infantis (Monte et al.,
2019) and was the dominating MLST type isolated from various
and numerous sources (broilers, pigs, cattle, food, human) in
different European countries (Hauser et al., 2012; Hindermann
et al., 2017; Gymoese et al., 2019). In this study, we describe the
occurrence of two single locus variants of ST32 within the S.
Infantis from German broiler production: ST2283 and ST1032.
The emergence of ST2283 in S. Infantis organisms from the
2010s is linked with the presence of a pESI-like plasmid that
confers a MDR pattern that has not been found among S.
Infantis ST32 strains originating from the 1990s. However, we
also identified two ST32 strains of S. Infantis from the 2010s
harboring the resistant coding plasmid. We observed general
concordance in cluster separation between the chromosome-
based tree and plasmid-based tree in all strains harboring pESI-
like megaplasmid (ST32 and ST2283) as shown also by Alba
et al. (2020). Therefore, we hypothesize that the plasmid has co-
evolved with the chromosome and both STs gained the plasmid
in two (or more) evolutionary independent events. However,
a rather rare occurrence of MDR clone ST32 compared with
the higher prevalence of MDR clone ST2283 in recent years
indicates an obvious greater tendency of dissemination of this
clone in Germany and perhaps European broiler production, and
therefore, another until now not detected property of ST2283.
We also detected two non-resistant ST1032 clones from the
1990s. This variant of ST32 had been described before in a
non-resistant isolate from food (Alba et al., 2020). In this
study, bioinformatics analysis revealed a correlation between
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FIGURE 2 | (A,B) Main genomic traits and alignment of the complete plasmid sequence of pESI119944 from the Israelian strain SI119944 and pESI2747 from the
German strain 19PM0148. The red frame indicates the non-common fragment in the alignment.
the resistance gene pattern named as ESIr [ant(3“)-la, sul1,
tet(A)] and the phenotypic resistance profile to aminoglycosides,
sulfonamides, and TETs. Furthermore, gen aac(6’)-Iaa was not
located on pESI119944 but on the chromosome. In line with the
literature, we found the gene aac(6’)-Iaa to be chromosomal-
encoded gene (Salipante and Hall, 2003). On the other hand,
German broiler derived S. Infantis strains showed phenotypic
resistance to quinolones like CIP and NAL. Genotype findings
do correlate with the phenotypic results as we detected the well-
studied mutation in gyrA gene that codifies for resistance to
those antibiotics (Chen et al., 2019). The predominant MDR
pattern found among the emergent S. Infantis clones from
Europe consists mainly of antimicrobials that belong to the major
classes of antibiotics FOT, CIP, cephalosporin, TET, sulfonamide,
fluoroquinolone, and TMP (Cloeckaert et al., 2007; Franco et al.,
2015; Acar et al., 2019). Phenotypic and genotypic variants of
this pattern have been observed in Hungary related to two
different pulsotype clusters (Nógrády et al., 2012). Variants
of this MDR pattern including ESBL resistant isolates of S.
Infantis were also found in Italy and Germany (Franco et al.,
2015; Fischer et al., 2017). Resistance and virulence traits
coevolved and interfere in the ecology of a strain (Beceiro et al.,
2013). Thus, the increasing emergence of a strain is not only
dependent on antimicrobial resistance, but also on virulence,
bacteriocin secretion, biocide resistance and, biofilm formation
(Acar et al., 2019). Consequently, in this study, the bioinformatics
analysis for virulence determinants showed a common pattern in
virulence and fitness genes within the MDR isolates. Salmonella
pathogenicity islands and other different gene complexes that
encode for fimbriae production, adherent and non-adherent
products, as well as curli structures, are of special interest
because of their involvement in host colonization, persistence,
motility, and invasion (Barnhart and Chapman, 2006; Rychlik
et al., 2009; Aviv et al., 2017). The strong dissemination of
S. Infantis not only in broilers during the last two decades
wonders whether the increased antimicrobial resistance, the
swift in MLST type, the virulence properties, the capability of
biofilm formation or other unknown factors are responsible
for this emergence. Different hypotheses try to explain this
phenomenon. For example, it is suspected that the increased
prevalence of S. Infantis could be due to the general decreased
prevalence of S. Enteritidis in poultry farms (Szmolka et al.,
2018). It is also suggested that the EU trade of broiler chicken
and the pyramidal structure of the poultry industry may be
factors of the rapid spread of emergent clones of S. Infantis
carrying the pESI-like plasmid beyond national borders (Alba
et al., 2020; Nagy et al., 2020). The long term use of special
groups of antimicrobial substances might have resulted in
selection pressure and increased emergence of particular bacterial
organisms (Nógrády et al., 2007, 2012). However, it is also
stated that antimicrobial usage is not always linked to a higher
Salmonella prevalence (Asai et al., 2007). The acquisition of the
megaplasmid pESI does not result in a significant burden to its
hosts as it is presented only as a single copy in the bacteria
genome, therefore, it does not seem to limit the dissemination
of the organisms (Aviv et al., 2016).
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Production of fimbriae and the ability to form biofilms
are discussed as factors enabling a long term persistence
of Salmonella organisms at poultry farms. The gene fyuA
(Schubert et al., 1998) together with the genes irp1 and irp2
are involved in biofilm formation (Hancock et al., 2008). In
this study, gene irp1 was found together with irp2 in all
strains that carry the pESI-like plasmid suggesting a possible
role in persistence of S. Infantis organisms. However, the
association of yersiniabactin and biofilm in serovar Infantis has
not been yet wide studied in contrast with other microorganisms
as in Uropathogenic Escherichia coli (UPEC) (Zamani and
Salehzadeh, 2018). It has been demonstrated before a higher
biofilm formation for pESI positive strains (Aviv et al., 2014).
Besides, very recently, it has been demonstrated a higher
cell adhesion of S. Infantis compared with other serovars.
Resistance to heavy metals or biocides like QACs might
also play a role in the emergence of S. Infantis. The gene
qacEdelta1 (Chuanchuen et al., 2007), located on pESI-like
megaplasmids codes for resistance against QACs and was
found in this study exclusively in strains from the 2010s.
On the other hand, detailed analysis of the sequence of
pESI-like pESI2747 has revealed not only resistance genes
but also virulence genes, toxin/antitoxin systems that as
previously described (Aviv et al., 2014; Acar et al., 2017)
play a clue role in the emergence of S. Infantis in poultry.
However, it is open whether the encoded resistance against
disinfectants might contribute to a higher S. Infantis persistence
at broiler farms.
In conclusion, broiler derived S. Infantis strains of ST2283 in
Germany show similarities to emergent S. Infantis strains from
Europe including the possession of the pESI-like megaplasmid
which encodes for antimicrobial resistance, virulence genes
(fimbrial clusters) and fitness determinants (toxin/antitoxin
system) that enhance bacterial adaptability. Therefore, the
involvement of the megaplasmid might explain the current
spread of these emergent S. Infantis organisms. However, specific
reasons for a suspected higher persistence of MLST2283 could
not be identified in this study. It seems that S. Infantis persistence
in broiler farms is caused by its occurrence in the primary
broiler production and ineffective cleaning and disinfection
protocols at least for these special clones. Epidemiological
studies on the occurrence of S. Infantis ST2283 in the whole
broiler production chain and the establishment of effective
control measures are essential to prevent these organisms from
entering the food chain.
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3.1. Supplementary figures from the Publication 
Figure S1. Mapping coverage of all pESI-like positive strains across the complete genome 
sequence of plasmid pESI119944. 
 
Figure S2. Tanglegram plot representing the comparison between pESI-like positive strains 
using the chromosome sequence of S. Infantis ESI119944 (CP047881) (left) as reference and 





Figure S3. Minimum spanning tree for previously reported emergent S. Infantis clones from 







The work presented in this thesis consisted of two parts: i) implementation and evaluation of 
an in–house bioinformatics pipeline (WGSBAC) for Salmonella in silico serotyping and ii) the 
application of the WGSBAC pipeline to study the potential occurrence and high tendency of 
dissemination of a MDR emergent S. Infantis population in German broiler farms.  
4.1. Implementation and evaluation of an in–house bioinformatics pipeline (WGSBAC) for 
Salmonella in silico serotyping 
Serotyping is an essential step in the investigation of outbreaks concerning Salmonella. It was 
proposed as a classification method for Salmonella genus in 1975 (KAUFFMANN 1975) and still 
today, it is considered the gold-standard for Salmonella typing (GRIMONT et al. 2007). 
However, the successful performance of WGS-based serotyping tools raises the question of 
whether the use of conventional Salmonella serotyping based on agglutination assays is 
coming to an end (ZHANG et al. 2015, ASHTON et al. 2016, YOSHIDA et al. 2016, YACHISON et 
al. 2017, RENE et al. 2018, ROBERTSON et al. 2018, ZHANG et al. 2019, UELZE et al. 2020). The 
list of disadvantages of conventional Salmonella serotyping includes among others low 
throughput, long turnaround times, demand of expertise (BOXRUD 2010), and production and 
quality control of a large number (more than 250) of antisera from immunized rabbits 
(MCQUISTON et al. 2004). Several molecular-based methods that aimed to replace antisera 
agglutination-based serotyping have been proposed in the last years (TANG et al. 2019). 
Among the molecular-based methods, PFGE and MLVA have shown useful results for 
subtyping in outbreak investigation, however, their use for serovar prediction supposes often 
a challenge in the case of polyphyletic serovars (e.g. Newport, Paratyphi B, or Kentucky 
serovars) and the standardization of profiles and protocols for inter and external-laboratory 
comparisons are required (TANG et al. 2019). Other attempts of molecular-based serotyping 
methods are rep-PCR, ribotyping, or MLST however, they have difficulties reflecting genetic 
relatedness between different serovars (XU et al. 2020). Recently, a genoserotyping system 
based on Multiplex Oligonucleotide Ligation – PCR (MOL-PCR) has been developed for the 
determination of specific invasive serovars in the poultry and pork sector (GAND et al. 2020). 
To evaluate the performance of three different Salmonella genoserotyping tools included in 
the previous version of WGSBAC (v. 2.0.0), we sequenced the genomes of 43 Salmonella 




their dificulty to be resolved by conventional serotyping (e.g. “rough” form isolates). Serovar 
prediction was carried out by three bioinformatics tools (SISTR, SeqSero, and SeqSero2) that 
were integrated within the previous version (v. 2.0.0) of the WGSBAC pipeline. The analysis 
concluded with the examination of the correlation between the serovar determination by slide 
agglutination test and the serovar prediction from in silico serotyping. The three tools 
performed the alignment of the sequenced query data to a curated database of O and H 
antigen allele reference sequences and the consequent assignment of the antigenic formula 
and/or the serovar name. SISTR works on assembled sequences by determination of the 
antigenic genes and the examination of cgMLST alleles and combines both approaches to 
report accurately the serovar (YOSHIDA et al. 2016, ROBERTSON et al. 2018). On the other 
hand, SeqSero and its updated version, SeqSero2, are mapping-based tools and work on raw 
reads as well as contigs (ZHANG et al. 2015, ZHANG et al. 2019). Besides, SeqSero2 has 
appeared as optimization of SeqSero including a k-mer based algorithm (“k-mer mode”) for 
rapid serovar prediction and a targeted micro-assembly approach (“allele mode”) (ZHANG et 
al. 2019). The results obtained were categorized into three main groups: “correct result”, 
“incorrect result” and “no result”. Furthermore, we subclassified the correct results into “full 
match”, “inconclusive” and “incongruent” according to the classification proposed by 
YACHISON et al. (2017) and also applied by UELZE et al. (2020)..Table S1, S2 and Figure S1 in 
the Appendix (section 8.2) present a detailed resolution of the results. 
We observed the highest correlation for SISTR (SISTR_consensus), reporting 34/43 (79.1%) of 
correct matches followed by SeqSero2 (reads in “k-mer mode”) (72.1%), SeqSero2 (reads in 
“allele mode”) (67.4%), SeqSero2 (assemblies in “k-mer mode”) (67.4%), SeqSero (with reads) 
(60.5%) and SeqSero (with assemblies) (58.1%). These results are in line with the study 
performed by UELZE et al. (2020) that employed a dataset consisting of 1624 Salmonella 
isolates of 72 different serovars and concluded that SISTR with 94% of correctly typed isolates 
is the most suitable prediction tool for routine serotyping. Another study performed in Canada 
(YACHISON et al. 2017) reported as well the highest record of correctly serotyped serovar for 
SISTR. Furthermore, our data is largely consistent with the benchmarking study conducted by 
the international ENGAGE project (RENE et al. 2018). The ENGAGE project was a European 
collaborative study that performed benchmarking exercises to promote the implementation 
of WGS for replacing conventional typing for outbreak investigations. Within the 




serotyped isolates with the tools SISTR, SeqSero, Metric Oriented Sequence Typer (MOST) 
(TEWOLDE et al. 2016), and SalmonellaTypeFinder (based on SRST2, MLST, and SeqSero) 
(INOUYE et al. 2014, ZHANG et al. 2015, ASHTON et al. 2016) and concluded that SISTR with a 
88% of correct results, shows the best correlation. 
Additionally to the correct matches, in our study, SISTR reported the highest percentage of 
incongruent results (7%). We considered as incongruent results those for isolates which 
serovar could not be resolved by conventional serotyping (e.g. “rough” forms isolates). Among 
them, we found that all the tools were able to predict serovar Dublin for two “rough” form 
isolates within the database, and only SISTR detected the variant Java for serovar Paratyphi B. 
The percentage of incongruent results was equivalent to the rest of the tools. UELZE et al. 
(2020) and the study performed by YACHISON et al. (2017) reported as well agreement for all 
the tools including SISTR (4.1% and 3.14% respectively). 
Regarding inconclusive predictions, those cases for which the tool listed at least two possible 
serovars, our analysis reported a percentage ranging from 0% (by SISTR) to 18.6% (by SeqSero 
using raw reads). However, the implementation of SeqSero2 (using reads in “allele mode”) 
could resolve half of these inconclusive predictions (9.3%). This occurred for serovars 
Bovismorbificans (typed by SeqSero as Bovismorbificans or Hindmarsh), serovar Hadar (typed 
as Hadar or Istanbul), serovar Indiana (typed as Indiana or II 4,12:z:1,7), and serovar Kottbus 
(typed as Kottbus or Ferruch). However, in three cases, both SeqSero and SeqSero2 could not 
resolve the correct serovar. For example for serovar Gallinarum, (typed as Gallinarum or 
Enteritidis), Goldcoast (typed as Goldcoast or Brikama), and Cholerasuis (typed as Cholerasuis 
or Paratyphi C or Typhisuis).  
Both YACHISON et al. (2017) and UELZE et al. (2020) showed as well a low percentage of 
inconclusive matches for SISTR (1.1% and 1.23% respectively) in contrast to high percentages 
for SeqSero (30% and 12.56% respectively). We agree with UELZE et al. (2020) that the ability 
of SISTR to resolve ambiguous results may be due to the high discrimination power offered by 
its cgMLST approach. On the other hand, it should be taken into consideration that the cgMLST 
approach does not allow SISTR to distinguish monophasic isolates in the cases in which the 
cgMLST distance is very small (e.g monophasic variant of serovar Typhimurium). In those 
cases, further analysis using the conventional serotyping technique would be required 




of serovar Typhimurium did not suppose an issue. In all the cases, SISTR could predict correctly 
the serovar with the antigenic formula I 4,[5],12:i:- and SeqSero and SeqSero2 could resolve it 
as “potential monophasic variant of Typhimurium”. However, we should take into 
consideration the small size of our dataset and the number of isolates of this serovar is not 
representative (7% (3/43) strains typed as “monophasic Typhimurium” and 5% (2/43) typed 
as Typhimurium).  
Surprisingly, in our study SISTR reported as well the highest number of incorrectly predicted 
serovars (14%) in an equal percentage as SeqSero using assemblies (14%). They were followed 
by SeqSero (using reads) (11.6%) and SeqSero2 (using reads in “allele mode”) (11.6%). 
However, SeqSero2 in “k-mer mode” using indistinctly raw reads or contigs reported the 
fewest percentage of incorrect results (9.3%). Interestingly for six isolates reported by 
traditional serotyping as serovar Panama, Abony, Tennessee, Enteritidis, Mbandaka, and 
Panama all the tools failed in the serovar prediction or were not able to determine any serovar. 
The mismatch was evident, for serovar Panama (isolate 16PM0121), for which all the tools 
agreed on the prediction of serovar Goettingen and for serovar Tenessee (isolate 16PM0161), 
for which all the tools agreed on the prediction of serovar Mbandaka (Supplementary Table 
1). We observe that the major difference between the mismatched serovar formulas resides 
in the second phase for the flagellar antigen. As reported before by YACHISON et al. (2017), 
one possible reason for the incorrect results is the inhability of the tool to call the correct 
flagellar antigenic determinant for close related serovars. Another reason could be the 
mistakenly reported serovar by conventional serotyping, however, this can not be supported 
in our study as the isolates were not retested either by conventional serotyping or 
bioinformatics analysis. 
SeqSero using contigs was the tool with a high percentage of non-determined serovars 
(14.0%), including one Salmonella enterica subsp. diarizonae (IIIb) strain that was correctly 
typed by the rest of the tools as serovar 61:k:1,5,7. On the contrary, when using raw reads, 
SeqSero reported only 4.7% of no results. Besides, SeqSero2 reported 11.6% of no results 
when used with assemblies in “k-mer mode”. For the majority of these cases, the tool reported 
possible inter serotype contamination and 7% when used with reads regardless of the mode. 
Our results demonstrate that WGSBAC is feasible to determine the antigenic profile in most 




that SeqSero 2 for reads in k-mer mode appeared as accurate as SISTR. This largely correlates 
with recent results (UELZE et al. 2020). We are aware that the small size of our dataset suppose 
a handicap to observe the performance of the three bioinformatics tools tested. This fact 
affected, for example the recognition of the GC bias effect of the GC for some serovars or the 
differences due to the use of different library preparation kits (Nextera XT DNA library 
preparation kit/Nextera DNA Flex library preparation kit).  
4.2. Application of the WGSBAC pipeline to study the potential occurrence and high 
tendency of dissemination of a MDR emergent S. Infantis population in German broiler 
farms.  
S. Infantis has doubled its prevalence in broiler flocks and the number of humans affected by 
this NTS serovar has reached a high level so that it is now considered a potential hazard for 
public health (EFSA 2019a). Only during the last year, several studies including the present 
one, have reported the emergent situation and rapid worldwide dissemination of S. Infantis 
isolates with recurrent resistance and virulence profiles (ALBA et al. 2020, GARCÍA-SOTO et al. 
2020, JOVCIC et al. 2020, LAPIERRE et al. 2020, MCMILLAN et al. 2020, NAGY et al. 2020, 
PROIETTI et al. 2020, TYSON et al. 2020, KUREKCI et al. 2021). Studies agree that the possession 
of a megaplasmid named pESI (plasmid of Emergent Salmonella Infantis) or similar ones (pESI-
like plasmids) characterize the emergent S. Infantis (ESI) population. In this study, the presence 
of a conjugative pESI-like plasmid has been detected within German broiler-derived S. Infantis 
strains. The genome comparison of the German plasmid pESI-like (pESI2747) and the Israeli 
(pESI119944) revealed a homology of 97.37%. Although in different locations, both contained 
the replicon IncFIB, the repB gene coding for RepFIB replication protein A, the complete IncI 
gene profile (ardA, pilL, sogS, trbA, and repI1 absent), and the origin of replication of an IncP 
plasmid. The homology in terms of genetic composition between the Israeli pESI and the 
German pESI-like has been observed within the strains collected from the 2010s and not within 
the ones from the 1990s. Besides, the in-detailed comparative genome analysis of the 
complete genome sequence of one pESI-like positive strain within the German dataset (2747) 
with the complete genome sequence of S. Infantis from Israel (ESI119944) and other ESI clones 
from Europe (FRANCO et al. 2015, OLASZ et al. 2015, WILK et al. 2016, WILK et al. 2017) 
confirms the homology between the resistance, virulence, and fitness genetic traits encoded 




the possession of the megaplasmid might be a potential reason for the switch in the 
occurrence of S. Infantis in broilers from non-MDR strains (until the 2000s) (ASAI et al. 2007, 
SHAHADA et al. 2008, WILK et al. 2017) to the emergence of MDR clones (during and after the 
end of the 2000s) (NÓGRÁDY et al. 2007, NÓGRÁDY et al. 2008, NÓGRÁDY et al. 2012).  
The predominant MDR phenotypic profile of the ESI clones from Europe consists mostly of 
resistance to the antimicrobial families (aminoglycosides, sulphonamides (trimethoprim), and 
tetracyclines) (CLOECKAERT et al. 2007, FRANCO et al. 2015, ACAR et al. 2019, PROIETTI et al. 
2020). The application of these antimicrobials for the prevention and therapy of diseases in 
poultry may facilitate the occurrence of this AMR profile among S. Infantis strains 
(WASSENAAR. 2005). The variable nature of the pESI plasmid as recently indicated by COHEN 
et al. (2020) enables genetic and phenotypic diversity, especially to the AMR profile. Among 
the AMR pattern variations found in other ESI clones from Europe, the presence of ESBL-
positive clones found mostly in Italy (FRANCO et al. 2015, PROIETTI et al. 2020), Hungary 
(SZMOLKA et al. 2018), and Switzerland (HINDERMANN et al. 2017) needs to be mentioned. 
The Italian ESI clones carry the gene blaCTX-M-1 conferring resistance to cephalosporin as well 
as the gene mcr-1 gene mediating colistin resistance (CARFORA et al. 2018). However, another 
recent study has reported reduced susceptibility to colistin among ESI isolates from poultry 
farms in Serbia (JOVCIC et al. 2020). They hypothesized that this reduction is due to the more 
prudent use of enrofloxacin in the past years. Furthermore, in Hungary, ESI was identified to 
carry the gene blaTEM-1 and the qnrS for beta-lactam and fluoroquinolone resistance on the 
pESI-like plasmid (pESI54/04) (SZMOLKA et al. 2018) while in Switzerland, only one strain 
contained the gene blaCTX-M-65 (HINDERMANN et al. 2017) reflecting the uncommon presence 
of the gene blaCTX-M-65 in the EU food-production chain. Contrarily, in North and South America 
due to the recurrent presence of the gene blaCTX-M-65, it has been used as a predictor for the 
detection of pESI plasmids (TATE et al. 2017, FUENTES-CASTILLO et al. 2019, MCMILLAN et al. 
2020). 
In the present study, in silico phenotyping has confirmed the recurrent MDR phenotype in the 
majority of German strains from the 2010s. We named the pattern “ESIr” (Emergent 
Salmonella Infantis resistance) and it consisted of the genes ant(3“)-la, sul1, and tet(A) that 
correlate with the phenotypic resistance profile of the strains to aminoglycosides, 




incongruence for the genes ant(3“)-la and aac(6′)-Iaa mediating resistance to aminoglycosides 
(ACAR et al. 2019, KUREKCI et al. 2021). We did not find the gene aac(6′)-Iaa within the pESI-
like plasmid, but on the chromosome, suggesting its nature as a chromosomal-encoded gene 
as indicated before (SALIPANTE et al. 2003). Additionally, within the chromosome of German 
ESI strains, a mutation in the gyrA gene was detected, known to deal with resistance to 
fluoroquinolones (ciprofloxacin and nalidixic acid)(CHENG et al. 2019). Recently, four different 
chromosomal point mutations of the gene gyrA were found as well in different proportions 
among European strains (ALBA et al. 2020). Within the German strains, we did not find any 
ESBL-positive clone, however, a study performed in Germany showed the presence of genes 
for beta-lactamases circulating in the food chain (FISCHER 2017).  
The backbone of pESI and pESI-like plasmids are not only defined to confer MDR profile to the 
ESI clones but also a specific set of virulence markers (AVIV et al. 2014, COHEN et al. 2020). In 
general, the virulence pattern consists of several virulence genes coding for structures 
involved in increasing host invasion and colonization, motility, and persistence of the ESI in 
the farms (AVIV et al. 2014, AVIV et al. 2016, AVIV et al. 2017). Among them, the 
yersiniabactin-iron acquisition system (Ybt) and the novel fimbriae complexes Klf (K88-like 
fimbria), and the Ipf (Infantis plasmid-encoded fimbria) have been detected. Furthermore, the 
toxin/antitoxin complexes such as CcdA/B, PemK/I, MazE/F, and VagCD have been reported 
as systems activated under stress conditions and play a role in the adaptability of plasmids and 
persistence of certain Salmonella serovars (GOEDERS et al. 2014, DI CESARE et al. 2016). 
Additionally, the mercury (mer) operon conferring bacterial tolerance to mercury (COHEN et 
al. 2020) and the gene qacEdelta1 known to provide resistance to heavy metals or biocides 
like quaternary ammonium compounds were found (QACs) (CHUANCHUEN et al. 2007).  
Regarding the virulence profile of the German ESI clones, the bioinformatics analysis found 
this specific virulence and fitness-associated genes pattern with some variations. We termed 
this pattern “ESIv” (Emergent Salmonella Infantis virulence) and it was only present among 
the strains collected from the 2010s. In contrast to the variable nature of the pESI-like 
plasmids, the chromosome of ESI strains provides a conserved distribution of  Salmonella 
pathogenicity islands (SPIs) across S. Infantis and other ESI clones genomes (COHEN et al. 
2020). In this study, within the chromosome of the ESI German clones, we found 10 intact SPIs 




Other gene complexes related to fimbrial production and known to be part of the core genome 
of NTS serovars (DHANANI et al. 2015) such us fim (type 1 fimbria) and lpf (long polar fimbria), 
were found among the chromosome of the S. Infantis from this study.  
S. enterica and other Enterobacteriaceae are known to carry plasmids involved in resistance 
and virulence (CARATTOLI 2009). Previous studies reported that certain Salmonella serovars 
commonly carry large (>40 kb), virulence-plasmids in low-copy numbers (1-2 copies) 
(SANCHEZ-ROMERO et al. 2020). The acquisition of virulence-plasmids may benefit specially 
host-adapted serovars as they may expand their host range (ROTGER et al. 1999). Some 
plasmids carry as well genes that control the expression of essential bacterial structures and 
others are also reservoirs of AMR (EMOND-RHEAULT et al. 2020, SANCHEZ-ROMERO et al. 
2020). Furthermore, there are so-called hybrid virulence-resistance plasmids in NTS such as S. 
Typhimurium and S. Cholerasuis (MENDOZA MDEL et al. 2009). 
As occurred in other bacterial pathogens, the presence of pESI or pESI-like plasmid-borne 
genes may ensure the evolutive success of the emergent S. Infantis population. It is accepted 
that the AMR and virulence-associated determinants encoded in pESI plasmid may play a 
beneficial role in the pathogenesis and rapid dissemination of the emergent S. Infantis 
population (AVIV et al. 2014, COHEN et al. 2020). However, the carriage of such large and 
complex plasmids may impose as well fitness stress and a metabolic cost on the host. The 
megaplasmid pESI is presented in a single copy and despite its large size (258081 bp), its 
presence does not result in a significant burden to its host and does not limit its transmission 
and dissemination potential (AVIV et al. 2016). Evidence of this is that fixing in the population 
has been demonstrated by AVIV et al. (2016) as well as an interspecies transfer into the mouse 
microbiota (from S. Infantis to Escherichia coli). The authors hypothesize about the role of 
microbiota in the transfer of genes between pathogenic and commensal bacteria. 
Furthermore, due to the fitness cost that conjugative transfer supposes, the plasmids encode 
mechanisms associated with their maintenance (PILLA et al. 2018). The comparative genome 
analysis performed by BOGOMAZOVA et al. (2019) showed that pESI-like plasmids contain a 
conservative 173kB sequence encoding genes responsible for plasmid maintenance and 
conjugative transfer. Among them transfer (tra) genes and pilus (pil) genes present also within 
the German pESI-like plasmid may play a role in the regulation of the plasmid metabolism. 




the virulence-plasmid of S. Typhimurium in strain LT2 (pSLT), toxin-antitoxin systems may 
ensure successful stability of megaplasmids (SANCHEZ-ROMERO et al. 2020). In particular, the 
CcdA-CcdB complex may be implicated as well in the adaptability and stability of pESI and pESI-
like megaplasmids (HAYES 2003, GOEDERS et al. 2014) 
Besides, genotyping and phylogenetic studies of the ESI clones revealed that the major ST 
among the ESI clones from Europe is ST32 (FRANCO et al. 2015, ALBA et al. 2020, KUREKCI et 
al. 2021). However, novels STs have been found recently in Serbia (ST413 and ST11) in strains 
corresponding to different geographical regions. Moreover, in Turkey, a single novel ST7091 
was found in a minor proportion compared to the dominant ST32 (KUREKCI et al. 2021). In this 
study, we found the ST32 within half of the German dataset (15 out of 30) as well as a novel 
ST2283 within the strains from the 2010s and the previously reported ST1032 (ALBA et al. 
2020) within non-emergent isolates from the 1990s. Interestingly, and in contrast to previous 
studies, we found ST32 among the majority of non-emergent strains from the 1990s and only 
two ESI strains from the 2010s. Meanwhile, the novel ST2283 was predominant among the ESI 
strains from the 2010s. This might indicate a greater tendency of dissemination of ESI clone 
ST2283 in Germany. A SNP-based and chromosome-based phylogenetic analysis showed 
general concordance in cluster separation between the chromosome- and the plasmid-based 
tree in all the strains (ST32 and ST2283) harboring the pESI-like plasmid as also shown by ALBA 
et al. (2020). Therefore, we hypothesized that the plasmid has co-evolved with the 
chromosome and both STs (ST32 and ST2283) gained the plasmid in two (or more) 
evolutionary independent events. GYMOESE et al. (2019) observed as well separation of 
clusters between S. Infantis strains carry pESI-like plasmids and plasmidless S. Infantis 
population. They suggested that the use of antimicrobials at the beginning of the poultry 
production industry (around 60 years ago) may select for the pESI-like positive S. Infantis 
population.  
The prompt dissemination of an ESI population observed during the last decade in Germany 
supposes an urgent public health concern. The study presented here gives evidence of the 
occurrence of an emergent MDR S. Infantis population in Germany able to strong 
dissemination within two decades. The acquisition of AMR, virulence-associated 
determinants, as well as the pESI-like encoded mechanisms such as toxin-antitoxin systems or 




promote this worrying epidemiological event. The use of WGS and our own implemented 
bioinformatics pipeline has successfully enabled i) the reliable serovar prediction of the strains 
driven by the previous implementation of an in-house pipeline for serovar prediction and ii) 
the power for the accurate and detailed characterization of German strains and comparison 
with other S. Infantis clones circulating in Europe and outside Europe. Nevertheless, we are 
aware of the limitations of this study and that further analysis is needed to provide a more 
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Einleitung: Salmonella enterica subspecies enterica serovar Infantis (S. Infantis) nimmt die 
vierte Position in der Rangliste der am häufigsten gemeldeten Salmonella-Serovare in Europa 
ein. Während des letzten Jahrzehnts hat das Auftreten einer multiresistenten Salmonella 
enterica subspecies enterica serovar Infantis (S. Infantis)-Population rapide zugenommen und 
ist in der europäischen und außereuropäischen Broilerproduktion weit verbreitet.  
Ziel der Untersuchungen: Die Studie zielte darauf ab, i) eine bioinformatische Pipeline für die 
in silico-Serotypisierung von Salmonellen zu implementieren und deren Leistungsfähigkeit zu 
bewerten, und ii) die genetischen Determinanten für das in der deutschen Broilerproduktion 
während des letzten Jahrzehnts beobachtete vermehrte Auftreten von S. Infantis zu 
identifizieren. 
Tiere, Material und Methoden: Zunächst wurde eine Bioinformatik-Pipeline (WGSBAC) und 
drei bioinformatische Tools (SISTR, SeqSero und SeqSero2) zur Genoserotypisierung von 43 
Salmonella spp.-Stämmen von 26 verschiedenen Serovaren durchgeführt. Zweitens führten 
wir die Genomsequenzierung von 30 S. Infantis Broiler-Isolaten durch, die in zwei 
unterschiedlichen Jahrzehnten (den 1990er und den 2010er Jahren) gesammelt wurden. Wir 
setzen die WGSBAC-Pipeline und externe Bioinformatik-Software ein, um i) die Qualität der 
sequenzierten Reads zu bewerten und zu kontrollieren, ii) Assemblierungen und 
Qualitätskontrollen von und iii) Annotation, Typisierung durch klassischen MLST, cgMLST, 




(SNPs) und in-silico-Phänotyp-Vorhersage, einschließlich antimikrobieller Resistenzgene 
(AMR), Virulenzgene und Plasmid-Replikons zu erkennen.  
Ergebnisse: Die Bioinformatik-Pipeline WGSBAC ist geeignet, das antigene Profil der meisten 
der in der Studie verwendeten Salmonella-Stämme zu bestimmen. Das Tool SISTR zeigte dabei 
die höchste Übereinstimmung (79,1 %), gefolgt von SeqSero2 (72,1 %) und SeqSero (60,5 %). 
Die Untersuchung der S. Infantis-Stämme ergab, dass im Gegensatz zu den Isolaten aus den 
1990er Jahren, die Mehrheit der Stämme aus den 2010er Jahren das Vorhandensein eines 
Megaplasmids zeigte, das homolog zu dem pESI-Plasmid aus Israel und anderen pESI-
ähnlichen Plasmiden aus europäischen Isolaten ist. Das deutsche pESI-ähnliche Plasmid 
kodierte für ein Muster von multiresistenten Genen (MDR), ein Muster von Virulenzgenen und 
mehrere Fitness-assoziierte Determinanten, welches wir "ESIr" nannten. Dieses korrelierte mit 
mindestens drei antimikrobiellen Familien: ant(3")-Ia (Aminoglykoside), sul1 (Sulfonamide) 
und tet(A) (Tetracycline). Der Genotyp korreliert hier vollständig mit dem antimikrobiellen 
Phänotyp. Außerdem bezeichneten wir das Virulenzmuster als "ESIv", welches Gene für 
Fimbrien-Cluster, Yersiniabactin-Siderophore, Quecksilberresistenz und Antitoxin/Antitoxin-
Systeme mit einschließt.  Die Genotypisierungsanalyse ergab das Vorhandensein eines neuen 
Sequenztyps (ST2283) bei der Mehrzahl der Stämme aus den 2010er Jahren und ST32 und 
ST1032 bei den Stämmen aus den 1990er Jahren. 
Schlussfolgerungen: Anhand eines auf Gesamtgenomsequenzierung-basierten Ansatzes 
zeigte diese Studie, dass MDR S. Infantis ST2283 Stämme, die ein pESI-ähnliches Plasmid 
tragen, während des letzten Jahrzehnts entstanden sind und derzeit in der deutschen 
Geflügelproduktionskette zirkulieren. Der Erwerb eines Megaplasmids, das für Resistenzen, 
Virulenz-assoziierte Determinanten und Fitnessmechanismen kodiert, könnte dieses schnelle 
und besorgniserregende epidemiologische Ereignis erklären. Dieses Ereignis stellt eine Gefahr 
für die öffentliche Gesundheit dar. Daher sind Kontrollmaßnahmen und die Unterstützung 
epidemiologischer Studien erforderlich, um den Eintritt, die Übertragung und die weitere 
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Background: Salmonella enterica subspecies enterica serovar Infantis (S. Infantis) places the 
fourth position in the ranking of most reported Salmonella serovars in Europe. During the last 
decade, a multi-drug resistant (MDR) S. Infantis population has rapidly increased and 
widespread in European and non-European broiler production.  
Goal: The study proposed here aimed to i) implement and evaluate the performance of a 
bioinformatics pipeline named WGSBAC for Salmonella in silico serotyping, and ii) identify the 
genetic determinants for the increased emergence of broiler-derived S. Infantis observed in 
Germany.  
Animals, material, and methods: First, we conducted an evaluation of WGSBAC and three 
bioinformatic tools (SISTR, SeqSero, and SeqSero2) for the characterization and 
genoserotyping of 43 Salmonella strains of 26 different serovars. Second, we performed 
sequencing of 30 broiler-derived S. Infantis isolates collected from two distant decades (the 
1990s and the 2010s). We applied the WGSBAC pipeline and external bioinformatics software 
to i) assess and control the quality of the sequenced reads ii) assembly and quality control of 
assemblies, and iii)  annotation, typing by classical MLST, cgMLST, genoserotyping, SNPs-based 
phylogenetic reconstruction and in silico phenotype prediction including antimicrobial 
resistance genes (AMR), virulence genes and plasmid replicons detection. To detect possible 




comparative genome analysis using 17 public genomes of other S. Infantis clones circulating 
in Europe. 
Results: WGSBAC was feasible for the serovar prediction of most of the 43 Salmonella strains. 
The tool SISTR reported the highest correlation (79.1%) followed by SeqSero2 (72.1%) and 
SeqSero (60.5%). The study of the S. Infantis strains revealed that in contrast to the isolates 
from the 1990s, the majority of the strains from the 2010s revealed the presence of a 
megaplasmid that carried a multidrug-resistant genes (MDR) pattern, a virulence genes 
pattern, and several fitness-associated determinants. We termed the MDR gene pattern “ESIr” 
and it coded for at least three antimicrobial families: ant(3”)-Ia (aminoglycosides), sul1 
(sulfonamides), and tet(A) (tetracyclines). Besides, we termed the virulence pattern as “ESIv” 
which includes genes for fimbriae cluster, yersiniabactin siderophore, mercury resistance, and 
antitoxin/antitoxin systems. Furthermore, the genotyping analysis revealed the presence of a 
novel sequence type (ST2283) among the majority of the strains from the 2010s and ST32 and 
ST1032 within the strains from the 1990s. This genetic traits may promote the rapid incidence 
and dissemination of a novel MDR S. Infantis population. 
Conclusion: Following a WGS-based approach, this study evidences that MDR S. Infantis 
ST2283 strains carrying a pESI-like plasmid have emerged during the last decade and are 
currently circulating in the German poultry production chain. This event results in an urgent 
public health hazard, thus, control measures and the support of epidemiological studies are 
needed to prevent the entrance, transmission, and further dissemination of this clonal 
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8.1. Supplementary Tables from the publication 
Table S1. S. Infantis genomes for previously reported emergent S. infantis clones from Israel 
(AVIV et al. 2014, AVIV et al. 2016), Hungary (OLASZ et al. 2015, WILK et al. 2016, WILK et al. 
2017), and Italy (FRANCO et al. 2015) used in this study and their general genome 
characteristics and genoserotyping (*Not applicable: N/A: CoG: contig; Cov: coverage). 
ID isolate Accesion Number Reference Source Year of isolation 
Region of 
isolation 
335-3 ATHK00000000 Aviv et al., 2014 Human 1970 Israel 
1326/28  LN649235 Olasz et al., 2015 Broiler 1973 United Kingdom 
SI69/94 JRXB00000000 Olasz et al., 2015 Broiler 1994 Hungary 
SI54/04  JRXC00000000 Olasz et al., 2015 Broiler 2004 Hungary 
ERS846145 ERR1014111 Franco et al., 2015 Broiler 2006 Italy 
ERS846143 ERR1014109 Franco et al., 2015 Broiler 2007 Italy 
SI119944 GCA010919335 Aviv et al., 2014 Broiler 2008 Israel 
ERS846152 ERR1014118 Franco et al., 2015 Broiler 2009 Italy 
ERS846151 ERR1014117 Franco et al., 2015 Broiler 2012 Italy 
SI3337/12 MIJS00000000 Wilk et al., 2016 Broiler 2012 Hungary 
ERS846147 ERR1014113 Franco et al., 2015 Broiler 2013 Italy 
ERS846148 ERR1014114 Franco et al., 2015 Broiler 2013 Italy 
SI757/13 MIJT00000000 Wilk et al., 2016 Broiler 2013 Hungary 
SI786/13 MIJR00000000 Wilk et al., 2016 Broiler 2013 Hungary 
ERS846150 ERR1014116 Franco et al., 2015 Broiler 2014 Italy 
SI1070/16 MRUX00000000 Wilk et al., 2017 Broiler 2016 Hungary 
SI240/16 MRUW00000000 Wilk et al., 2017 Broiler 2016 Hungary 
 
Continuation Table S1 





335-3 Infantis 79 N/A 152,157 52.3 4.60 32 Infantis 
1326/28  Infantis 1 N/A 4,710,675 52.3 4.70 32 Infantis 
SI69/94 Infantis 175 N/A 479,709 52.1 4.90 32 Infantis 
SI54/04  Infantis 78 N/A 290,766 52.1 5.00 32 Infantis 
ERS846145 Infantis 44 151 202,383 52.2 4.80 32 Infantis 
ERS846143 Infantis 49 85 416,324 52.1 4.90 32 Infantis 
SI119944 Infantis 2 N/A 4,725,957 52.2 5.00 32 Infantis 
ERS846152 Infantis 47 99 416,371 52.2 4.90 32 Infantis 
ERS846151 Infantis 47 127 386,563 52.2 4.90 32 Infantis 
SI3337/12 Infantis 47 N/A 264,211 52.1 5.00 32 Infantis 
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ERS846148 Infantis 50 174 386,579 52.2 4.90 32 Infantis 
SI757/13 Infantis 53 N/A 343,219 52.2 4.90 32 Infantis 
SI786/13 Infantis 48 N/A 285,944 52.2 4.90 32 Infantis 
ERS846150 Infantis 47 120 386,585 52.2 4.90 32 Infantis 
SI1070/16 Infantis 58 N/A 445,038 52.1 4.90 32 Infantis 






















Table S2. Specific gene sequences dow
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ized databases for 
ABRicate and available databases dow
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KI/M
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ercury operon, and allele sequences 
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patibility groupsplasm
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subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
49897..50115 219 CP047882 
Cohen et al., 2020 
(PMID: 32145019) 
type II toxin-antitoxin 




subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
50117..50422 306 CP047882 Cohen et al., 2020 
(PMID: 32145019) 
type II toxin-antitoxin 




subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
 14789..15121 333 CP047882 
Cohen et al., 2020 
(PMID: 32145019) 






subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
14531..14788 258 CP047882 
Cohen et al., 2020 
(PMID: 32145019) 
antitoxin PemI-like fitness_IS 
merE 
Salmonella enterica 
subsp. enterica serovar 
Infantis strain 119944 














subsp. enterica serovar 
Infantis strain 119944 































subsp. enterica serovar 
Infantis strain 119944 












subsp. enterica serovar 
Infantis strain 119944 











subsp. enterica serovar 
Infantis strain 119944 














subsp. enterica serovar 
Infantis strain 119944 












subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
172570..173004 435 CP047882 









subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
38569..39108 540 CP047882 
Cohen et al., 2020 
(PMID: 32145019) 












DESCRIPTION NAME DB 
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faeD 
Salmonella enterica 
subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
39133..41565 2433 CP047882 
Cohen et al., 2020 
(PMID: 32145019) 
F4 (K88) fimbrial 




subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 









subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
42409..42900 492 CP047882 
Cohen et al., 2020 
(PMID: 32145019) 
fimbrial protein fimbrial_clusters 
faeH 
Salmonella enterica 
subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
44110..44901 792 CP047882 
Cohen et al., 2020 
(PMID: 32145019) 
F4 (K88) fimbria 





subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
44929..45693 765 CP047882 
Cohen et al., 2020 
(PMID: 32145019) 




subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
53160..53696 537 CP047882 
Cohen et al., 2020 
(PMID: 32145019) 












DESCRIPTION NAME DB 




subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
53818..54480 663 CP047882 









subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 









subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
57230..58279 1050 CP047882 
Cohen et al., 2020 
(PMID: 32145019) 




subsp. enterica serovar 
Infantis strain 119944 
plasmid pESI, complete 
sequence 
1..1011 1011 CP047882 































Plasmid RK2 (from E.coli) 
DNA with transposon 
(Tn1723) insertion sites 
1..811 811 M20134 








NAME ACCESION NUMBER 
SIZE 
(bp) START END STRAIN DESCRIPTION 
Continuation Table S2 







NC_006905.1:2960260-3003748 Salmonella enterica subsp. enterica 
serovar Choleraesuis str. SC-B67, complete genome 
SPI-1 NC_003198_P5 41851 2858736 2900586 
Salmonella enterica 
subsp. enterica 
serovar Typhi CT18 
NC_003198.1:2858736-2900586 Salmonella enterica subsp. enterica 
serovar Typhi str. CT18, complete genome 
SPI-1 NC_004631_P2 41851 2844593 2886443 
Salmonella enterica 
subsp. enterica 
serovar Typhi Ty2 
NC_004631.1:2844593-2886443 Salmonella enterica subsp. enterica 
serovar Typhi str. Ty2, complete sequence 







NC_006905.1:1497670-1539498 Salmonella enterica subsp. enterica 
serovar Choleraesuis str. SC-B67, complete genome 
SPI-2 NC_003198_P3 41605 1624920 1666524 
Salmonella enterica 
subsp. enterica 
serovar Typhi CT18 
NC_003198.1:1624920-1666524 Salmonella enterica subsp. enterica 
serovar Typhi str. CT18, complete genome 
SPI-2 NC_004631_P1 41610 1314607 1356216 
Salmonella enterica 
subsp. enterica 
serovar Typhi Ty2 
NC_004631.1:1314607-1356216 Salmonella enterica subsp. enterica 
serovar Typhi str. Ty2, complete sequence 













NAME ACCESION NUMBER 
SIZE 
(bp) START END STRAIN DESCRIPTION 
Continuation Table S2 







NC_006905.1:3890879-3903697 Salmonella enterica subsp. enterica 
serovar Choleraesuis str. SC-B67, complete genome 
SPI-3 NC_003198_P7 16941 3883613 3900553 
Salmonella enterica 
subsp. enterica 
serovar Typhi CT18 
NC_003198.1:3883613-3900553 Salmonella enterica subsp. enterica 
serovar Typhi str. CT18, complete genome 
SPI-4 AF060869 27290 1 27290 Salmonella enterica LT2 
AF060869.1 Salmonella typhimurium excision nuclease UvrA (uvrA) 
gene, partial cds; single-strand binding protein (ssb) gene, complete 
cds; tRNA-Thr gene, complete sequence; pathogenicity island SPI-4 
operon, complete sequence; yjcB gene, complete cds; and yjcC 
gene, partial cds 
SPI-4 AJ576316 24660 1 24660 Salmonella enterica ST4/74 
AJ576316.1 Salmonella typhimurium Salmonella Pathogenicity 
Island 4 siiABCDEF genes 






NC_006905.1:4411902-4438599 Salmonella enterica subsp. enterica 
serovar Choleraesuis str. SC-B67, complete genome 
SPI-4 NC_003198_P8 23391 4322993 4346383 
Salmonella enterica 
subsp. enterica 
serovar Typhi CT18 
NC_003198.1:4322993-4346383 Salmonella enterica subsp. enterica 





NAME ACCESION NUMBER 
SIZE 
(bp) START END STRAIN DESCRIPTION 
Continuation Table S2 
SPI-5 AF060858 9739 1 9739 Salmonella enterica 2229 
AF060858.1 Salmonella dublin regulatory protein CopR (copR), 
histidine kinase (copS), SPI-4 pathogenicity island containing 
dipeptidase homolog (pipD), SopB (sopB), PipC (pipC), PipB (pipB), 
and PipA (pipA) genes, complete cds; and tRNA-Ser gene, complete 
sequence; and unknown genes 






NC_006905.1:1155936-1161624 Salmonella enterica subsp. enterica 
serovar Choleraesuis str. SC-B67, complete genome 
SPI-5 NC_003198_P2 7496 bp 1085068 1092563 
Salmonella enterica 
subsp. enterica 
serovar Typhi CT18 
NC_003198.1:1085068-1092563 Salmonella enterica subsp. enterica 
serovar Typhi str. CT18, complete genome 
SPI-6 NC_003198_P1 58666 bp 302092 360757 
Salmonella enterica 
subsp. enterica 
serovar Typhi CT18 
NC_003198.1:302092-360757 Salmonella enterica subsp. enterica 
serovar Typhi str. CT18, complete genome 
SPI-7 NC_003198_P9 133638 bp 4409511 4543148 
Salmonella enterica 
subsp. enterica 
serovar Typhi CT18 
NC_003198.1:4409511-4543148 Salmonella enterica subsp. enterica 
serovar Typhi str. CT18, complete genome 
SPI-7 NC_004631_P3 131749 bp 4394302 4526050 
Salmonella enterica 
subsp. enterica 
serovar Typhi Ty2 
NC_004631.1:4394302-4526050 Salmonella enterica subsp. enterica 
serovar Typhi str. Ty2, complete sequence 
SPI-8 NC_003198_P6 6885 3132530 3139414 
Salmonella enterica 
subsp. enterica 
serovar Typhi CT18 
NC_003198.1:3132530-3139414 Salmonella enterica subsp. enterica 





NAME ACCESION NUMBER 
SIZE 
(bp) START END STRAIN DESCRIPTION 
Continuation Table S2 
SPI-9 NC_003198_P4 15696 2743495 2759190 
Salmonella enterica 
subsp. enterica 
serovar Typhi CT18 
NC_003198.1:2743495-2759190 Salmonella enterica subsp. enterica 
serovar Typhi str. CT18, complete genome 
SPI-10 NC_003198_P10 32934 4683605 4716538 
Salmonella enterica 
subsp. enterica 
serovar Typhi CT18 
NC_003198.1:4683605-4716538 Salmonella enterica subsp. enterica 
serovar Typhi str. CT18, complete genome 







NC_006905.1:1350481-1366166 Salmonella enterica subsp. enterica 
serovar Choleraesuis str. SC-B67, complete genome 







NC_006905.1:2354604-2365678 Salmonella enterica subsp. enterica 
serovar Choleraesuis str. SC-B67, complete genome 
CS54 AF140550 25252 1 25252 Salmonella enterica ATCC14028 
AF140550 AF140550.2 Salmonella typhimurium exonuclease VII 
(xseA), ShdA (shdA), RatC (ratC), RatB (ratB), RatA (ratA), SinI (sinI), 


































e Sequencing general characteristics and genoserotyping of the 
 S. Infantis strains from
 G
erm
any used in this study. 
ID isolate ID strain Total reads (bp) Total contigs Coverage N50 (bp) Identified species % 1st match Identified genera % 1st match 
2945 19PM0346 1,811,804 42 93 264.378 Salmonella enterica 97.1 Salmonella 97.79 
2947 19PM0348 1,771,342 46 90 332.767 Salmonella enterica 91.87 Salmonella 92.5 
2948 19PM0349 2,124,116 51 107 201.973 Salmonella enterica 97.12 Salmonella 97.83 
2949 19PM0350 1,945,002 54 102 240.386 Salmonella enterica 87.27 Salmonella 87.83 
2951 19PM0351 2,509,738 37 128 353.754 Salmonella enterica 97.15 Salmonella 97.81 
3222 20PM0240 991.352 49 47 204.015 Salmonella enterica 96.41 Salmonella 97.21 
3225 20PM0243 1,470,222 46 67 304.608 Salmonella enterica 96.04 Salmonella 96.96 
3227 20PM0245 2,191,574 38 96 397.341 Salmonella enterica 95.96 Salmonella 97.03 
3230 20PM0248 524.688 85 24 90.139 Salmonella enterica 96.41 Salmonella 97.27 
3234 20PM0252 832.998 91 37 90.406 Salmonella enterica 95.5 Salmonella 96.64 
3239 20PM0257 90.067 52 42 184.048 Salmonella enterica 95.86 Salmonella 96.71 
3242 20PM0260 1,181,000 60 57 138.816 Salmonella enterica 96.64 Salmonella 97.51 
3243 20PM0261 1,270,948 53 59 204.015 Salmonella enterica 94.14 Salmonella 94.99 





 General genome characteristics Kraken classification 
Continuation Table S3 
3249 20PM0267 1,522,276 52 73 213.614 Salmonella enterica 94.59 Salmonella 95.34 
3250 20PM0268 1,271,966 45 59 229.154 Salmonella enterica 96.4 Salmonella 97.42 
3252 20PM0270 793.374 89 35 123.937 Salmonella enterica 93.52 Salmonella 94.55 
3253 20PM0271 560.54 86 26 118.236 Salmonella enterica 94.31 Salmonella 95.15 
3255 20PM0273 1,163,972 48 55 202.039 Salmonella enterica 93.11 Salmonella 94.05 
3257 20PM0275 660.432 56 32 212.700 Salmonella enterica 94.83 Salmonella 95.52 
2954 19PM0355 1,159,090 50 52 222.196 Salmonella enterica 93.72 Salmonella 94.79 
2957 19PM0358 1,529,268 52 76 353.112 Salmonella enterica 94.76 Salmonella 95.39 
2959 19PM0360 1,357,154 49 64 255025 Salmonella enterica 93.95 Salmonella 94.92 
2747 19PM0148 2,071,834 49 92 416.366 Salmonella enterica 93.51 Salmonella 94.56 
2748 19PM0149 2,031,940 48 90 416.095 Salmonella enterica 94.39 Salmonella  93.32 
2749 19PM0150 2,022,404 46 91 416.184 Salmonella 94.59 Salmonella enterica 93.58 
2750 19PM0151 1,301,816 51 56 333.573 Salmonella 89.8 Salmonella enterica 88.75 
2752 19PM0153 1,629,922 48 72 333.259 Salmonella 94.22 Salmonella enterica 93.15 
2753 19PM0154 1,676,256 51 74 232.037 Salmonella 94.61 Salmonella enterica 93.51 





 Kraken classification SISTR in silico serovar prediction Typing 
Continuation Table S3 
ID ID strain Identified species 
% 1st 
match O antigen h1 antigen h2 antigen Serovar Serovar_antigen 
Serovar_cg
MLST MLST (ST) 
2945 19PM0346 Salmonella enterica 97.1 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
2947 19PM0348 Salmonella enterica 91.87 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
2948 19PM0349 Salmonella enterica 97.12 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
2949 19PM0350 Salmonella enterica 87.27 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
2951 19PM0351 Salmonella enterica 97.15 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
3222 20PM0240 Salmonella enterica 96.41 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
3225 20PM0243 Salmonella enterica 96.04 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
3227 20PM0245 Salmonella enterica 95.96 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
3230 20PM0248 Salmonella enterica 96.41 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 








 Kraken classification SISTR in silico serovar prediction Typing 
Continuation Table S3 
3239 20PM0257 Salmonella enterica 95.86 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
3242 20PM0260 Salmonella enterica 96.64 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
3243 20PM0261 Salmonella enterica 94.14 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
3245 20PM0263 Salmonella enterica 95.21 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
3249 20PM0267 Salmonella enterica 94.59 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
3250 20PM0268 Salmonella enterica 96.4 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
3252 20PM0270 Salmonella enterica 93.52 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
3253 20PM0271 Salmonella enterica 94.31 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
3255 20PM0273 Salmonella enterica 93.11 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
3257 20PM0275 Salmonella enterica 94.83 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 







 Kraken classification SISTR in silico serovar prediction Typing 
Continuation Table S3 
2957 19PM0358 Salmonella enterica 94.76 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
2959 19PM0360 Salmonella enterica 93.95 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
2747 19PM0148 Salmonella enterica 93.51 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
2748 19PM0149 Salmonella enterica 93.32 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
2749 19PM0150 Salmonella enterica 93.58 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
2750 19PM0151 Salmonella enterica 88.75 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
2752 19PM0153 Salmonella enterica 93.15 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 
2753 19PM0154 Salmonella enterica 93.51 6,7,14 r 1,5 Infantis Infantis|Senegal Infantis 32 






















































ong the S. infantis strains used in this study.  
ATHK000000
00 335-3 Israel 1970 1 - 100 - - . - - - - - - - - . - - - - - - 
LN649235 1326/28 UK 1973 1 - 100 - - . - - - - - - - - . - - - - - - 
19PM0346 2945 Germany 1992 1 - 100 - - . - - - - - - - - . - - - - - - 
19PM0348 2947 Germany 1992 4 100 100 - - 99.59 - - - - - - - - 100 - - 100  - - 
19PM0349 2948 Germany 1992 1 - 100 - - . - - - - - - - - . - - - - - - 
19PM0350 2949 Germany 1992 4 100 100 - - 99.59 - - - - - - - - 100 - - 100  - - 
19PM0351 2951 Germany 1994 1 - 100 - - . - - - - - - - - . - - - - - - 
20PM0240 3222 Germany 1994 1 - 100 - - . - - - - - - - - . - - - - - - 
JRXB000000
00 
SI69/94 Hungary 1994 1 - 100 - - . - - - - - - - - . - - - - - - 
20PM0243 3225 Germany 1995 1 - 100 - - . - - - - - - - - . - - - - - - 
20PM0245 3227 Germany 1995 1 - 100 - - . - - - - - - - - . - - - - - - 
20PM0248 3230 Germany 1996 1 - 100 - - . - - - - - - - - . - - - - - - 
20PM0252 3234 Germany 1997 1 - 100 - - . - - - - - - - - . - - - - - - 
20PM0257 3239 Germany 1998 1 - 100 - - . - - - - - - - - . - - - - - - 
20PM0260 3242 Germany 1998 1 - 100 - - . - - - - - - - - . - - - - - - 
JRXC000000
00 
SI54/04 Hungary 2004 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 92.24 100 - - 
ERR1014111 ERS84614
5 
Italy 2006 6 - 100 100 97.92 82.51 - - - - 100 - - - . 100 - - - - - 
ERR1014109 ERS84614
3 
Italy 2007 1 - 100 - - . - - - - - - - - . - - 99.89 100 - - 
GCA0109193
35 













































































Israel 2008 5 - 100 - - 99.59 - - - - - 100 - - 100 - 97.8 98.17 - - 100 
ERR1014118 
ERS8461
52 Italy 2009 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 100 99.61 - - 
ERR1014117 
ERS8461




2 Hungary 2012 5 - 100 - - 99.59 - - - 82.46 - - - - 100 - 97.8 100 97.17 - - 
ERR1014113 
ERS8461
47 Italy 2013 7 - 100 - - 82.51 - - 100 - - 100 100 - 100 - 97.8 100 - 92.24 - 
ERR1014114 ERS8461
48 
Italy 2013 7 - 100 - - . 100 - 100 - - 100 100 - 100 - 97.8 98.17 - 99.89 - 
MIJT000000
00 
SI757/13 Hungary 2013 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 100 97.17 - - 
MIJR000000
00 
SI786/13 Hungary 2013 1 - 100 - - . - - - - - - - - . - - - 98.17 - - 
20PM0261 3243 Germany 2014 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 100 99.61 - - 
20PM0263 3245 Germany 2014 1 - 100 - - . - - - - - - - - . - - - - - - 
ERR1014116 ERS8461
50 
Italy 2014 6 - 100 - - 82.51 - - 100 - - - 100 - 100 - 97.8 100 - 100 - 
20PM0267 3249 Germany 2015 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 100 98.28 - - 
20PM0268 3250 Germany 2015 1 - 100 - - . - - - - - - - - . - - - - - - 
20PM0270 3252 Germany 2015 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 100 99.89 - - 
20PM0271 3253 Germany 2016 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 100 97.17 - - 
20PM0273 3255 Germany 2016 1 - 100 - - . - - - - - - - - . - - - - - - 









































Continaution Table S4 
MRUX00000
000 
SI1070/16 Hungary 2016 2 - 100 - - . - 100 - - - - - - . - - - 98 - - 
MRUW0000
0000 
SI240/16 Hungary 2016 6 - 100 - - 99.59 - - - 82.46 - - - 100 100 - 97.8 100 97.17 - - 
19PM0355 2954 Germany 2017 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 100 100 - - 
19PM0358 2957 Germany 2018 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 93.75 98.28 - - 
19PM0148 2747 Germany 2019 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 90.11 98.28 - - 
19PM0149 2748 Germany 2019 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 100 99.61 - - 
19PM0150 2749 Germany 2019 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 90.11 98.28 - - 
19PM0151 2750 Germany 2019 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 90.11 99.91 - - 
19PM0153 2752 Germany 2019 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 100 99.91 - - 
19PM0154 2753 Germany 2019 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 100 98.28 - - 
19PM0360 2959 Germany 2019 4 - 100 - - 99.59 - - - - - - - - 100 - 97.8 100 99.61 - - 




SEQUENCE ISOLATE COUNTRY YEAR GENES FOUND avrA csgA csgB csgC csgD csgE csgF csgG entB faeD faeE Table S5. Virulence genes, SPIs, fim
brial cluster genes, and fitness genes found am
ong the S. 
Infantis strains used in this study (CoG




ATHK00000000 335-3 Israel 1970 104 100 100 100 100 100 100 100 100 99.18 - - 
LN649235 1326/28 UK 1973 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
19PM0346 2945 Germany 1992 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
19PM0348 2947 Germany 1992 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
19PM0349 2948 Germany 1992 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
19PM0350 2949 Germany 1992 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
19PM0351 2951 Germany 1994 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
20PM0240 3222 Germany 1994 104 100 100 100 100 100 100 100 100 99.18 - - 
JRXB00000000 SI69/94 Hungary 1994 104 100 100 100 100 100 100 100 100 99.18 - - 
20PM0243 3225 Germany 1995 104 100 100 100 100 100 100 100 100 99.18 - - 
20PM0245 3227 Germany 1995 104 100 100 100 100 100 100 100 100 99.18 - - 
20PM0248 3230 Germany 1996 104 100 100 100 100 100 100 100 100 99.18 - - 
20PM0252 3234 Germany 1997 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
20PM0257 3239 Germany 1998 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
20PM0260 3242 Germany 1998 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
JRXC00000000 SI54/04 Hungary 2004 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
ERR1014111 ERS846145 Italy 2006 104 100 100 100 100 100 100 100 100 99.18 - - 
ERR1014109 ERS846143 Italy 2007 104 100 100 100 100 100 100 100 100 99.18 - - 
GCA010919335 119944 Israel 2008 104 100 100 100 100 100 100 100 100 99.18 - - 
ERR1014118 ERS846152 Italy 2009 104 100 100 100 100 100 100 100 100 99.18 - - 
ERR1014117 ERS846151 Italy 2012 103 100 100 100 100 100 100 100 100 99.18 - - 
MIJS00000000 SI3337/12 Hungary 2012 104 100 100 100 100 100 100 100 100 99.18 - - 
ERR1014113 ERS846147 Italy 2013 104 100 100 100 100 100 100 100 100 99.18 - - 
ERR1014114 ERS846148 Italy 2013 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
MIJT00000000 SI757/13 Hungary 2013 104 100 100 100 100 100 100 100 100 99.18 - - 




SEQUENCE ISOLATE COUNTRY YEAR GENES FOUND avrA csgA csgB csgC csgD csgE csgF csgG entB faeD faeE 
Continuation Table S5  
20PM0261 3243 Germany 2014 103 100 100 100 100 100 100 100 100 99.18 - - 
20PM0263 3245 Germany 2014 116 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
ERR1014116 ERS846150 Italy 2014 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
20PM0267 3249 Germany 2015 104 100 100 100 100 100 100 100 100 99.18 - - 
20PM0268 3250 Germany 2015 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
20PM0270 3252 Germany 2015 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
20PM0271 3253 Germany 2016 104 100 100 100 100 100 100 100 100 99.18 - - 
20PM0273 3255 Germany 2016 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
20PM0275 3257 Germany 2016 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
MRUX00000000 SI1070/16 Hungary 2016 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
MRUW00000000 SI240/16 Hungary 2016 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
19PM0355 2954 Germany 2017 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
19PM0358 2957 Germany 2018 103 100 100 100 100 100 100 100 100 99.18 - - 
19PM0360 2959 Germany 2019 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
19PM0148 2747 Germany 2019 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
19PM0149 2748 Germany 2019 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
19PM0150 2749 Germany 2019 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
19PM0151 2750 Germany 2019 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
19PM0153 2752 Germany 2019 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 
19PM0154 2753 Germany 2019 117 100 100 100 100 100 100 100 100 99.18 96.60 91.25 









SEQUENCE ISOLATE fepC fepG fimC fimD fimF fimH fimI fyuA invA invB invC invE invF invG invH invI invJ 
Continuation Table S5  
ATHK00000000 335-3 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
LN649235 1326/28 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0346 2945 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0348 2947 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0349 2948 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0350 2949 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0351 2951 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0240 3222 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
JRXB00000000 SI69/94 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
20PM0243 3225 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
20PM0245 3227 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
20PM0248 3230 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
20PM0252 3234 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0257 3239 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0260 3242 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
JRXC00000000 SI54/04 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014111 ERS846145 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
ERR1014109 ERS846143 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
GCA010919335 119944 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
ERR1014118 ERS846152 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100  
ERR1014117 ERS846151 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
MIJS00000000 SI3337/12 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
ERR1014113 ERS846147 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
ERR1014114 ERS846148 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJT00000000 SI757/13 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 




SEQUENCE ISOLATE fepC fepG fimC fimD fimF fimH fimI fyuA invA invB invC invE invF invG invH invI invJ Continuation Table S5  
20PM0261 3243 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
20PM0263 3245 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014116 ERS846150 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0267 3249 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
20PM0268 3250 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0270 3252 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0271 3253 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
20PM0273 3255 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0275 3257 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MRUX00000000 SI1070/16 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MRUW00000000 SI240/16 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0355 2954 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0358 2957 96.45 91.54 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
19PM0360 2959 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0148 2747 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0149 2748 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0150 2749 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0151 2750 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0153 2752 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0154 2753 96.45 91.54 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 







SEQUENCE ID ISOLATE ID irp1 irp2 lpfA lpfB lpfC lpfD lpfE mgtB mgtC mig.14 misL ompA orgA orgB orgC pipB Continuation Table S5  
ATHK00000000 335-3 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
LN649235 1326/28 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0346 2945 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0348 2947 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0349 2948 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0350 2949 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0351 2951 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0240 3222 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
JRXB00000000 SI69/94 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0243 3225 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0245 3227 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0248 3230 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0252 3234 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0257 3239 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0260 3242 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
JRXC00000000 SI54/04 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014111 ERS846145 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014109 ERS846143 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
GCA010919335 119944 - - 100 100 100 100 100 100 100 100 100 100 100 99.85 100 100 
ERR1014118 ERS846152 - - 100 100 100 100 100 100 100 100 100 100 100 99.85 100 100 
ERR1014117 ERS846151 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJS00000000 SI3337/12 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014113 ERS846147 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014114 ERS846148 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJT00000000 SI757/13 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJR00000000 SI786/13 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0261 3243 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0263 3245 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014116 ERS846150 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0267 3249 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 





SEQUENCE ID ISOLATE ID irp1 irp2 lpfA lpfB lpfC lpfD lpfE mgtB mgtC mig.14 misL ompA orgA orgB orgC pipB Continuation Table S5  
20PM0270 3252 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0271 3253 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0273 3255 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0275 3257 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MRUX00000000 SI1070/16 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MRUW0000000
0 SI240/16 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0355 2954 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0358 2957 - - 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0360 2959 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0148 2747 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0149 2748 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0150 2749 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0151 2750 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0153 2752 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0154 2753 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0045 3027 - - 100;100 100 100 100 100 100 100 100 100 100 100 100 100 100 
 
SEQUENCE ID ISOLATE ID pipB2 prgH prgI prgJ prgK ratB shdA sicA sicP sifA sifB sinH sipA.sspA sipB.sspB sipC.sspC sipD 
ATHK00000000 335-3 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
LN649235 1326/28 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0346 2945 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 





SEQUENCE ID ISOLATE ID pipB2 prgH prgI prgJ prgK ratB shdA sicA sicP sifA sifB sinH sipA.sspA sipB.sspB sipC.sspC sipD 
Continuation Table S5  
19PM0349 2948 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0350 2949 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0351 2951 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0240 3222 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
JRXB00000000 SI69/94 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0243 3225 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0245 3227 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0248 3230 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0252 3234 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0257 3239 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0260 3242 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
JRXC00000000 SI54/04 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014111 ERS846145 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014109 ERS846143 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
GCA010919335 119944 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014118 ERS846152 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014117 ERS846151 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJS00000000 SI3337/12 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014113 ERS846147 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014114 ERS846148 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJT00000000 SI757/13 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJR00000000 SI786/13 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0261 3243 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0263 3245 100 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
ERR1014116 ERS846150 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 





SEQUENCE ID ISOLATE ID pipB2 prgH prgI prgJ prgK ratB shdA sicA sicP sifA sifB sinH sipA.sspA sipB.sspB sipC.sspC sipD 
Continuation Table S5  
20PM0268 3250 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0270 3252 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0271 3253 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0273 3255 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0275 3257 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MRUX00000000 SI1070/16 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MRUW00000000 SI240/16 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0355 2954 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0358 2957 100 100 100 100 100 100 - 100 100 100 100 100 100 100 100 100 
19PM0360 2959 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0148 2747 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0149 2748 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0150 2749 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0151 2750 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0153 2752 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0154 2753 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0045 3027 100 100 100 100 100 100 83.32 100 100;100 100 100 100 100 100 100 100 
 
SEQUENCE ID ISOLATE ID slrP sopA sopB.sigD sopD sopD2 sopE2 spaO spaP spaQ spaR spaS spiC.ssaB sptP ssaC ssaD ssaE 
ATHK00000000 335-3 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
LN649235 1326/28 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0346 2945 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0348 2947 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 





SEQUENCE ID ISOLATE ID slrP sopA sopB.sigD sopD sopD2 sopE2 spaO spaP spaQ spaR spaS spiC.ssaB sptP ssaC ssaD ssaE 
Continuation Table S5  
19PM0350 2949 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0351 2951 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0240 3222 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
JRXB00000000 SI69/94 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0243 3225 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0245 3227 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0248 3230 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0252 3234 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0257 3239 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0260 3242 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
JRXC00000000 SI54/04 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014111 ERS846145 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014109 ERS846143 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
GCA010919335 119944 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014118 ERS846152 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014117 ERS846151 100 89.70 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJS00000000 SI3337/12 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014113 ERS846147 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014114 ERS846148 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJT00000000 SI757/13 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJR00000000 SI786/13 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0261 3243 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0263 3245 100 100 100 100 88.54 100 100 100 100 100 100 100 100 100 100 100 
ERR1014116 ERS846150 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 




SEQUENCE ID ISOLATE ID slrP sopA sopB.sigD sopD sopD2 sopE2 spaO spaP spaQ spaR spaS spiC.ssaB sptP ssaC ssaD ssaE 
Continuation Table S5  
20PM0268 3250 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0270 3252 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0271 3253 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0273 3255 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0275 3257 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MRUX00000000 SI1070/16 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MRUW00000000 SI240/16 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0355 2954 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0358 2957 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0360 2959 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0148 2747 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0149 2748 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0150 2749 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0151 2750 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0153 2752 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0154 2753 100 100 100 100 100;100 100 100 100 100 100 100 100 100 100 100 100 
20PM0045 3027 100 100 100 100 100 100 100 100 100 100 100 100;100 100 100 100 100 
 
SEQUENCE ID ISOLATE ID ssaG ssaH ssaI ssaJ ssaK ssaL ssaM ssaN ssaO ssaP ssaQ ssaR ssaS ssaT ssaU ssaV sscA 
ATHK00000000 335-3 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
LN649235 1326/28 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0346 2945 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0348 2947 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0349 2948 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0350 2949 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0351 2951 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 




SEQUENCE ID ISOLATE ID ssaG ssaH ssaI ssaJ ssaK ssaL ssaM ssaN ssaO ssaP ssaQ ssaR ssaS ssaT ssaU ssaV sscA Continuation Table S5  
JRXB00000000 SI69/94 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0243 3225 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0245 3227 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0248 3230 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0252 3234 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0257 3239 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0260 3242 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
JRXC00000000 SI54/04 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014111 ERS846145 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014109 ERS846143 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
GCA010919335 119944 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014118 ERS846152 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014117 ERS846151 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJS00000000 SI3337/12 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014113 ERS846147 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014114 ERS846148 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJT00000000 SI757/13 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJR00000000 SI786/13 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0261 3243 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0263 3245 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014116 ERS846150 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0267 3249 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0268 3250 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0270 3252 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0271 3253 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0273 3255 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0275 3257 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MRUX00000000 SI1070/16 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MRUW00000000 SI240/16 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0355 2954 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 





SEQUENCE ID ISOLATE ID ssaG ssaH ssaI ssaJ ssaK ssaL ssaM ssaN ssaO ssaP ssaQ ssaR ssaS ssaT ssaU ssaV sscA Continuation Table S5  
19PM0360 2959 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0148 2747 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0149 2748 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0150 2749 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0151 2750 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0153 2752 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0154 2753 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0045 3027 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
 
SEQUENCE ID ISOLATE ID sscB sseA sseB sseC sseD sseE sseF sseG sseJ sseK1 sseK2 sseL sspH2 steA steB steC ybtA 
ATHK00000000 335-3 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
LN649235 1326/28 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0346 2945 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0348 2947 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0349 2948 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0350 2949 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0351 2951 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0240 3222 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
JRXB00000000 SI69/94 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
20PM0243 3225 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
20PM0245 3227 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
20PM0248 3230 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
20PM0252 3234 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0257 3239 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0260 3242 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 





SEQUENCE ID ISOLATE ID sscB sseA sseB sseC sseD sseE sseF sseG sseJ sseK1 sseK2 sseL sspH2 steA steB steC ybtA Continuation Table S5 
ERR1014111 ERS846145 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
ERR1014109 ERS846143 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
GCA010919335 119944 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
ERR1014118 ERS846152 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
ERR1014117 ERS846151 100 100 100 100 100 100 100 100 100 100 100 - 100 100 100 100 - 
MIJS00000000 SI3337/12 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
ERR1014113 ERS846147 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
ERR1014114 ERS846148 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MIJT00000000 SI757/13 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
MIJR00000000 SI786/13 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0261 3243 100 100 100 100 100 100 100 100 100 100 100 100 - 100 100 100 - 
20PM0263 3245 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
ERR1014116 ERS846150 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0267 3249 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
20PM0268 3250 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0270 3252 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0271 3253 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
20PM0273 3255 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0275 3257 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MRUX00000000 SI1070/16 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
MRUW00000000 SI240/16 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0355 2954 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0358 2957 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
19PM0360 2959 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0148 2747 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 




SEQUENCE ID ISOLATE ID sscB sseA sseB sseC sseD sseE sseF sseG sseJ sseK1 sseK2 sseL sspH2 steA steB steC ybtA 
Continuation Table S5 
19PM0150 2749 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0151 2750 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0153 2752 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
19PM0154 2753 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
20PM0045 3027 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 - 
 
SEQUENCE ID ISOLATE ID ybtE ybtP ybtQ ybtS ybtT ybtU ybtX 
ATHK00000000 335-3 - - - - - - - 
LN649235 1326/28 100 100 100 99.62 100 100 100 
19PM0346 2945 100 100 100 99.62 100 100 100 
19PM0348 2947 100 100 100 99.62 100 100 100 
19PM0349 2948 100 100 100 99.62 100 100 100 
19PM0350 2949 100 100 100 99.62 100 100 100 
19PM0351 2951 100 100 100 99.62 100 100 100 
20PM0240 3222 - - - - - - - 
JRXB00000000 SI69/94 - - - - - - - 
20PM0243 3225 - - - - - - - 
20PM0245 3227 - - - - - - - 
20PM0248 3230 - - - - - - - 
20PM0252 3234 100 100 100 99.62 100 100 100 
20PM0257 3239 100 100 100 99.62 100 100 100 
20PM0260 3242 100 100 100 99.62 100 100 100 
JRXC00000000 SI54/04 100 100 100 99.62 100 100 100 




SEQUENCE ID ISOLATE ID ybtE ybtP ybtQ ybtS ybtT ybtU ybtX 
Continuation Table S5 
ERR1014109 ERS846143 - - - - - - - 
GCA010919335 119944 - - - - - - - 
ERR1014118 ERS846152 - - - - - - - 
ERR1014117 ERS846151 - - - - - - - 
MIJS00000000 SI3337/12 - - - - - - - 
ERR1014113 ERS846147 - - - - - - - 
ERR1014114 ERS846148 100 100 100 99.62 100 100 100 
MIJT00000000 SI757/13 - - - - - - - 
MIJR00000000 SI786/13 100 100 100 99.62 100 100 100 
20PM0261 3243 - - - - - - - 
20PM0263 3245 100 100 100 99.62 100 100 100 
ERR1014116 ERS846150 100 100 100 99.62 100 100 100 
20PM0267 3249 - - - - - - - 
20PM0268 3250 100 100 100 99.62 100 100 100 
20PM0270 3252 100 100 100 99.62 100 100 100 
20PM0271 3253 - - - - - - - 
20PM0273 3255 100 100 100 99.62 100 100 100 
20PM0275 3257 100 100 100 99.62 100 100 100 
MRUX00000000 SI1070/16 100 100 100 99.62 100 100 100 
MRUW00000000 SI240/16 100 100 100 99.62 100 100 100 
19PM0355 2954 100 100 100 99.62 100 100 100 
19PM0358 2957 - - - - - - - 
19PM0360 2959 100 100 100 99.62 100 100 100 
19PM0148 2747 100 100 100 99.62 100 100 100 




SEQUENCE ID ISOLATE ID ybtE ybtP ybtQ ybtS ybtT ybtU ybtX Continuation Table S5 
19PM0149 2748 100 100 100 99.62 100 100 100 
19PM0150 2749 100 100 100 99.62 100 100 100 
19PM0151 2750 100 100 100 99.62 100 100 100 
19PM0153 2752 100 100 100 99.62 100 100 100 
19PM0154 2753 100 100 100 99.62 100 100 100 
20PM0045 3027 - - - - - - - 
 







ATHK00000000 335-3 Israel 1970 + + + + + + - - + - + + + 
132628 1326/28 UK 1973 + + + + + + - - + - + + + 
19PM0346 2945 Germany 1992 + + + + + + - - + - + + + 
19PM0348 2947 Germany 1992 + + + + + + - - + - + + + 
19PM0349 2948 Germany 1992 + + + + + + - - + - + + + 
19PM0350 2949 Germany 1992 + + + + + + - - + - + + + 
19PM0351 2951 Germany 1994 + + + + + + - - + - + + + 
20PM0240 3222 Germany 1994 + + + + + + - - + - + + + 
JRXB00000000 SI69/94 Hungary 1994 + + + + + + - - + - + + + 
20PM0243 3225 Germany 1995 + + + + + + - - + - + + + 
20PM0245 3227 Germany 1995 + + + + + + - - + - + + + 
20PM0248 3230 Germany 1996 + + + + + + - - + - + + + 
20PM0252 3234 Germany 1997 + + + + + + - - + - + + + 
20PM0257 3239 Germany 1998 + + + + + + - - + - + + + 
20PM0260 3242 Germany 1998 + + + + + + - - + - + + + 
JRXC00000000 SI54/04 Hungary 2004 + + + + + + - - + - + + + 
ERR1014111 ERS846145 Italy 2006 + + + + + + - - + - + + + 
ERR1014109 ERS846143 Italy 2007 + + + + + + - - + - + + + 











Continuation Table S5 
ERR1014118 ERS846152 Italy 2009 + + + + + + - - + - + + + 
ERR1014117 ERS846151 Italy 2012 + + + + + + - - + - + + + 
MIJS00000000 SI3337/12 Hungary 2012 + + + + + + - - + - + + + 
ERR1014113 ERS846147 Italy 2013 + + + + + + - - + - + + + 
ERR1014114 ERS846148 Italy 2013 + + + + + + - - + - + + + 
MIJT00000000 SI757/13 Hungary 2013 + + + + + + - - + - + + + 
MIJR00000000 SI786/13 Hungary 2013 + + + + + + - - + - + + + 
20PM0261 3243 Germany 2014 + + + + + + - - + - + + + 
20PM0263 3245 Germany 2014 + + + + + + - - + - + + + 
ERR1014116 ERS846150 Italy 2014 + + + + + + - - + - + + + 
20PM0267 3249 Germany 2015 + + + + + + - - + - + + + 
20PM0268 3250 Germany 2015 + + + + + + - - + - + + + 
20PM0270 3252 Germany 2015 + + + + + + - - + - + + + 
20PM0271 3253 Germany 2016 + + + + + + - - + - + + + 
20PM0273 3255 Germany 2016 + + + + + + - - + - + + + 
20PM0275 3257 Germany 2016 + + + + + + - - + - + + + 
MRUX00000000 SI1070/16 Hungary 2016 + + + + + + - - + - + + + 
MRUW00000000 SI240/16 Hungary 2016 + + + + + + - - + - + + + 
19PM0355 2954 Germany 2017 + + + + + + - - + - + + + 
19PM0358 2957 Germany 2018 + + + + + + - - + - + + + 
19PM0148 2747 Germany 2019 + + + + + + - - + - + + + 
19PM0149 2748 Germany 2019 + + + + + + - - + - + + + 
19PM0150 2749 Germany 2019 + + + + + + - - + - + + + 
19PM0151 2750 Germany 2019 + + + + + + - - + - + + + 
19PM0153 2752 Germany 2019 + + + + + + - - + - + + + 
19PM0154 2753 Germany 2019 + + + + + + - - + - + + + 
19PM0360 2959 Germany 2019 + + + + + + - - + - + + + 











Continuation Table S5 
ERR1014119 ERS846153 Italy 2014 + + + + + + - - + - + + + 
MRUX00000000 SI1070/16 (GCA001906515) Hungary 2016 + + + + + + - - + - + + + 
MRUW00000000 SI240/16 (GCA001906535) Hungary 2016 + + + + + + - - + - + + + 
MIJS00000000 SI3337/12 (GCA001766495) Hungary 2012 + + + + + + - - + - + + + 
JRXC00000000 SI54/04 Hungary 2004 + + + + + + - - + - + + + 
JRXB00000000 SI69/94 Hungary 1994 + + + + + + - - + - + + + 
MIJT00000000 SI757/13 (GCA001766505) Hungary 2013 + + + + + + - - + - + + + 
MIJR00000000 SI786/13 (GCA001766515) Hungary 2013 + + + + + + - - + - + + + 
CP047882 pESI119944 Israel 2008 + + + + + + - - + - + + + 
GCA010919335 SI119944 Israel 2008 + + + + + + - - + - + + + 
 
SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE 










19PM0148 2747 12 87200 87862 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0148 2747 12 87984 88520 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0148 2747 12 95987 96751 faeI_GVI52_23095 1-765/765 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 






SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 
19PM0148 2747 12 98780 99271 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0148 2747 12 99307 100092 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 





19PM0148 2747 12 102572 103111 faeC_GVI52_23065 1-540/540 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 










19PM0149 2748 19 24353 25015 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0149 2748 19 25137 25673 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0149 2748 19 33140 33904 faeI_GVI52_23095 1-765/765 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0149 2748 19 33932 34723 faeH 1-792/792 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0149 2748 19 35933 36424 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0149 2748 19 36460 37245 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 



















SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 





19PM0150 2749 13 87201 87863 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0150 2749 13 87985 88521 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0150 2749 13 95988 96752 faeI_GVI52_23095 1-765/765 ======== 0/0 100.00 99.87 Fimbrial clusters 
This 
study 
19PM0150 2749 13 96780 97571 faeH 1-792/792 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0150 2749 13 98781 99272 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0150 2749 13 99308 100093 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 





19PM0150 2749 13 102573 103112 faeC_GVI52_23065 1-540/540 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0151 2750 11 27605 28144 faeC_GVI52_23065 1-540/540 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 





19PM0151 2750 11 30624 31409 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0151 2750 11 31445 31936 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0151 2750 11 33146 33937 faeH 1-792/792 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 







SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE 
Continuation Table S5 
19PM0151 2750 11 42196 42732 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0151 2750 11 42854 43516 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 










19PM0153 2752 17 27605 28144 faeC_GVI52_23065 1-540/540 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 





19PM0153 2752 17 30624 31409 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0153 2752 17 31445 31936 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0153 2752 17 33146 33937 faeH 1-792/792 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0153 2752 17 33965 34729 faeI_GVI52_23095 1-765/765 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0153 2752 17 42196 42732 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0153 2752 17 42854 43516 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 



















SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 
 






19PM0154 2753 13 87201 87863 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0154 2753 13 87985 88521 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0154 2753 13 95988 96752 faeI_GVI52_23095 1-765/765 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0154 2753 13 96780 97571 faeH 1-792/792 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0154 2753 13 98781 99272 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0154 2753 13 99308 100093 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 





19PM0154 2753 13 102573 103112 faeC_GVI52_23065 1-540/540 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0355 2954 22 27605 28144 faeC_GVI52_23065 1-540/540 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 





19PM0355 2954 22 30624 31409 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0355 2954 22 31445 31936 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0355 2954 22 33146 33937 faeH 1-792/792 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 







SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 
 




19PM0355 2954 22 42854 43516 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 










19PM0358 2957 16 27605 28144 faeC_GVI52_23065 1-540/540 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 





19PM0358 2957 16 30624 31409 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0358 2957 16 31445 31936 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0358 2957 16 33146 33937 faeH 1-792/792 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0358 2957 16 33965 34729 faeI_GVI52_23095 1-765/765 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0358 2957 16 42196 42732 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0358 2957 16 42854 43516 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 


















SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 





19PM0360 2959 23 30624 31409 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0360 2959 23 31445 31936 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0360 2959 23 33146 33937 faeH 1-792/792 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0360 2959 23 33965 34729 faeI_GVI52_23095 1-765/765 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0360 2959 23 42196 42732 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
19PM0360 2959 23 42854 43516 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 




















20PM0045 3027 17 18274 18936 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0045 3027 17 19058 19594 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0045 3027 17 27061 27825 faeI_GVI52_23095 1-765/765 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 








SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 
 




20PM0045 3027 17 30381 31166 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 





20PM0045 3027 17 33646 34185 faeC_GVI52_23065 1-540/540 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0261 3243 14 27605 28144 faeC_GVI52_23065 1-540/540 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 





20PM0261 3243 14 30624 31409 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0261 3243 14 31445 31936 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0261 3243 14 33146 33937 faeH 1-792/792 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0261 3243 14 33965 34729 faeI_GVI52_23095 1-765/765 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0261 3243 14 42196 42732 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0261 3243 14 42854 43516 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 


















SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 
 






20PM0267 3249 12 30624 31409 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0267 3249 12 31445 31936 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0267 3249 12 33146 33937 faeH 1-792/792 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0267 3249 12 33965 34729 faeI_GVI52_23095 1-765/765 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0267 3249 12 42196 42732 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0267 3249 12 42854 43516 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 










20PM0270 3252 10 27605 28144 faeC_GVI52_23065 1-540/540 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 





20PM0270 3252 10 30624 31409 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0270 3252 10 31445 31936 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0270 3252 10 33146 33937 faeH 1-792/792 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 








SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 
 




20PM0270 3252 10 42854 43516 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 




















20PM0271 3253 32 10039 10701 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0271 3253 32 10823 11359 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0271 3253 32 18826 19590 faeI_GVI52_23095 1-765/765 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0271 3253 32 19618 20409 faeH 1-792/792 ======== 0/0 100.00 99.87 Fimbrial clusters 
This 
study 
20PM0271 3253 32 21619 22110 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0271 3253 32 22146 22931 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 





20PM0271 3253 32 25411 25950 faeC_GVI52_23065 1-540/540 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 








SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 
 






20PM0275 3257 28 3675 4460 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0275 3257 28 4496 4987 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0275 3257 28 6197 6988 faeH 1-792/792 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0275 3257 28 7016 7780 faeI_GVI52_23095 1-765/765 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0275 3257 28 15247 15783 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
20PM0275 3257 28 15905 16567 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 















ERR1014109 ERS846143 19 28166 30598 faeD 
1-





























SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 










ERR1014109 ERS846143 19 43555 46107 ipfC_GVI52_23170 
1-





ERR1014109 ERS846143 19 46264 47313 ipfD_GVI52_23175 
1-










ERR1014113 ERS846147 12 28190 30622 faeD 
1-



































ERR1014113 ERS846147 12 43578 46130 ipfC_GVI52_23170 
1-





ERR1014113 ERS846147 12 46287 47336 ipfD_GVI52_23175 
1-















SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 
ERR1014114 ERS846148 18 28190 30622 faeD 
1-



































ERR1014114 ERS846148 18 43578 46130 ipfC_GVI52_23170 
1-





ERR1014114 ERS846148 18 46287 47336 ipfD_GVI52_23175 
1-










ERR1014116 ERS846150 18 28190 30622 faeD 
1-






























SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 










ERR1014116 ERS846150 18 43578 46130 ipfC_GVI52_23170 
1-





ERR1014116 ERS846150 18 46287 47336 ipfD_GVI52_23175 
1-










ERR1014117 ERS846151 18 28182 30614 faeD 
1-



































ERR1014117 ERS846151 18 43570 46122 ipfC_GVI52_23170 
1-





ERR1014117 ERS846151 18 46279 47328 ipfD_GVI52_23175 
1-





ERR1014118 ERS846152 17 20540 21589 ipfD_GVI52_23175 
1-










SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 
ERR1014118 ERS846152 17 21746 24298 ipfC_GVI52_23170 
1-



































ERR1014118 ERS846152 17 37255 39687 faeD 
1-




















JRXC01000000 SI54/04 1 28031 28693 ipfB_GVI52_23165 1-663/663 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
JRXC01000000 SI54/04 1 28815 29351 ipfA_GVI52_23160 1-537/537 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
JRXC01000000 SI54/04 1 36818 37582 faeI_GVI52_23095 1-765/765 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 








SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 
JRXC01000000 SI54/04 1 39611 40102 faeF_GVI52_23080 1-492/492 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
JRXC01000000 SI54/04 1 40138 40923 faeE_GVI52_23075 1-786/786 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 





JRXC01000000 SI54/04 1 43403 43942 faeC_GVI52_23065 1-540/540 ======== 0/0 100.00 100.00 Fimbrial clusters 
This 
study 
MIJR01000000 SI786/13 1 20423 21472 ipfD_GVI52_23175 
1-





MIJR01000000 SI786/13 1 21629 24181 ipfC_GVI52_23170 
1-



































MIJR01000000 SI786/13 1 37137 39569 faeD 
1-










MIJS01000000 SI3337/12 1 20423 21472 ipfD_GVI52_23175 
1-










SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 
MIJS01000000 SI3337/12 1 21629 24181 ipfC_GVI52_23170 
1-



































MIJS01000000 SI3337/12 1 37137 39569 faeD 
1-










MIJT01000000 SI757/13 1 20423 21472 ipfD_GVI52_23175 
1-





MIJT01000000 SI757/13 1 21629 24181 ipfC_GVI52_23170 
1-





























SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 










MIJT01000000 SI757/13 1 37137 39569 faeD 
1-













6 1 20423 21472 ipfD_GVI52_23175 
1-








6 1 21629 24181 ipfC_GVI52_23170 
1-
























































6 1 37137 39569 faeD 
1-













MRUX01000000 SI1070/16 1 20405 21454 ipfD_GVI52_23175 
1-









SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 
MRUX01000000 SI1070/16 1 21611 24163 ipfC_GVI52_23170 
1-



































MRUX01000000 SI1070/16 1 37119 39551 faeD 
1-















GCA010919335 SI119944 1 39133 41565 faeD 
1-





























SEQUENCE ISOLATE CoG START END GENE Cov Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 










GCA010919335 SI119944 1 54521 57073 ipfC_GVI52_23170 
1-





GCA010919335 SI119944 1 57230 58279 ipfD_GVI52_23175 
1-






SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE 
19PM0148 2747 12 91258 91563 ccdB 1-306/306 ========= 0/0 100.00 100.00 fitness_
SI 
This study 
















19PM0148 2747 15 10414 10776 merD 1-363/363 ========= 0/0 100.00 100.00 
fitness_
SI This study 





















19PM0148 2747 15 13709 14143 merR 1-435/435 ========= 0/0 100.00 100.00 
fitness_





SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 




















1695/1695 ========= 0/0 100.00 100.00 
fitness_
SI This study 








19PM0149 2748 19 28411 28716 ccdB 1-306/306 ========= 0/0 100.00 100.00 fitness_
SI 
This study 
















19PM0150 2749 13 91566 91784 ccdA 1-219/219 ========= 0/0 100.00 100.00 fitness_
SI 
This study 



















SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 





















19PM0150 2749 16 13709 14143 merR 1-435/435 ========= 0/0 100.00 100.00 
fitness_
SI This study 








19PM0151 2750 11 38933 39151 ccdA 1-219/219 ========= 0/0 100.00 100.00 fitness_
SI 
This study 





















19PM0151 2750 14 12540 12962 merC 1-423/423 ========= 0/0 100.00 100.00 fitness_
SI 
This study 



















SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 





















19PM0153 2752 14 93904 94266 merD 1-363/363 ========= 0/0 100.00 100.00 
fitness_
SI This study 








19PM0153 2752 17 3846 4178 PemK/MazF 1-333/333 ========= 0/0 100.00 100.00 fitness_
SI 
This study 
















19PM0154 2753 13 126539 126871 PemK/MazF 1-333/333 ========= 0/0 100.00 100.00 fitness_
SI 
This study 




















SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 





















19PM0355 2954 16 10181 10417 merE 1-237/237 ========= 0/0 100.00 100.00 
fitness_
SI This study 













19PM0355 2954 16 12540 12962 merC 1-423/423 ========= 0/0 100.00 100.00 fitness_
SI 
This study 
















19PM0355 2954 22 3846 4178 PemK/MazF 1-333/333 ========= 0/0 100.00 100.00 fitness_
SI 
This study 




















SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 





















19PM0358 2957 12 13709 14143 merR 1-435/435 ========= 0/0 100.00 100.00 
fitness_
SI This study 








19PM0358 2957 16 38933 39151 ccdA 1-219/219 ========= 0/0 100.00 100.00 fitness_
SI 
This study 
















19PM0360 2959 16 91718 92140 merC 1-423/423 ========= 0/0 100.00 100.00 fitness_
SI 
This study 


























SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 




19PM0360 2959 23 38933 39151 ccdA 1-219/219 ========= 0/0 100.00 100.00 
fitness_
SI This study 








20PM0045 3027 11 91043 91393 merT 1-351/351 ========= 0/0 100.00 100.00 fitness_
SI 
This study 




20PM0045 3027 11 91718 92140 merC 1-423/423 ========= 0/0 100.00 100.00 
fitness_
SI This study 













20PM0045 3027 11 94263 94499 merE 1-237/237 ========= 0/0 100.00 100.00 fitness_
SI 
This study 
















20PM0261 3243 14 3588 3845 PemI-like 1-258/258 ========= 0/0 100.00 100.00 
fitness_
SI This study 












SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 




20PM0261 3243 17 10181 10417 merE 1-237/237 ========= 0/0 100.00 100.00 
fitness_
SI This study 













20PM0261 3243 17 12540 12962 merC 1-423/423 ========= 0/0 100.00 100.00 fitness_
SI 
This study 




20PM0261 3243 17 13287 13637 merT 1-351/351 ========= 0/0 100.00 100.00 
fitness_
SI This study 








20PM0267 3249 12 3846 4178 PemK/MazF 1-333/333 ========= 0/0 100.00 100.00 fitness_
SI 
This study 




















1695/1695 ========= 0/0 100.00 100.00 
fitness_
SI This study 












SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 




20PM0267 3249 18 13709 14143 merR 1-435/435 ========= 0/0 100.00 100.00 
fitness_
SI This study 








20PM0270 3252 10 38933 39151 ccdA 1-219/219 ========= 0/0 100.00 100.00 fitness_
SI 
This study 




20PM0270 3252 23 10181 10417 merE 1-237/237 ========= 0/0 100.00 100.00 
fitness_
SI This study 













20PM0270 3252 23 12540 12962 merC 1-423/423 ========= 0/0 100.00 100.00 fitness_
SI 
This study 
















20PM0271 3253 24 65564 65914 merT 1-351/351 ========= 0/0 100.00 100.00 
fitness_
SI This study 












SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 









20PM0271 3253 24 68425 68787 merD 1-363/363 ========= 0/0 100.00 100.00 
fitness_
SI This study 








20PM0271 3253 32 14404 14622 ccdA 1-219/219 ========= 0/0 100.00 100.00 fitness_
SI 
This study 




20PM0271 3253 32 49710 49967 PemI-like 1-258/258 ========= 0/0 100.00 100.00 
fitness_
SI This study 








20PM0273 3255 17 34169 34437 merP 8-276/276 ========= 0/0 97.46 84.39 fitness_
SI 
This study 





















20PM0275 3257 15 9925 10161 merE 1-237/237 ========= 0/0 100.00 100.00 
fitness_
SI This study 

















SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 




20PM0275 3257 15 12742 13017 merP 1-276/276 ========= 0/0 100.00 100.00 
fitness_
SI This study 








20PM0275 3257 28 11984 12202 ccdA 1-219/219 ========= 0/0 100.00 100.00 fitness_
SI 
This study 




20PM0275 3257 31 3588 3845 PemI-like 1-258/258 ========= 0/0 100.00 100.00 
fitness_
SI This study 








CP047882 SI119944 1 14789 15121 PemK/MazF 1-333/333 ========= 0/0 100.00 100.00 fitness_
SI 
This study 




















1695/1695 ========= 0/0 100.00 100.00 
fitness_
SI This study 












SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 




CP047882 SI119944 1 172570 173004 merR 1-435/435 ========= 0/0 100.00 100.00 
fitness_





























113 12 3588 3845 PemI-like 1-258/258 ========= 0/0 100.00 100.00 
fitness_






















































1695/1695 ========= 0/0 100.00 100.00 
fitness_





























114 13 7951 8313 merD 1-363/363 ========= 0/0 100.00 100.00 
fitness_


































114 13 11246 11680 merR 1-435/435 ========= 0/0 100.00 100.00 
fitness_


















































116 13 91716 92138 merC 1-423/423 ========= 0/0 100.00 100.00 
fitness_


































116 18 3588 3845 PemI-like 1-258/258 ========= 0/0 100.00 100.00 
fitness_





























117 13 7943 8305 merD 1-363/363 ========= 0/0 100.00 100.00 
fitness_























































117 18 38946 39164 ccdA 1-219/219 ========= 0/0 100.00 100.00 
fitness_

































1695/1695 ========= 0/0 100.00 100.00 
fitness_





























118 17 28398 28703 ccdB 1-306/306 ========= 0/0 100.00 100.00 
fitness_

















17 64032 64289 PemI-like 1-258/258 ========= 0/0 100.00 100.00 fitness_
SI 
This study 





















JRXC01000000 SI54/04 1 12892 13167 merP 1-276/276 ========= 0/0 100.00 100.00 
fitness_
SI This study 












SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 




JRXC01000000 SI54/04 1 32396 32614 ccdA 1-219/219 ========= 0/0 100.00 100.00 
fitness_
SI This study 






















2 1 91578 91853 merP 1-276/276 ========= 0/0 100.00 100.00 
fitness_























































2 1 63914 64171 PemI-like 1-258/258 ========= 0/0 100.00 100.00 
fitness_
SI This study 












SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 




MIJT01000000 SI757/13 1 91890 92312 merC 1-423/423 ========= 0/0 100.00 100.00 
fitness_
SI This study 













MIJT01000000 SI757/13 1 94435 94671 merE 1-237/237 ========= 0/0 100.00 100.00 fitness_
SI 
This study 




MIJT01000000 SI757/13 1 28587 28805 ccdA 1-219/219 ========= 0/0 100.00 100.00 
fitness_
SI This study 








GCA001766515 SI786/13 1 28280 28585 ccdB 1-306/306 ========= 0/0 100.00 100.00 fitness_
SI 
This study 





















6 1 28587 28805 ccdA 1-219/219 ========= 0/0 100.00 100.00 
fitness_




















SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 




GCA001906535 SI240/16 1 91215 91565 merT 1-351/351 ========= 0/0 100.00 100.00 
fitness_
SI This study 












========= 0/0 100.00 100.00 fitness_
SI 
This study 




GCA001906535 SI240/16 1 94435 94671 merE 1-237/237 ========= 0/0 100.00 100.00 
fitness_
SI This study 








GCA001906535 SI240/16 1 63563 63895 PemK/MazF 1-333/333 ========= 0/0 100.00 100.00 fitness_
SI 
This study 
















GCA010919335 SI119944 1 50117 50422 ccdB 1-306/306 ========= 0/0 100.00 100.00 
fitness_
SI This study 













SEQUENCE SAMPLE CoG START END GENE COVERAGE Cov MAP GAPS %Cov %ID DB SOURCE Continuation Table S5 









GCA010919335 SI119944 1 171401 171823 merC 1-423/423 ========= 0/0 100.00 100.00 
fitness_
SI This study 


























SEQUENCE SAMPLE COUNTRY YEAR CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB ACCESSION  Table S6. Plasm
id replicons, plasm
id pM
LST typing and genes encoding for plasm
id 
origin of replication found am
ong the S. Infantis strains used in this study (CoG
: 
contig; Cov: coverage; ID: identity; DB: database). 



































































































































































































































































































































































SEQUENCE SAMPLE COUNTRY YEAR CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB ACCESSION Continuation Table S6
 

























































































































































SEQUENCE SAMPLE COUNTRY YEAR CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB ACCESSION Continuation Table S6
 







































































SEQUENCE SAMPLE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE 


























SEQUENCE SAMPLE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE Continuation Table S6
 









































































SEQUENCE SAMPLE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE 
Continuation Table S6 















































































SEQUENCE SAMPLE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE 
Continuation Table S6 
















































































SEQUENCE SAMPLE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE Continuation Table S6 


















































































SEQUENCE SAMPLE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE Continuation Table S6 


















































































SEQUENCE SAMPLE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE Continuation Table S6 









































































































SEQUENCE SAMPLE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE Continuation Table S6 
ERS846145 
ERR1014
















































































































SEQUENCE SAMPLE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE Continuation Table S6 
ERS846150 ERR1014
116 






























































































































































































































SEQUENCE SAMPLE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE Continuation Table S6 
MRUW00000


























































































SEQUENCE ISOLATE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE 
19PM0148 2747 15 14311 15122 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
19PM0148 2747 26 14467 15477 
repB_GVI52_
22855 
1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
19PM0149 2748 14 89558 90369 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
19PM0149 2748 27 9085 10095 
repB_GVI52_
22855 1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
19PM0150 2749 16 14311 15122 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
19PM0150 2749 25 9085 10095 
repB_GVI52_
22855 
1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 





SEQUENCE SAMPLE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE Continuation Table S6 
19PM0151 2750 27 9085 10095 
repB_GVI52_
22855 1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
19PM0153 2752 14 89558 90369 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
19PM0153 2752 25 14467 15477 
repB_GVI52_
22855 
1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
19PM0154 2753 17 89558 90369 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
19PM0154 2753 27 14467 15477 repB_GVI52_
22855 
1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
19PM0355 2954 16 14311 15122 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
19PM0355 2954 31 9085 10095 
repB_GVI52_
22855 
1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
19PM0358 2957 12 14311 15122 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
19PM0358 2957 27 9085 10095 repB_GVI52_
22855 
1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
19PM0360 2959 16 89558 90369 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
19PM0360 2959 29 14467 15477 
repB_GVI52_
22855 
1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
20PM0045 3027 11 89558 90369 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
20PM0045 3027 27 9085 10095 
repB_GVI52_
22855 
1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
20PM0261 3243 17 14311 15122 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
20PM0261 3243 30 14467 15477 
repB_GVI52_
22855 1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
20PM0267 3249 18 14311 15122 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
20PM0267 3249 27 14467 15477 
repB_GVI52_
22855 
1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
20PM0270 3252 23 14311 15122 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
20PM0270 3252 50 9085 10095 
repB_GVI52_
22855 1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
20PM0271 3253 24 64079 64890 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
20PM0271 3253 54 2004 3014 
repB_GVI52_
22855 
1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 





SEQUENCE SAMPLE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE 
Continuation Table S6 
20PM0275 3257 33 14467 15477 
repB_GVI52_




27 9061 10071 
repB_GVI52_
22855 




15 89556 90367 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
ERS846147 ERR1014
113 
27 14488 15498 repB_GVI52_
22855 
1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
ERS846148 
ERR1014




25 14488 15498 
repB_GVI52_
22855 




13 89556 90367 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
ERS846150 ERR1014
116 
25 9083 10093 repB_GVI52_
22855 








26 9075 10085 
repB_GVI52_
22855 
1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
ERS846152 ERR1014
118 
13 14311 15122 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
ERS846152 
ERR1014
118 25 14467 15477 
repB_GVI52_










1 14639 15649 
repB_GVI52_
22855 
1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
MIJT0100000
0 
SI757/13 1 89730 90541 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
MIJT0100000
0 SI757/13 1 14639 15649 
repB_GVI52_
22855 1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
MIJR0100000
0 
SI786/13 1 14639 15649 
repB_GVI52_
22855 





1 14639 15649 
repB_GVI52_
22855 










SEQUENCE SAMPLE CoG START END GENE Cov Cov_MAP GAPS %Cov %ID DB SOURCE 





1 14639 15649 
repB_GVI52_
22855 








incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
GCA0109193
35 SI119944 CP047882 1 1011 
repB_GVI52_
22855 1-1011/1011 =============== 0/0 100 100 repB_pESI119944 This study 
JRXC0100000
0 
SI54/04 1 72051 72862 incP_Tn1723 1-811/811 ========/====== 1/1 100 99,63 incP_plasmids This study 
JRXC0100000
0 
SI54/04 1 25527 26537 
repB_GVI52_
22855 




8.2. Supplementary Table from the Dissertation 
Table S1. Results of the analysis of Salmonella genoserotyping study performed by the 
bioinformatics pipeline WGSBAC and the tools SISTR, SeqSero, and  SeqSero2. 























16PM0089 Hadar 61,8,z10,e,n,x Hadar|Istanbul Hadar Hadar 
6,8:z10:e,n
,x 
16PM0105 Gallinarum 1,9,12 
Gallinarum|Pullo
rum 
Gallinarum Gallinarum 1,9,12:-:- 

















Mbandaka Mbandaka Mbandaka 
6,7,14:z10:
e,n,z,15 
16PM0171 Livingstone 6,7,14:d:l,w Livingstone Livingstone Livingstone 
6,7,14:d:l,
w 
16PM0176 Stourbridge 6,8:b:1,6 Stourbridge Stourbridge Stourbridge 6,8:b:1,6 
16PM0256 Goldcoast 6,8:r:l,w 
Brikama|Goldcoa
st 















Tennessee Tennessee Tennessee 
6,7,14:z29:
- 












Continuation Table S1 
  Traditional analyisis (KWS) Analysis by SISTR (WGS) 






































17PM0271 Indiana 1,4,12:z:1,7 Indiana Indiana Indiana 
1,4,12:z:1
,7 











4,5-:i:1-,2-, I 4,[5],12:i:- I 4,[5],12:i:- I 4,[5],12:i:- 
4,[5],12:i:
- 










18PM0007 Coeln 1,4,(5),y,1,2 Coeln Coeln Coeln 
1,4,[5],12
:y:1,2 






4, 5, i, 1-, 2-, I 4,[5],12:i:- I 4,[5],12:i:- I 4,[5],12:i:- 
| 4, [5], 
12:i:- 


















Continuation Table S1 
  Traditional analyisis (KWS) Analysis by SISTR (WGS) 


















Choleraesuis Choleraesuis 6,7:c:1,5 
























18PM0092 Paratyphi B 4,5-,b,1,2 
Paratyphi 
B|Paratyphi B var. 
Java 
Paratyphi B var. 
Java 





61, 8, e, h, 1, 
5 Ferruch|Kottbus Kottbus Kottbus 
6,8:e,h:1,
5 










18PM0112 Typhimurium 4,5-,i,1,2 Typhimurium Typhimurium Typhimurium 
1,4,[5],12
:i:1,2 










18PM0135 Kottbus 61,8,e,h,1,5 Ferruch|Kottbus Kottbus Kottbus 
6,8:e,h:1,
5 





















Continuation Table S1 
 Traditional analyisis (KWS) Analysis by SISTR (WGS) 























18PM0246 Stourbridge 6, 8, b, 1, 6 Stourbridge Stourbridge Stourbridge 6,8:b:1,6 











1, 9, 12, l, v, 
1, 5 
Mathura I 4,[5],12:i:- Mathura 
9,46: i: 
e,n, z15 
19PM0011 Newport  - Bardo|Newport Newport Newport 6,8,20:e,h
:1,2 
  Traditional analyisis (KWS) Analysis by SeqSero using reads 
























does not exist in 
the KWS 
8:r:- 





16PM0105 Gallinarum 1,9,12 * 9:g,m:- * 9:g,m:- 
















16PM0124 III_diarizonae 61:k:1,5,7 
N/A The predicted 
antigen profile 
does not exist in 
the KWS 






Continuation Table S1 
 Traditional analyisis (KWS) Analysis by SeqSero using reads 




















Mbandaka 7:z10:e,n,z15 Mbandaka 
7:z10:e,n,
z15 
16PM0171 Livingstone 6,7,14:d:l,w Livingstone 7:d:l,w Livingstone 7:d:l,w 
16PM0176 Stourbridge 6,8:b:1,6 Stourbridge 8:b:1,6 Stourbridge 8:b:1,6 
16PM0256 Goldcoast 6,8:r:l,w Goldcoast or 
Brikama 




Anatum 3,10:e,h:1,6 Anatum 
3,10:e,h:1
,6 
17PM0009 Enteritidis 1,9,12,g,m 
N/A The predicted 
antigen profile 












II 6,7:z29:[z42] or 
Tenesse* 
7:z29:- 
II 6,7:z29:[z42] or 
Tenesse* 
7:z29:- 




Agona 4:f,g,s:- Agona 4:f,g,s:- 
17PM0054 Muenster 3,(10,15,34),
e,h,1,5 
Muenster 3,10:e,h:1,5 Muenster 3,10:e,h:1
,5 




Meleagridis 3,10:e,h:l,w Meleagridis 
3,10:e,h:l,
w 
17PM0271 Indiana 1,4,12:z:1,7 
Indiana or II 
4,12:z:1,7* 4:z:1,7 
Indiana or II 
4,12:z:1,7* 4:z:1,7 


















Continuation Table S1 
 Traditional analyisis (KWS) Analysis by SeqSero using reads 

































18PM0004 Dublin 1,9,12:g,p Dublin 9:g,p:- Dublin 9:g,p:- 
18PM0007 Coeln 1,4,(5),y,1,2 Coeln 4:y:1,2 Coeln 4:y:1,2 





















18PM0026 Dublin 1, 9, 12, g, p Dublin 9:g,p:- Dublin 9:g,p:- 
18PM0031 Choleraesuis 6,7:c:1,5 
Paratyphi C or 
Cholerasuis or 
Typhisuis* 




Paratyphi C or 
Cholerasuis or 
Typhisuis* 
7:c:1,5 Hissar 7:c:1,2 
18PM0045 Derby 4,(5),f,g,(1,2) Derby 4:f,g:- Derby 4:f,g:- 
18PM0045
B Derby 4,(5),f,g,(1,2) Derby 4:f,g:- Derby 4:f,g:- 
18PM0089 Rauform - Dublin 9:g,p:- Dublin 9:g,p:- 
18PM0092 Paratyphi B 4,5-,b,1,2 Paratyphi B 4:b:1,2 Paratyphi B 4:b:1,2 
18PM0109 Kottbus 







does not exist in 
the KWS 
8:e,h:- 




Continuation Table S1 
 Traditional analyisis (KWS) Analysis by SeqSero using reads 






















18PM0128 Dublin 1, 9, 12, g, p Dublin 9:g,p:- Dublin 9:g,p:- 
18PM0135 Kottbus 61,8,e,h,1,5 
Kottbus or 
Ferruch* 
8:e,h:1,5 Kottbus or 
Ferruch* 
8:e,h:1,5 
18PM0158 Anatum  - Anatum 3,10:e,h:1,6 Anatum 
3,10:e,h:1
,6 
18PM0174 Dublin 1, 9, 12, g, p Dublin 9:g,p:- Dublin 9:g,p:- 
18PM0195 Dublin 1, 9, 12, g, p Dublin 9:g,p:- Dublin 9:g,p:- 
18PM0246 Stourbridge 6, 8, b, 1, 6 Stourbridge 8:b:1,6 Stourbridge 8:b:1,6 
18PM0262 Dublin 1, 9, 12, g, p Dublin 9:g,p:- Dublin 9:g,p:- 
18PM0291 Panama 
1, 9, 12, l, v, 












does not exist in 
the KWS 
8:e,h:- 
  Traditional analyisis (KWS) Analysis by SeqSero2 using reads and allele microassembly 
workflow 






antigenic profile NOTES 
16PM0056 Bovismorbificans 6,8,20:r:1,5 Bovismorbificans 8:r:1,5 - 
16PM0089 Hadar 61,8,z10,e,n,x Hadar 8:z10:e,n,x - 
16PM0105 Gallinarum 1,9,12 
 Gallinarum or 
Enteritidis 
 9:g,m:- 
sdf gene not detected. The 
predicted serotypes share 





Continuation Table S1 
 Traditional analyisis (KWS) 
Analysis by SeqSero2 using reads and allele microassembly 
workflow 















I 4:b:-  4:b:- 
This predicted serotype is 
not in the Kauffman-White 
scheme. 




Mbandaka 7:z10:e,n,z15 - 
16PM0171 Livingstone 6,7,14:d:l,w Livingstone 7:d:l,w - 
16PM0176 Stourbridge 6,8:b:1,6 Stourbridge  8:b:1,6 - 




The predicted serotypes 




Anatum  3,10:e,h:1,6 - 
17PM0009 Enteritidis 1,9,12,g,m  I 4:g,m:1,2  4:g,m:1,2 
This predicted serotype is 
not in the Kauffman-White 
scheme. Co-existence of 
multiple serotypes detected, 
indicating potential inter-
serotype contamination. See 
'Extracted_antigen_alleles.fa




,n,z15 Tennessee  7:z29:- - 
17PM0051 Kentucky 8,20:i:z6 Kentucky  8:i:z6 - 
17PM0053 Agona 4,(5),f,g,s,(1,
2) 




 Muenster  3,10:e,h:1,5 
Co-existence of multiple 
serotypes detected, 
indicating potential inter-
serotype contamination. See 
'Extracted_antigen_alleles.fa






Continuation Table S1 
 Traditional analyisis (KWS) 
Analysis by SeqSero2 using reads and allele microassembly 
workflow 












 Meleagridis  3,10:e,h:l,w - 
17PM0271 Indiana 1,4,12:z:1,7 Indiana  4:z:1,7 - 
17PM0282 Typhimurium 4,5:i:1,2 Typhimurium  4:i:1,2 - 
17PM0296 
Typhimurium 
mono 4,5:i:1-,2-,  I 4:-:-  4:-:- 
H antigens were not 
detected. This is an atypical 
result that should be further 
investigated. Most 
Salmonella strains have at 
least fliC, encoding the Phase 





4,5-:i:1-,2-,  I 4,[5],12:i:-   4:i:- 
 Detected a deletion that 
causes O5- variant of 
Typhimurium. 
18PM0004 Dublin 1,9,12:g,p Dublin  9:g,p:- - 
18PM0007 Coeln 1,4,(5),y,1,2 Coeln   4:y:1,2 - 




4, 5, i, 1-, 2-, I 4,[5],12:i:-  4:i:- - 
18PM0026 Dublin 1, 9, 12, g, p Dublin 9:g,p:- - 
18PM0031 Choleraesuis 6,7:c:1,5 




The predicted serotypes 





















Continuation Table S1 
 Traditional analyisis (KWS) 
Analysis by SeqSero2 using reads and allele microassembly 
workflow 








18PM0089 Rauform - Dublin 9:g,p:- - 
18PM0092 Paratyphi B 4,5-,b,1,2 - -:-:- -:-:- 
The input genome cannot be 
identified as Salmonella. 





61, 8, e, h, 1, 
5 Kottbus 8:e,h:1,5 - 
18PM0111 Dublin 1, 9, 12, g, p Dublin 9:g,p:- - 
18PM0112 Typhimurium 4,5-,i,1,2 Typhimurium 4:i:1,2 
Detected a deletion that 
causes O5- variant of 
Typhimurium. 
18PM0128 Dublin 1, 9, 12, g, p Dublin 9:g,p:- - 
18PM0135 Kottbus 61,8,e,h,1,5 Kottbus 8:e,h:1,5 - 
18PM0158 Anatum   Anatum 3,10:e,h:1,6 - 
18PM0174 Dublin 1, 9, 12, g, p Dublin 9:g,p:- - 
18PM0195 Dublin 1, 9, 12, g, p Dublin 9:g,p:- - 
18PM0246 Stourbridge 6, 8, b, 1, 6 Stourbridge 8:b:1,6 - 
18PM0262 Dublin 1, 9, 12, g, p Dublin 9:g,p:- - 
18PM0291 Panama 
1, 9, 12, l, v, 
1, 5 
Brandenburg  4:l,v:e,n,z15 
Co-existence of multiple 
serotypes detected, 
indicating potential inter-
serotype contamination. See 
'Extracted_antigen_alleles.fa
sta' for detected serotype 
determinant alleles. 





Continuation Table S1 
  Traditional analyisis (KWS) 
Analysis by SeqSero2 using reads and k-mer-based 
workflow 






16PM0056 Bovismorbificans 6,8,20:r:1,5 Bovismorbificans 8:r:1,5 - 
16PM0089 Hadar 61,8,z10,e,n,x Hadar 8:z10:e,n,x - 




16PM0121 Panama 1,9,12,l,v,1,5 Goettingen 9:l,v:e,n,z15 - 
16PM0122 Abony 1,4,(5),12,27,b,e,n,x  I 4:b:- 4:b:- 
This predicted 
serotype is not in 
the Kauffman-
White scheme. 
16PM0124 III_diarizonae 61:k:1,5,7  IIIb 61:k:1,5,(7) 61:k:1,5,7 - 
16PM0161 Tennessee 6,7,14:z29:(1,2,7) Mbandaka 7:z10:e,n,z15 - 
16PM0171 Livingstone 6,7,14:d:l,w Livingstone 7:d:l,w - 
16PM0176 Stourbridge 6,8:b:1,6 Stourbridge 8:b:1,6 - 
16PM0256 Goldcoast 6,8:r:l,w 




serotypes share the 
same general 
formula: 8:r:l,w. 
16PM0296 Anatum 3,(10,15,34):e,h:1,6 Anatum 3,10:e,h:1,6 - 
17PM0009 Enteritidis 1,9,12,g,m  I 9:g,m:1,2 9:g,m:1,2 
This predicted 
serotype is not in 
the Kauffman-
White scheme. 
17PM0024 Mbandaka 6,7,14:z10:e,n,z15 Tennessee 7:z29:- - 
17PM0051 Kentucky 8,20:i:z6 Kentucky 8:i:z6 - 
17PM0053 Agona 4,(5),f,g,s,(1,2) Agona 4:f,g,s:- - 




Continuation Table S1 
  Traditional analyisis (KWS) 
Analysis by SeqSero2 using reads and k-mer-based 
workflow 







17PM0072 Rauform - Dublin 9:g,p:- - 
17PM0167 Meleagridis 3,(10,15,34):e,h:l,w Meleagridis 3,10:e,h:l,w - 
17PM0271 Indiana 1,4,12:z:1,7 Indiana 4:z:1,7   




4,5:i:1-,2-,  I 4:-:-  4:-:- 
H antigens were 
not detected. This 
is an atypical result 




have at least fliC, 
encoding the Phase 
1 H antigen, even if 




4,5-:i:1-,2-, I 4,[5],12:i:- 4:i:- 
 Detected a 
deletion that 
causes O5- variant 
of Typhimurium. 
18PM0004 Dublin 1,9,12:g,p Dublin 9:g,p:- - 
18PM0007 Coeln 1,4,(5),y,1,2 Coeln 4:y:1,2 - 




4, 5, i, 1-, 2-, I 4,[5],12:i:- 4:i:- - 
18PM0026 Dublin 1, 9, 12, g, p Dublin  9:g,p:- - 
18PM0031 Choleraesuis 6,7:c:1,5 





serotypes share the 
same general 
formula: 7:c:1,5. 
18PM0031B Choleraesuis 6,7:c:1,5 
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 Traditional analyisis (KWS) 
Analysis by SeqSero2 using reads and k-mer-based 
workflow 







18PM0045 Derby 4,(5),f,g,(1,2) Derby 4:f,g:- - 
18PM0045B Derby 4,(5),f,g,(1,2) Derby 4:f,g:- - 
18PM0089 Rauform - Dublin 9:g,p:- - 
18PM0092 Paratyphi B 4,5-,b,1,2 Paratyphi B 4:b:1,2 - 
18PM0109 Kottbus 61, 8, e, h, 1, 5 Kottbus 8:e,h:1,5 - 
18PM0111 Dublin 1, 9, 12, g, p Dublin  9:g,p:- - 
18PM0112 Typhimurium 4,5-,i,1,2 Typhimurium 4:i:1,2 - 
18PM0128 Dublin 1, 9, 12, g, p Dublin 9:g,p:- - 
18PM0135 Kottbus 61,8,e,h,1,5 Kottbus 8:e,h:1,5 - 
18PM0158 Anatum   Anatum 3,10:e,h:1,6 - 
18PM0174 Dublin 1, 9, 12, g, p Dublin 9:g,p:- - 
18PM0195 Dublin 1, 9, 12, g, p Dublin 9:g,p:- - 
18PM0246 Stourbridge 6, 8, b, 1, 6 Stourbridge 8:b:1,6 - 
18PM0262 Dublin 1, 9, 12, g, p Dublin 9:g,p:- - 
18PM0291 Panama 1, 9, 12, l, v, 1, 5 I 9:i:e,n,z15  9:i:e,n,z15 
This predicted 
serotype is not in 
the Kauffman-
White scheme. 
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  Traditional analyisis (KWS) 
Analysis by SeqSero2 using assemblies and k-mer-based 
workflow 






16PM0056 Bovismorbificans 6,8,20:r:1,5 Bovismorbificans 8:r:1,5 - 
16PM0089 Hadar 61,8,z10,e,n,x Hadar  8:z10:e,n,x - 
16PM0105 Gallinarum 1,9,12 
 Gallinarum or 
Enteritidis 
9:g,m:- 
sdf gene not 
detected. The 
predicted serotypes 
share the same 
general formula: 
9:g,m:-. 
16PM0121 Panama 1,9,12,l,v,1,5 Goettingen 9:l,v:e,n,z15 - 
16PM0122 Abony 1,4,(5),12,27,b,e,n,x - 4:-:-  4:-:- 
The input genome 
cannot be identified 
as Salmonella. 




16PM0124 III_diarizonae 61:k:1,5,7  IIIb 61:k:1,5,(7) 61:k:1,5,7 - 
16PM0161 Tennessee 6,7,14:z29:(1,2,7)  Mbandaka  7:z10:e,n,z15 - 
16PM0171 Livingstone 6,7,14:d:l,w Livingstone  7:d:l,w - 
16PM0176 Stourbridge 6,8:b:1,6 Stourbridge  8:b:1,6 - 
16PM0256 Goldcoast 6,8:r:l,w 




serotypes share the 
same general 
formula: 8:r:l,w. 
16PM0296 Anatum 3,(10,15,34):e,h:1,6 Anatum  3,10:e,h:1,6 - 
17PM0009 Enteritidis 1,9,12,g,m I 4:g,m:1,2  4:g,m:1,2 
This predicted 
serotype is not in 
the Kauffman-White 
scheme. 
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 Traditional analyisis (KWS) 
Analysis by SeqSero2 using assemblies and k-mer-
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17PM0051 Kentucky 8,20:i:z6 Kentucky  8:i:z6 - 
17PM0053 Agona 4,(5),f,g,s,(1,2) Agona  4:f,g,s:- - 
17PM0054 Muenster 3,(10,15,34),e,h,1,5 Muenster  3,10:e,h:1,5 - 
17PM0072 Rauform - Dublin 9:g,p:- - 
17PM0167 Meleagridis 3,(10,15,34):e,h:l,w  Meleagridis  3,10:e,h:l,w - 
17PM0271 Indiana 1,4,12:z:1,7  Indiana  4:z:1,7 - 
17PM0282 Typhimurium 4,5:i:1,2 I -:i:1,2 -:i:1,2 
O antigen was not 
detected. This 
result may be due 
to a rough strain 
that has deleted 
the rfb region. For 
raw reads input, 
the k-mer workflow 
is sometimes more 





should be used with 
this approach 
because the k-mer 
result may be due 





4,5:i:1-,2-,  - -:-:- -:-:- 
The input genome 
cannot be identified 
as Salmonella. 







4,5-:i:1-,2-,  I 4,[5],12:i:- 4:i:- 
Detected a deletion 
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 Traditional analyisis (KWS) 
Analysis by SeqSero2 using assemblies and k-mer-
based workflow 







18PM0004 Dublin 1,9,12:g,p Dublin  9:g,p:- - 
18PM0007 Coeln 1,4,(5),y,1,2 Coeln  4:y:1,2 - 




4, 5, i, 1-, 2-,  I 4,[5],12:i:- 4:i:- - 
18PM0026 Dublin 1, 9, 12, g, p Dublin 9:g,p:- - 
18PM0031 Choleraesuis 6,7:c:1,5 





serotypes share the 
same general 
formula: 7:c:1,5. 
18PM0031B Choleraesuis 6,7:c:1,5 





serotypes share the 
same general 
formula: 7:c:1,5. 
18PM0045 Derby 4,(5),f,g,(1,2) Derby  4:f,g:- - 
18PM0045B Derby 4,(5),f,g,(1,2) Derby 4:f,g:- - 
18PM0089 Rauform - Dublin 9:g,p:- - 
18PM0092 Paratyphi B 4,5-,b,1,2    - -:-:-   -:-:- 
The input genome 
cannot be identified 
as Salmonella. 




18PM0109 Kottbus 61, 8, e, h, 1, 5 Kottbus 8:e,h:1,5 - 
18PM0111 Dublin 1, 9, 12, g, p Dublin 9:g,p:- - 
18PM0112 Typhimurium 4,5-,i,1,2  Typhimurium 4:i:1,2 
Detected a deletion 
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 Traditional analyisis (KWS) 
Analysis by SeqSero2 using assemblies and k-mer-
based workflow 







18PM0128 Dublin 1, 9, 12, g, p Dublin  9:g,p:- - 
18PM0135 Kottbus 61,8,e,h,1,5 Kottbus 8:e,h:1,5 - 
18PM0158 Anatum   Anatum  3,10:e,h:1,6 - 
18PM0174 Dublin 1, 9, 12, g, p Dublin  9:g,p:- - 
18PM0195 Dublin 1, 9, 12, g, p Dublin  9:g,p:- - 
18PM0246 Stourbridge 6, 8, b, 1, 6 Stourbridge  8:b:1,6 - 
18PM0262 Dublin 1, 9, 12, g, p Dublin   9:g,p:- - 
18PM0291 Panama 1, 9, 12, l, v, 1, 5  I 9:i:e,n,z15  9:i:e,n,z15 
This predicted 
serotype is not in 
the Kauffman-
White scheme. 













Table S2. Performance (% of strains) of the genoserotyping tools used within WGSBAC 
 SISTR SeqSero SeqSero2 







Full match 27.9 79.1 79.1 60.5 58.1 67.4 72.1 67.4 
Incorrect 14.0 14.0 14.0 11.6 14.0 11.6 9.3 9.3 
Inconclusive 58.1 0.0 0.0 18.6 9.3 9.3 7.0 7.0 
Incongruent 0.0 7.0 7.0 4.7 4.6 4.7 4.7 4.7 
No result 0.0 0.0 0.0 4.7 14.0 7.0 7.0 11.6 
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